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Abstract
According to the American Cancer Society, approximately 1,479,000 new cases
of cancer were expected to be diagnosed, while 562,340 Americans were expected to die
from cancer in 2009 alone. Even though advances in early diagnosis and therapy over the
past few decades have led to continual decreases in incidence and mortality, cancer
remains the second leading cause of death among all Americans. Consequently, further
technological development in all areas of cancer detection and treatment are still of great
importance not only to the scientific community, but to society itself.
To address the shortcomings in current cancer diagnosis and treatment, a novel,
highly adaptable, targeted nanoparticle system based on alternating amphiphilic
copolymers has been developed having a variety of potential clinical applications. These
polymers consist of an alternating copolymer backbone composed of hydrophilic
polyethylene glycol-900 (PEG900) and dimethyl 5-hydroxyisophthalate (linker)
monomer units. The linker within the backbone polymer has a free hydroxyl group to
which a variety of sidechains can be attached, including hydrophobic groups to impart
amphiphilicity, targeting ligands, as well as contrast agents for imaging applications.
Three major areas of investigation were addressed to develop and evaluate the
performance of the proposed amphiphilic alternating copolymers: (1) backbone polymer
synthesis, (2) attachment of radioiodine, and (3) targeted delivery in vitro and in vivo.
The first step in the production of the alternating amphiphilic copolymers is a
chemo-enzymatic condensation polymerization of polyethylene glycol (PEG) and
dimethyl 5-hydroxyisophthalate (linker) to produce backbone polymer. Because of their
generally low equilibrium constants, condensation polymerizations require effective
removal of the condensation byproduct (in this case, methanol) in order to achieve
significant increases in molecular weight. The increased viscosities at higher molecular
weights not only increase the difficulty of byproduct removal, but may also affect the
mixing characteristics as well as the mass transfer of other species in the reaction.
The enzymatic polymerization was investigated using both predictive modeling
and experiment. The ultimate goal was to increase the molecular weight of the
synthesized polymer to allow for increased substitution of the polymer backbone. Key
experimental variables were tested in glass flasks typically used in organic synthesis. In
these reactions, 4A molecular sieves had the greatest affect on the backbone polymer
molecular weight. In particular, addition of sieves, which can act as sinks for both water
and methanol, led to a twofold increase in weight-average molecular weight above that
observed previously for the enzymatic polymerization. The Protherm, a novel, thin-film
reactor was employed in order to improve methanol mass transfer and mixing within the
polymer melt. Three separate reactions in the Protherm produced the highest Mw
backbone polymer (approximately 20 kDa). A blade speed of 500 rpm with molecular
sieves present was able to achieve this Mw in 48 hr.
Two separate models were proposed to describe the polymerization, including a
homogeneous kinetic model and a Fick's Law mass transfer model. Significant
differences were observed between the experimental results and the predictions of the
homogeneous model. The mass transfer modeling, which estimated the increase in
reactant and methanol surface concentration relative to the concentration in the bulk, was
unable to bridge the gap between experiment and model results. Limited knowledge of
key model parameters, including the equilibrium constant and methanol solubility, was
one proposed explanation for the observed discrepancy.
In order to assess the performance of a nanoparticle delivery system in biological
applications, a label that is detectable under a wide range of conditions and
concentrations must be present within the molecule. Radioiodine was selected because of
its multiple potential applications depending on the selected isotope, including 124I for
positron emission tomography, 131I for radiotherapy, and 125I for inexpensive, quantitative
research applications.
A standard protein-labeling technique was adapted for application to the
copolymers in this work. The successful adaptation of this procedure for use with our
polymers represented the first demonstration in the field of a nanoparticle-forming
polymer that was directly labeled with radioiodine without any additional chemical-
alterations or intermediate reactions. The process was characterized using a variety of
chromatographic techniques and radiometric measurements to confirmed covalent, stable
attachment of iodine in a product with high radiochemical purity.
The alternating amphiphilic copolymers were combined with an engineered
peptide having an extremely high binding affinity for the epidermal growth factor
receptor (EGFR), a biomarker prevalent in a variety of human cancers. This high-affinity
binder, the E13.4.3 peptide, was developed by collaborator Dr. Benjamin Hackel under
the guidance of Professor K. Dane Wittrup. A number of polymer design variables were
considered, including the targeting ligand density, identity of the hydrophobic sidechain,
polymer molecular weight, and length of the spacer connecting the peptide to the
backbone. The ligand density and hydrophobic sidechain identity were chosen for study.
Initial studies demonstrated selective uptake of E13.4.3-conjugated polymers into
a target-bearing, EGFR-positive human cancer cell line relative to untargeted controls.
Preparative gel permeation chromatography (GPC) was used to create high molecular
weight, low polydispersity fractions of backbone polymer. Polymers synthesized from
these fractions achieved the greatest increase in selective uptake in vitro with a four- to
sixfold increase in uptake for E13.4.3-conjugated polymers relative to untargeted
controls. Animal studies measured the biodistribution, blood circulation, and tumoral
accumulation of various polymer formulations. Statistically significant selective tumor
accumulation was observed for two different targeted polymers, each having different
targeting ligand density and different hydrophobic sidechains.
The E13.4.3-polymers have proven a rich platform for study. Their demonstrated
ability to selectively accumulate in targeted tumors combined with their potential use in
diagnostic and/or therapeutic clinical applications makes them an attractive option for
intensified investigation.
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1. Introduction
1.1 Cancer
According to data compiled by the American Cancer Society available publicly
on their website, approximately 1,479,000 new cases of cancer were expected to be
diagnosed while 562,340 Americans were expected to die from cancer in 2009 alone.
The lifetime probability of developing cancer is 43.9% for men and 37.4% for women.
Even though advances in early diagnosis and therapy over the past few decades have led
to continual decreases in cancer incidence and mortality, cancer remains the second
leading cause of death among all Americans trailing only heart disease [1]. It is therefore
apparent that further technological development in all areas of cancer detection and
treatment are still of great importance not only to the scientific community, but to society
itself.
In the field of cancer imaging, moderate progress has been achieved in increasing
the speed and resolution of computed tomography (CT) and magnetic resonance (MR)
imaging. The primary shortcoming of these 'traditional' imaging methods is their
inability to detect tumors smaller than 2 mm in width (containing fewer than 500,000
cells). A significant consequence of this detection limit is the resulting underdiagnosis of
metastatic disease, [2] which is significant because occurrence of metastases drastically
reduce patient survival rates. Finally, the response to therapeutic treatment is also
unsatisfactorily monitored by current imaging techniques. To most effectively overcome
these shortcomings, the ability of a tumor to differentially scatter, absorb, or emit
radiation must be maximized using new imaging techniques, novel imaging agents, or a
combination of both.
In the area of cancer treatment, advances in chemotherapy and
radioimmunotherapy, in conjunction with the progress in cancer diagnosis, have led to a
decrease in cancer incidence and mortality rates. However, the in vitro potency of
therapeutics rarely translates directly when administered to patients. A successful
therapeutic must not only be effective in the solid tumor microenvironment, but must also
reach the target in sufficient quantities and with minimal toxicity to normal tissues [3, 4].
Although it would be ideal to build pharmacological features such as solubility, stability,
permeability, and targeting into the bioactive agent itself, it is more reasonable to build
such features into a delivery system that enhances the drug function [5].
1.2 A novel amphiphilic alternating copolymer
The group of Arthur Watterson at the University of Massachusetts Lowell has
developed an alternating amphiphilic chemo-enzymatically synthesized copolymer that
forms micelles with a highly adaptable chemistry with potential application as a carrier of
imaging agents or therapeutics [6]. These micelles, which have been observed to have
hydrodynamic diameters between 10-100 nm, will be referred to as nanoparticles.
The alternating amphiphilic copolymers are produced by a well-developed
synthetic scheme (FIGURE 1. 1A). A trifunctional diester linker molecule (shown
schematically in purple) is copolymerized with the hydrophilic diol, poly(ethylene
glycol) (PEG, in green), in an enzymatically catalyzed condensation reaction to form a
polyester designated the 'backbone polymer.' A hydrophobic sidechain is then attached
to the backbone via the remaining functional group on the linker molecule. Under the
proper aqueous conditions, the resulting alternating amphiphilic polymer chains
spontaneously self-assemble to form nano-sized micelles, or nanoparticles. The organic
chemistry of the required reaction scheme is described in the second chapter: Synthesis.
A B
Figure 1.1. Schematic diagram of the (A) chemo-enzymatic synthesis of the amphiphilic alternating
copolymers, and (B) the resulting nanoparticles modified for targeted delivery applications.
To address the challenges in cancer diagnosis and therapy outlined above,
additional synthetic methods have been developed at UML and at MIT to incorporate
contrast and therapeutic agents, as well as targeting moieties, into the nanoparticles via
either direct chemical conjugation or encapsulation. Examples of these modifications are
shown schematically in FIGURE 1. 1B. Targeting ligands (red triangles) can be attached
to the polymer via hydrophilic PEG spacer groups (green). These ligands are attached to
direct the nanoparticles to target-bearing cells, in vitro and, ultimately, in vivo. Selection
of agents for active targeting of human cancer cell lines is discussed in the subsequent
section.
Contrast agents for enhanced imaging techniques have also been attached directly
to or encapsulated by the nanoparticles. Examples of these applications include the
attachment and encapsulation of perfluorocarbon chains that are responsive in 19F
magnetic resonance imaging applications. Interestingly, the perfluorocarbon chains
attached as sidechains contribute to the final application not only as a potential contrast
agent, but as the hydrophobic sidechain required to impart the amphiphilicity required in
the final polymer for spontaneous self-assembly. The study of perfluorinated polymers
was a significant portion of a previous thesis in the Colton lab completed by Dr. Jin Zhou
Dawson [7].
The alternating amphiphilic copolymers have also been used to encapsulated
chemotherapeutic and therapeutic agents, such as doxorubicin, paclitaxel [8], and aspirin
[9]. This application is shown schematically in FIGURE 1. 1A by the blue circles.
Encapsulation of chemotherapeutics is an attractive application for our polymer system
and others like for two reasons: (1) chemotherapeutics typically have large, hydrophobic
structures that make them poorly soluble in water or the bloodstream and (2) the
hydrophobic interior of polymeric micelle nanoparticles contains a microenvironment in
which chemotherapeutics have significant solubility. Encapsulation of chemotherapeutic
agents can also increase the stability of the micelle, which may also be a desirable
advantage. Previous work in the Colton lab by Dr. Michelle Miller investigated our
polymer system for its potential use in targeted therapeutic applications [8].
The flexibility of the chemical structure used to create the nanoparticles described
above provided even more options beyond those studied in the theses of Drs. Dawson and
Miller. For this work, attachment of radiolabels, specifically radioisotopes of iodine, was
chosen as the focus. The unique chemical structure of the polymer system allowed for
direct attachment of radioiodine using methods originally developed for radiolabeling of
small proteins and antibodies. Radioiodine was also an attractive option due to its use in a
wide array of clinical application depending on the selected isotope. For example, 124I is a
positron emitting isotope that can be used in positron emission tomography (PET), 1251
and 1231 are gamma emitting isotope used in single photon emission computed
tomography (SPECT) and nuclear scintigraphy, while 1311 is a strong gamma emitting
isotope used commonly in clinical radioimmunotherapy. For the purposes of this
research, 125I was chosen as the primary isotope due to its comparatively low cost and
ease of detection using standard gamma counting techniques.
In addition to those previously described, synthetic schemes have also been
developed to attach fluorescent dyes, including Cy5.5 and FITC for near infrared
fluorescence (NIRF) and optical imaging applications, respectively.
1.3 Tumor Targeting by Passive and Active Mechanisms
Targeting is required to increase the delivery of an intended agent to a tumor in
vivo. An effective targeting technique will be highly specific for the targeted tumor in
order to minimize the accumulation in untargeted, normal tissues in the body. By
minimizing non-specific accumulation, the toxic side-effects of chemo- and
radiotherapeutic agents can be significantly reduced while the efficacy of the
administered dose is maintained by effective targeting.
Tumor targeting can be achieved through two distinct mechanisms in cancer
applications: (1) passive or (2) active. These two mechanisms are not necessarily
mutually exclusive and can therefore both be exploited for maximum targeting efficiency.
In passive tumor targeting, macromolecules take advantage of the "leaky vasculature"
commonly observed in tumors in vivo. This increased passive uptake by tumors, which
was originally described by Maeda, is known as the enhance permeability and retention
(EPR) effect [10-12]. According to the EPR effect theory, tumors grow so rapidly that
they are unable to develop fully functional vascularization or effective lymphatic
drainage systems. These vascular and lymphatic defects allow macromolecular particles,
typically between 5 and 200 nm in hydrodynamic diameter [13-16], to preferentially
accumulate in tumors by completely passive, mass transfer-related mechanisms.
Tumor targeting can also be achieved through active mechanisms, specifically the
through targeting of a receptor present on the cell surface of a cancerous cell in a tumor.
This targeting is achieved by attaching a targeting ligand to a circulating delivery system,
such as a nanoparticle, that has a high affinity and specificity to the targeted cell surface
receptor. There is a wide array of targeting pairs under investigation in the literature. The
most common of these is folate used to target the folate receptor [17-21]. Other targeting
pairs include epidermal growth factor (EGF) and the epidermal growth factor receptor
(EGFR) [22], anti-carcinoembryonic antigen (CEA) antibody and CEA [23], and
telomerase inhibitor and telomerase [24].
For this research, the epidermal growth factor receptor (EGFR), the
overexpression of which is associated with reduced survival in 70% in a variety of human
carcinomas [25], was chosen as the target antigen due to the availability of an extremely
high affinity (low dissociation constant) targeting ligand by means of a collaboration with
a colleague in the Department of Chemical Engineering at MIT, Dr. Benjamin Hackel.
The pertinent details for the high affinity binder, which was given the designation E13.4.3
by its inventor, are presented in the introduction to Chapter 5.
1.4 Summary of the Research
The overall goal of this project was the development and biological evaluation of
a novel, highly adaptable, targeted nanoparticle system for potential imaging and
radioimmunotherapeutic applications in the diagnosis and treatment of cancer. The three
major areas of investigation were (1) nanoparticle synthesis, (2) radiolabeling with
isotopes of iodine, and (3) biological evaluation both in vitro and in vivo.
The nanoparticle synthesis involved the investigation and development of a
chemo-enzymatic polymerization reaction to produce significant quantities of high
molecular weight backbone polymer for use as the starting material in the synthesis of the
targeted alternating amphiphilic copolymers. To accomplish this, the polymerization was
studied as it was originally developed - in flasks. These initial studies, together with
theoretical kinetic and mass transfer modeling, were used to develop improvements to the
polymerization. These improvements included both improved reaction conditions and
reactor configurations aimed at reducing mass transfer limitations. A novel, continuous
thin-film evaporator prototype developed by our industrial collaborators at Artisan
Industries (Waltham, MA) was adapted for use as a thin-film batch reactor. These
advances in backbone polymer molecular weight sought to improve the biological
performance of the resulting targeted nanoparticles.
The area of polymer radiolabeling focused on the adaptation and implementation
of a procedure commonly used to radioiodinate proteins for use with our polymer system.
Successful radiolabeling with radioiodine provided two important benefits. In the near
term, labeling with iodine-125 enabled quantitative analysis of the performance of the
labeled polymers in in vitro and in vivo experimentation. In the long term, this developed
method could be used with different isotopes of iodine for a variety of imaging and
therapeutic applications in either research or clinical settings. A number of
characterization tests were performed to validate the successful adaptation of the
iodination method, including measurements of the structure and stability of the labeled
polymer. Additional studies sought to determine the reaction and purification conditions
required to maximize reaction yield and product recovery while minimizing
radiochemical impurities.
Finally, the biological characterization investigated the nanoparticles in in vitro
cellular uptake studies to determine whether the presence of the targeting ligand could
increase uptake relative to that measured for untargeted control polymers. Any increase
in uptake due to targeting would represent selectivity for the targeted antigen on the cell
surface. The nanoparticles tested in vitro would also be tested in in vivo biodistribution
and blood circulation studies to determine their tumor targeting efficacy. These biological
studies were also supported by particle size distribution measurements by dynamic light
scattering.
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2. Chemical Synthesis of Amphiphilic Alternating Copolymers
2.1 Polymer Synthetic Scheme
A number of synthetic schemes have been investigated to produce amphiphilic
alternating copolymers conjugated to a variety of sidegroups, including hydrophobic
chains, hydrophilic (PEG) chains, targeting peptides, fluorescent dyes, and other organic
molecules [1-6]. The majority of this work has been performed, under the guidance of
Professor Arthur C. Watterson (UMass-Lowell), by Rajesh Kumar, Rahul Tyagi, Mukesh
Pandey, Vijayendra Kumar, and Bhavna Gupta, in collaboration with Clark Colton et al.
The different reactants, intermediates, and reaction conditions were studied for their
effect on yield, purity, cross-linking, polymer aggregation, and cytotoxicity. Based on
these studies and the specific requirements of the proposed work, the following synthetic
scheme has been developed, characterized, and implemented to supply the radiochemical,
physico-chemical, in vitro and in vivo experiments described in subsequent chapters.
The first step in the synthesis is the chemo-enzymatic polymerization reaction to
form the alternating copolymer designated as 'backbone polymer.' The chemical
structure for this step is presented in FIGURE 2.1.
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Figure 2.1. Enzymatically catalyzed polymerization to synthesize the alternating copolymer
backbone.
In this reaction, dimethyl 5-hydroxyisophthalate, which will be referred to as the
linker, reacts with PEG (MW = 900 or 1000 Da) to produce the alternating copolymer
backbone and the methanol byproduct. This reaction is catalyzed by Novozym435, a
lipase derived from Candida antarctica immobilized on an acrylic resin, and is typically
performed under bulk, solvent-free conditions. The backbone polymer product contains
free aromatic hydroxyl groups available for reaction to attach the various sidechains
listed above. Before any further attachments occur, activation reactions are performed to
prepare the intended sidechains, including the PEG spacer as well as the hydrocarbon and
perfluorocarbon hydrophobic chains, for reaction with the linker hydroxyls (FIGURE
2.2).
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Figure 2.2. Intended sidechains are activated through reaction with bromoacetyl bromide.
All three sidechains are reacted with bromoacetyl bromide to produce the
activated form of the sidechain that is terminated with the bromoester. Activation in this
manner provides a strong leaving group that is highly reactive with the linker hydroxyls.
Although a PEG of unspecified length is represented in the scheme, this reaction has been
successfully performed with PEG 900, 1500, and 3400, along with triethylene glycol
(TEG). All three unactivated sidechains are commercially available; however, the
bifunctional high MW PEG molecules are a specialty chemical available from Lysan Bio
(Arab, AL). The bifunctional PEG, with its carboxylate and hydroxyl endgroups can be
used to synthesize PEGs with a single activated site. Use of the bifunctional PEG
therefore mitigates potential cross-linking that would occur for a dually activated PEG
diol.
The activated PEG (or TEG) spacer molecule is attached to the backbone polymer
according to the scheme depicted in FIGURE 2.3. Because of the high reactivity of the
bromoester, the reaction between the activated PEG and backbone polymer goes to
completion. Consequently, the percent substitution of the PEG spacer, X, could be varied
by adjusting the amount of activated PEG added to the reaction. The reaction is
performed in acetonitrile in the presence of the base, potassium carbonate, at room
temperature (RT).
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Figure 2.3. Attachment of the activated PEG spacer to the backbone polymer via the linker hydroxyl.
The activated spacer is added according to the desired percent substitution, X.
The hydrophobic sidechains are added by the same reaction, including the same
reaction conditions, as that for the PEG spacer (FIGURE 2.4). Either hydrocarbon or
perfluorocarbon chains can be attached by this method.
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Figure 2.4. Attachment of the activated hydrophobic sidechain, either hydrocarbon or
perfluorocarbon, to the backbone polymer via the remaining linker hydroxyls.
If the targeting peptide is to be attached, the terminal hydroxyl on the PEG spacer
is activated using N-hydroxysuccinimide (NHS) in the presence of
dicyclohexylcarbodiimide (DCC) in acetonitrile at room temperature. This reaction
(FIGURE 2.5) produces an activated NHS-ester that reacts readily with amino groups,
such as the lysine residues or N-terminal amines present in proteins. The acetonitrile is
allowed to evaporate in a fume hood and the polymer is resuspended in a phosphate
buffered saline (PBS) solution containing the E13.4.3 peptide. The peptide is added
stoichiometrically with respect to the activated ester groups on the PEG spacer. The
product of this reaction is dialyzed for 24 hr using a dialysis bag with a MWCO of 10
kDa (MEI3.4.3 =12.5 kDa). The final result is an amphiphilic alternating copolymer
conjugated to the E13.4.3 targeting peptide.
~ 0I ?0K 0 , C ..... E 0 3 4 3 p ptid
d--OtPBS pH 7 2RI
x$0 I'100-X bx O-
17O O
x 0 0 0
0.. DCC, RT
0 0
R
REPE 3400
0 OH0
o0.
EE334.3 peptide
PBS, pH 7T2
"4;- X .1e100AX
0 /0
PEG3400I
0'
E13-4-3 peptide
Figure 2.5. Activation of the terminal PEG carboxylate to an NHS-ester and subsequent reaction
with E13.4.3 peptide to produce the targeted amphiphilic alternating copolymer.
Product characterization was performed primarily by nuclear magnetic resonance
(NMR) spectroscopy. The synthesis of model compounds was performed as necessary to
simplify the spectra in order to more easily identify the peaks and peak shifts that are
representative of the anticipated reaction. For example, an arginine-glycine-aspartic acid
(RGD) tripeptide was used as a surrogate for the much more complicated E13.4.3 peptide.
Although thorough analysis and characterization of the synthesized polymers were
integral to the successful execution of the research, it is beyond the scope and intent of
this document to faithfully reproduce our collaborator's synthetic chemical analyses.
2.2 Peptide Production
The E13.4.3 peptide is produced by standard bacterial fermentation procedures [7]
using Escherichia coli as the recombinant host cell. Briefly, Rosetta(DE3) cells (EMD
Chemicals, Gibbstown, NJ) are transformed by heat shock in order to insert the
appropriate E13.4.3-expressing, kanamycin-resistant plasmid. A starter colony is grown
on a yeast extract peptone (YEPD) plate in the presence of kanamycin. A large culture is
induced from the starter colony and isopropyl p-D-1-thiogalactopyranoside (ITPG) is
added to stimulate transcription. This culture is incubated in a shake flask until reaching
an optical density of approximately 1.
At this point, cells are centrifuged, separated from supernatant, and lysed with
lysis buffer (50 mM phosphates, pH 8.0, 0.5M NaCl, 5% glycerol, 5 mM CHAPS, 25
mM imidazole). The lysed cells are filtered and subsequently purified using TALON
metal-affinity chromatographic resin according to the manufacturer's protocol. The
TALON resin is designed to selectively bind the six-histidine tag engineered into the N-
terminus of the E13.4.3 peptide. Multiple small-scale (1 L shake flask) peptide production
and purifications were kindly performed by Dr. Benjamin Hackel.
To supply the expanded in vitro and in vivo studies with E13.4.3-conjugated
polymer, large-scale peptide production was implemented in a 5 L bioreactor by
Professor Carl Lawton at UMass-Lowell. The protocol for these productions was
identical to that described for the small-scale with two exceptions. The expanded culture
from a 1 L shake flask was transferred into the 5 L bioreactor and diluted with fresh
media. As before, the cells were lysed upon achieving an optical density of
approximately one. The large-volume cell lysis was performed using a microfluidizer
(Microfluidics Corp., Newton, MA).
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Reaction Engineering of an Enzymatically Catalyzed
Condensation Polymerization'
3.1 Background
3.1.1 Enzymatic polymerization
Recent investigation has demonstrated the utility of employing enzymes to
perform traditional chemical polymerizations in a more efficient and selective manner [1,
2]. In particular, Candida antarctica Lipase B immobilized on acrylic resin beads, which
was developed and is marketed as Novozyme-435 by Novozymes A/S (Copenhagen,
Denmark), overcomes a number of problems traditionally encountered in polyester
chemistry. The high enantio- and regiospecificity of the enzyme in the condensation
reaction of diacids/diesters with diols to form polyesters is desirable since protection and
deprotection steps may be avoided while attaining a high molecular weight linear
polymerization product with very little branching. These benefits are even more
pronounced as the size and complexity of selected monomers increases. Because of the
solubility of many diacids and diesters in diols, condensation polymerizations have often
been performed in solvent-free, bulk conditions. Lipase immobilization maintains the
enzymatic activity across a broad range of temperatures, up to at least 90'C and solvents,
including polymer melts [3]. The polymerization, therefore, is an example of a 'green
chemistry' [4].
Novozyme-435 has been used in various polyesterifications, including the
polymerization of adipic acid and butane-1,4-diol to form a polyester (FIGURE 1). Use
of the immobilized enzyme allows for mild reaction conditions, 40-60 "C, compared to
Major portions of the work presented in this chapter were completed during 10.26 projects sponsored by
the author in 2007 and 2009. Team members included Nathalie Pinkerton, Julie Shi, Drew Cameron, Greg
Johnson, Anisa McCree, and Jose Sepulveda, as well as faculty advisor, William Dalzell.
those used in typical industrial production processes, >150 *C, while still achieving
comparably high molecular weights [5] (FIGURE 3.1). In both cases, strong vacuum
must be applied to remove the condensation byproduct.
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Figure 3.1. Examples of bulk polyesterification of a diester with diol using Novozyme-435 under mild
reaction conditions, where R = H [61, -CH=CH 2 [5].
A critical factor in achieving a high molecular weight product is the removal of
the condensation byproduct, ROH, such as water or methanol, or in the case of the work
of Chaudhary [5], the tautomerization of the vinyl alcohol byproduct to form
acetaldehyde (CH3CHO). Continual removal of the condensation byproduct shifts the
equilibrium towards the polymer product.
The mechanism for the polymerization by Novozyme-435 has been investigated
by Binns et. al. by performing GPC analysis of the oligomers present during the reaction
using synthesized low molecular weight intermediates for comparison [6]. In the
proposed mechanism (FIGURE 3.2), the enzyme forms an active complex by acylating
the diacid (or diester), A, forming A-Enz. This activated complex then reacts with the
diol, B, to form the single polymer repeat unit, AB. The step is repeated for each
subsequent chain extension, which leads to the eventual formation of the B(AB)n
oligomer presented in FIGURE 1. In the acylation step, the enzyme attaches itself to the
oligomer via a 'pseudo-ester bond' forming a highly reactive intermediate where the
enzyme itself is the leaving group in the subsequent reaction. This step-wise mechanism
was also reported by Okumura during investigation of polyesterification using
Aspergillus niger lipase [7].
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Figure 3.2. Chemical structural representation of the proposed mechanism for lipase-catalyzed
polyesterifications. The reaction of adipic acid (A) with butane-1,4-diol to form a single polymer
repeat unit is presented as an example.
A reaction scheme has been developed by Watterson and colleagues [4, 8-10] that
utilizes Novozyme-435 to synthesize a novel alternating copolymer (FIGURE 3.3).
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Figure 3.3. Enzymatic condensation using Novozyme-435 of a diester and diol to form a polyester.
For this reaction, dimethyl 5-hydroxyisophthalate (A) participates as the diester
while poly(ethylene glycol-900) (B) is the diol. The product is the polyester
poly[poly(oxyethylene-900)-oxy-5-hydroxyisophthaloyl] ((AB)m) The condensation
byproduct, methanol, is removed from the reacting mixture by vacuum applied to the
vapor phase. The condensation product, 3, is henceforth referred to as the 'backbone
polymer.' Application of a suitably low vacuum removing the methanol is necessary to
shift the equilibrium towards the polymer product since the reaction energetics alone are
not favorable enough to achieve sufficiently high molecular weights. In fact, the
equilibrium constant for transesterifications is in the range of 0.1-1 (while that for
polyesterifications is 1-10 and polyamidations 100-1000) [11]. Therefore, all polymer
chain extension is driven by the removal of the transesterification byproduct, either
methanol or water.
The backbone polymer is a precursor in the synthesis of polymers intended for
targeted delivery applications in cancer. As originally developed (FIGURE 3.3) by our
collaborator, Dr. Arthur Watterson, the polymerization was performed at low pressure (<
1 mm Hg) using either magnetic or mechanical stirring. Reactions performed at these
conditions, as well as in similar set-ups constructed at MIT, produced low molecular
weight product having typically < 4 repeat units (Mj = 3 kDa, Mw = 5 kDa) with little or
no progression in molecular weight observed after 48 hours, which suggested that steady-
state had been reached. Moreover, the key variables affecting the backbone
polymerization were poorly understood. Therefore, an experimental and theoretical
reaction engineering study was performed to identify and determine the relative
contribution of these key variables in the synthesis of the backbone polymer.
It was also proposed that increasing molecular weight would improve the
biological performance of the polymer by potentially increasing particle size as well as
the number of targeting ligands that could be linked to a single polymer chain.
3.1.2 Reactor designfor mass transfer limited processes
The first reaction configuration employed a round-bottom flask with a magnetic
stirring bar for mixing. The schematic diagram in FIGURE 3.4 represents a typical
progression of the polymerization reaction as originally developed.
stirred stagnant
" ," " bead viscosity
Figure 3.4. Typical progression of polymerization reaction in round-bottom flasks with magnetic
stirring. Reaction mixture is well-stirred initially, but as the reaction proceeds and higher MW is
achieved, the corresponding increase in viscosity leads to a cessation in stirring and stagnation of the
melt.
Initially, the reaction is well-stirred by the magnetic stirring bar and the catalyst
beads are dispersed throughout the melt. As the reaction proceeds and molecular weight
increases, the viscosity of the melt increases such that the stirring bar becomes decoupled
from the magnetic drive. Soon after, the reaction mixture is stagnant and unmixed and the
catalyst beads settle to the flask bottom by gravity. A stagnant polymer melt is
undesirable, not only for promoting efficient methanol removal, but for increasing the
collision frequency of individual reactants and the enzyme. FIGURE 3.5 presents a
qualitative representation of the various mass transfer limitations that may play a role in
the process, both in the stirred and stagnant cases.
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Figure 3.5. Qualitative representation of the condensation profiles describing the potential mass
transfer limitations in the backbone condensation polymerization. The diagram on the left represents
a well-mixed reaction mixture in the bulk with a mass transfer boundary layer around each bead
through which reactants and products, including methanol, diffuse. The diagram on the right
represents a stagnant reaction mixture in which diffusion of reactants and products occurs
throughout the stagnant layer between the catalyst beads and the vapor-liquid interface.
In the single-bead case, the primary mass transfer limitation is the movement of
reactants and products to and from the catalyst surface across the mass transfer boundary
layer around the bead. The methanol and reactant concentrations are constant throughout
the homogeneous melt. In the stagnant case, the mass transfer of both reactants and
methanol is limited primarily by rates of diffusion from the settled catalyst beads to the
vapor-liquid interface, which results in the linear concentration profiles within the melt.
In both cases, the removal of methanol from the reaction mixture into the evacuated
headspace occurs at the vapor-liquid interface, where the methanol concentration in the
reaction melt is related to its partial pressure in the vapor by an equilibrium partition
coefficient.
The problem of achieving high molecular weight polymers by sequential
condensation reactions is not a new one. Industrial production of nylon 6,6, a polyamide,
combining adipic acid and hexane-1,6-diamine (FIGURE 3.6), requires special reactor
design to achieve high molecular weights. For example, molecular weights of 10 kDa can
be readily achieved in a CSTR [12, 13]. However, the diffusivity of water, the
condensation byproduct for nylon 6,6, is significantly lowered at molecular weights
exceeding 10 kDa due to the high viscosity of the polymer melt. As a result, diffusion of
water to the vapor-liquid interface is extremely slow such that the byproduct can no
longer be removed to shift the equilibrium towards the condensation product [14].
Considering the observations previously described (FIGURE 3.4), it was hypothesized
that the low molecular weights achieved in the first setup were due to mass transfer
limitations similar to those observed industrially for similar reactions.
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Figure 3.6. Chemical structure representation the polymerization reaction to produce nylon 6,6, the
most common industrial polyamide.
A number of 'thin film' reactor designs have been employed to address the issue
of poor byproduct mass transfer. These reactors fall into several categories, including
wiped film and falling film reactors [15], representations for which are shown in
FIGURE 3.7. In the wiped film reactor shown in FIGURE 3.7A, the reacting polymer is
deposited along the edges of a tubular reactor by rotating blades [14]. The blades, which
are pitched to move the polymer melt through the continuous reactor (direction of motion
into the page), continually remove and deposit the polymer film repeatedly exposing the
surface to high vacuum (shown in white). In FIGURE 3.7B, a cylinder rotating in the
polymer bulk creates a thin polymer film that is exposed to high vacuum. The bulk
polymer mixture moves through the reactor (into the page) [16], while the effectiveness
of this design depends heavily on minimizing the bulk volume through the introduction
of a large diameter cylinder. In FIGURE 3.7C, a polymer film falls along a heated
corrugated wall allowing for vacuum removal of the byproduct. The film thickness is
determined primarily by the polymer inlet flow rate and the nature of the interactions
between the polymer and the wall.
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Figure 3.7. Schematic diagrams of different 'thin film' reactors. a.) and b.) Wiped-film reactors [14,
16]. c.) Corrugated falling film reactor.
These designs attempt to maximize the ratio of surface area-to-volume for the
polymer reaction mixture. By maximizing this ratio, the area over which byproduct is
transferred from the bulk is greatly increased while the byproduct diffusion length is
reduced. Continuing the example from above, the 10,000 Da nylon 6,6 polymer produced
in a CSTR is oftentimes transferred to a thin film reactor as a 'finishing stage' where
molecular weights up to 20,000 Da can be achieved. It would not be possible to achieve a
polymer of this molecular weight without using one of these specially designed reactors
[14].
The Protherm reactor (shown schematically in FIGURE 8), which is an example
of a thin-film evaporator, was manufactured by our industrial collaborator, Artisan
Industries (Waltham, MA). The manner in which the Protherm was employed in
experimentation is described in the Methods. The device is a scaled-down prototype of
larger equipment, marketed under the brand name RotothermTM, developed for
continuous processing of liquids. In the Protherm, liquid is spread into a thin-film by
rotating blades having a 1.5 mm clearance between the blade tips and cylinder wall. If
desired, vacuum can be applied to increase the stripping of undesired species within the
thin-film, such as the methanol reaction byproduct. The rotor speed and wall temperature
are controlled by external controllers.
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Figure 3.8. (A) Side view: Operation of the Protherm, as originally designed, in a continuous process
with an inlet at the top right and an outlet toward the bottom left. In this research, the Protherm was
modified to operate in batch mode (see FIGURE XX.X). (B) Front view: The Protherm blades rotate
counter-clockwise to produce fillets on the advancing edge. Fluid flow within the fillets occurs in the
clockwise direction.
The blade rotation in the Protherm, which creates the thin film, also creates a
secondary fluid element that has been observed previously in similar processes [ 17]. This
so-called fillet, which is a buildup of fluid in front of the rotating blade, occurs once
thresholds for fluid viscosity and blade rotational speed are met [ 17]. Theory and
experiment have shown that significant mixing may occur within fillets due to the
rotational motion of fluids with the fillet [17, 18]. Transfer of fluid between the thin film
and rotating fillet due to hydraulic jump may further promote mixing, particularly at
lower viscosities [18]. The intermixing between the film and fillet becomes less
prominent at higher viscosities where hydraulic jump is likely no longer encountered.
The improved mass transfer and mixing characteristics in the Protherm when compared
to round-bottom flasks make the Protherm a potentially powerful tool in the effort to
increase the extent of reaction for the polymerization and, consequently increase the
backbone polymer molecular weight.
Although previous studies have focused on the fillet as the primary location for
mixing in a horizontal thin film reactor, mixing may also occur due to other instabilities
in the thin film. In particular, the repeated formation and destruction of Pearson
instabilities [19], ridges that form when a high viscosity fluid passes through a small gap
while being spread into a thin film, was also considered as another possible source of
mixing.
Researchers have also proposed theoretical models that represent the reaction
kinetics and transport phenomena present in these thin film reactors [14-16, 20]. The
theoretical models generally yield two key dimensionless groups, the Damk6hler number
of the first kind (Da 1), which represents the ratio of characteristic residence and reaction
times, and the Damkihler number of the second kind (Da II), which represents the ratio
of characteristic reaction and diffusion times. The models rely heavily on system-
specific, temperature-dependent parameters including rate and equilibrium constants.
These parameters were determined, with significant effort, for the widely studied nylon
6,6 polymerization. Because no such library of data exists for the backbone
polymerization in this study, system-specific parameters were either measured or
assumed and subsequently tested for their sensitivity.
3.1.3 The Relevance of Backbone Polymer Molecular Weight to Targeted Delivery
The backbone polymer is the precursor to a class of amphiphilic alternating
copolymers used in targeted delivery applications in cancer. In subsequent synthetic steps
developed in the laboratory of Arthur Watterson at UMass Lowell [8, 10, 21], sidechains
are attached for a variety of purposes by means of the free hydroxyl group on the
isophthalate linker within the backbone polymer. Hydrophobic chains can be attached to
impart amphiphilicity such that the polymers self-assemble to form nanoparticle micelles
that exhibit desirable behavior in vivo [22], while targeting ligands attached directly or by
a spacer promote cancer cell-specific targeting [23]. These modifications to the backbone
polymer are shown schematically in FIGURE 3.9.
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Figure 3.9. Chemical structure of backbone polymer substituted with representations of various
sidechains, including targeting ligands and hydrophobic sidechains.
Recently, there has been increasing evidence that polyvalency, which refers to
single molecules or particles that have multiple targeting ligands, is essential for
successful targeting of cell-surface receptors [24, 25]. Theoretical models developed to
described the phenomenon have shown that polyvalency improves the avidity of a
targeted delivery system by increasing the local concentration of targeting ligand once a
receptor-ligand interaction occurs [24, 26]. The potential to improve the performance of
our targeted polymers using polyvalency has been studied in detail by applying the cited
theoretical models [27].
The diagram in FIGURE 3.10 illustrates an important consideration when
increasing the targeting ligand polyvalency along the backbone polymer. A single
backbone polymer chain has a finite number of reactive sites for the addition of
sidechains; consequently, increasing the fractional substitution of targeting ligand reduces
that for hydrophobic sidechains. In order to increase the number of targeting ligands per
chain while maintaining the ability to form micelles, the backbone polymer molecular
weight must be increased. In practice, appropriate physico-chemical characterization
techniques, such as dynamic light scattering or surface tension measurements, must be
used to determine the relative levels of substitution required for micelle formation.
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Figure 3.10. Schematic diagram illustrating the trade-off between the number of targeting ligands
per polymer chain and the ability to form targeted micelles. The impact of increasing ligand
substitution and polymer molecular weight on micelle formation, particle size, and biological
function is uncertain.
Increasing the number of targeting ligands per polymer chain by increasing
backbone polymer weight does not guarantee a greater density of targeting ligands in the
final nanoparticle. This is because the aggregation number as well as the particle size
may be affected by differences in molecular weight. Nonetheless, the ability to increase
molecular weight beyond that previously attained increases the design space for the
targeted polymers. Molecular weight could also potentially be adjusted to control
properties of the targeted polymers both in terms of their physico-chemical properties like
particle size and critical micelle concentration, as well as their biological function in
targeted delivery applications.
3.2 Materials and Methods
3.2.1 Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless
otherwise noted. Glassware was purchased from Chemglass (Vineland, NJ) and Kimble-
Kontes (Vineland, NJ). Heavy wall flasks, adapters, and manifolds were selected to
withstand high vacuum conditions.
3.2.2 Polymerization Procedure in Flasks
The experimental setup for the flask polymerizations is shown in FIGURE 11.
Flasks were immersed in a silicon oil bath that was maintained at 90 *C by an immersion
circulator (Cole-Parmer, Vernon Hills, IL). Vacuum was applied by means of a vacuum
hose connection to a glass adapter (not shown) and any volatilized material was captured
by means of a dry ice cold trap. Polymerizations were stirred mechanically in three-neck
round-bottom flasks using a variable speed Servodyne motorized electronic mixing
system (Cole-Parmer, Vernon Hills, IL). The drive motor rotated a glass stirring blade
that was fitted at the end of a glass shaft (both from Chemglass, Vineland, NJ).
Polymerizations were stirred magnetically in single-neck flat-bottom flasks using one-
inch stirring bars driven by magnetic stirring plates located beneath the silicon oil bath.
For the magnetic apparatus, the flask was placed as close to the stirring plate in order to
maximize the magnetic coupling. Sampling was performed via the sample ports by
depressurizing the system and removing the stopper.
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Figure 3.11. Schematic diagram of the experimental setup for flask polymerizations using either
mechanical or magnetic stirring. Multiple reactions could be run simultaneously using a large
heating bath and multiple vacuum manifolds.
Polyethylene glycol (PEG) was added to a 250 mL flat-bottom flask and dried for
at least 1 hr at 90"C under high vacuum (10-100 pm Hg) using a rotary vane direct drive
vacuum pump (Labconco, Kansas City, MO); and pressure was measured using a analog
vacuum gage (Chemglass, Vineland, NJ). The flask was removed from vacuum, and the
dried PEG was reweighed before addition of dimethyl 5-hydroxyisophthalate (linker) and
Novozym435 (See also [28], Sigma catalog number L47772). Linker was added in an
equimolar amount to the dried PEG and Novozym435 was added at 10 wt% (w/w) of the
total combined mass of PEG and linker. Care was taken to add the reactants quickly in
order to minimize the readsorption of water into the PEG. A representative starting
mixture for flask reactions presented in the following includes 9 g of dried PEG900, 2.1 g
of linker, and 1.1 g of Novozym435.
The mixture was heated to 90"C, and vacuum was applied after the linker was
dissolved and Novozym435 was dispersed throughout the PEG melt by either magnetic
or mechanical stirring (usually <1 min). Samples (less than 20 mg) were taken at
specified times for subsequent analysis by gel permeation chromatography (GPC) using a
metal spatula. The vacuum was reapplied after sampling, which typically required about
1-2 min to restabilize. At the end of the reaction period 100 mL of deionized water was
added. Novozym435 beads were removed from the resulting slurry by vacuum filtration
using qualitative filter paper (Whatman LTD, Piscataway, NJ). The filtrate was then
frozen (-4"C) and placed on a freeze dryer (VirTis, Gardiner, NY) under 10 pm Hg
vacuum to isolate final polymer product in solid form.
3.2.3 Polymerization Procedure in the Protherm
The Protherm was originally designed to be used as a continuous, flow-through
evaporator (FIGURE 3.12A).In continuous mode, fluid enters through the inlet (top right)
and is immediately spread into a thin film by the rotating blades. Addition of more fluid
2 There are a number of immobilized Candida antarctica lipase B products commercially available. They
vary in activity, original enzyme expression system, support material, and cost. All data presented were
generated using Novozym435 that was manufactured by Novozymes and distributed by Sigma-Aldrich
(Cat# L4777). Our collaborators at UML used Novozym435 received from Novozymes as a gift.
Novozyme435 is Candida antarctica Lipase B expressed in Aspergillus niger, immobilized on a
macroporous acrylic resin (Lewatit VP OC 1600, Bayer) with an activity of >10,000 U/mg.
creates flow through the reactor (right-to-left) and fluid exits the cylinder through the
outlet (bottom left) by gravity. Modifications were made in order to use the Protherm as a
batch reactor. Due to restrictions imposed by our industrial collaborator, the inlet and
bottoms outlet could not be removed to create a sealed reaction zone (shaded region in
FIGURE 3.12B). Instead, only modifications to the Protherm orientation could be made
to prevent leakage of the polymer melt. To minimize loss of the reaction mixture to the
bottoms outlet, the Protherm was rotated 900 axially and elevated 10 above horizontal
(FIGURE 3.12B). Rotating the bottoms outlet (and inlet) to horizontal positions
minimized loss due to gravity, while the slight elevation further reduced the loss through
the bottoms outlet.
Polyethylene glycol drying and subsequent linker and Novozym435 mixing were
performed as described above using the magnetic stirring setup. Once the linker and
Novozym435 were dissolved and dispersed in the dried PEG, the entire reaction mixture
was poured through the opening on the left end of the Protherm ('cap'), which had been
pre-heated by setting the temperature controlled heating jacket to 90 "C. To add the
reaction mixture, the cap was opened and the Protherm was temporarily elevated to 450
above horizontal such that the mixture quickly entered the heated reaction zone to
minimize loss due to solidification.
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Figure 3.12. Schematic representation of the modifications necessary to convert the Protherm from
(A) continuous to (B) batch operation mode. The Protherm is depicted in the transverse (left) and
axial (right) directions. The reaction mixture is poured by opening the cap indicated on the leftmost
side of the schematic. The bottoms out and inlet are labeled for completeness in (B) - they are not
used in batch mode (indicated by italics).
Vacuum was applied via the 'vapor out' port and pressure of approximately 100
im Hg was measured using an inline analog vacuum gage (Chemglass, Vineland, NJ).
Temperature was maintained at 90 0C by means of a temperature controller and a
thermocouple placed between the heating jacket and the wall of the Protherm. The blade
speed was set to 2000 rpm unless otherwise specified. The time of simultaneous
application of vacuum and initiation of blade rotation was designated t=O for the
Protherm reactions.
Samples for subsequent GPC analysis were taken at various time points by
reopening the cap through which the reaction mixture was originally added. A metal
spatula was used to take approximately 20 mg samples at various locations throughout
the reaction zone (FIGURE 3.13).
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Figure 3.13. Schematic diagram of circumferential and axial views showing the various sampling
locations within the Protherm. Samples were taken from the front, middle, and back, including four
circumferential locations at the middle.
The starting reaction mixture for the Protherm was twice as large as that used in
the flask reactions; the total volume of this doubled mixture (18 g PEG900, 4.2 g linker,
2.2 g Novozym435) was approximately 20 mL. At this batch size, only about 1 mL of the
reaction mixture leaked out of the bottoms outlet. There was no benefit to increasing the
batch size further because any additional reaction mixture charged to the Protherm leaked
out the bottoms outlet when blade rotation was initiated.
3.2.4 Flow Visualizations
Flow visualizations were performed to better understand the fluid mechanics
extant in the Protherm. In these experiments, 20 ml of PEG 1000 or PEG 4600 at 90*C
were added to the Protherm, which was then set to rotor speeds of 500, 1200 and 2000
rpm. The flow within the Protherm was observed by removing the end cap and
illuminating the cylinder with a strobe light set to three times the blade rpm. Qualitative
observations of the extent of thin film development and the physical characteristics of the
fillet were recorded and are presented in the Results.
3.2.5 Comminution of Novozym435
Because of the high shear created by the rapidly rotating blades in the Protherm
and the low mechanical strength of the acrylic catalyst beads upon which the enzyme is
immobilized, Novozym435 was ground before use in the Protherm and occasionally
before addition to flask reactions as well. Crushed beads were prepared by grinding the
beads to a powder with a mortar and pestle for approximately 5 min until the originally
0.3-1 mm beads had become a fine powder. Additional details concerning the bead size,
porosity, and enzyme localization have been determined previously by others [28].
3.2.6 Effect of Molecular Sieves on the Polymerization
Certain experiments investigated the effect of molecular sieves, a drying agent
capable of sequestering polar molecules such as methanol or water from fluids, on the
polymerization reaction. Powdered 4A molecular sieves were obtained from Sigma-
Aldrich (P/N 69836, St. Louis, MO) and activated in a vacuum oven (Pabs = 1 mm Hg) at
2500C for at least 8hr. Activated sieves were weighed and added, where indicated, to the
reaction mixture along with the linker and Novozym435. Sieves were added at 10 wt% of
the PEG and linker combined mass. Care was taken to minimize the exposure of the
sieves to ambient conditions in order to maximize their capacity.
3.2.7 Forward Rate Constant Determination
The forward rate constant was measured experimentally for use in the theoretical
kinetic modeling by reacting 1.05 g of linker (A) with 7.5 g of mono-methoxy PEG750
(B') in the magnetic stirring setup. These masses of reactants create a 2:1 stoichiometric
ratio of PEG to linker; however, since the linker is bifunctional and the PEG is
monofunctional, the stoichiometric ratio of hydroxyl and ester groups in the mixture is
1:1. Mono-methoxyPEG750 was used because no PEG900 equivalent was commercially
available. Novozym435 (whole beads) was added at 10 wt% (w/w) of the total combined
mass of PEG and linker. A structural representation of the overall reaction, as well as the
forward and reverse elementary reactions for the two potential reaction steps, is provided
(FIGURE 3.14).
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Figure 3.14. Scheme presenting the overall reaction of two equivalents of mono-methoxy PEG750
(A') and with one equivalent of dimethyl 5-hydroxyisophthalate linker (B) to form B'A'B. The two
elementary reaction steps are also presented.
Samples were taken as described above. The concentration of the linker in each
sample, which was assumed to be representative of the concentration of linker in the
reaction melt, was determined using the GPC system. Because the linker peak in the GPC
chromatogram was completely resolved from those for PEG750 and any higher
molecular weight species, any decrease in the height of the linker peak corresponded
directly to reaction of linker with PEG.
The GPC refractive index detector response was calibrated for linker
concentration according to the following method. Standard solutions of linker dissolved
in THF at four different concentrations were measured by GPC. The heights of the linker
peak in the resulting chromatograms were used to construct a calibration curve. The
resulting calibration, which was linear over the range of concentrations measured, was
used to determine the concentration of linker present in a particular GPC vial, CLGPC.
CGPC = llHpeak
where i is the refractive index calibration constant, and Hpeak is the height of the linker
peak in the chromatogram.
Again, assuming that the concentration of linker in the reaction sample, CL ample
equal to that in the reaction melt, CLmel, the definitions in EQUATIONS 2 and 3 were
used to convert from CLGPC to CLmelt
sample
VTHF
C melt =sample -
msample
L L L (a3p)
Vsample
where mLsample is the mass of linker in the sample, VTHF is the volume of THF added to
dissolve the sample, and Vsampie is the volume of the sample taken from the reaction melt.
Combining EQUATIONS 2 and 3 yields:
C = CGPC VTHF (4)
Vsample
Vsampie was determined by:
Vsampme = sample (5)
Pmelt
where msample was the mass of the sample and Pmelt was the density of the reaction melt,
which was determined to be 1.1 g/mL by measuring the weight and volume of the
reaction melt, including the catalyst beads.
Combining EQUATIONS 1, 4, and 5 yields:
Celt = (Hp) VTHFPmeIt (6)
sample
which was used to calculate the concentration of linker in the reaction melt at various
times 3. A second-order kinetic reaction model was developed (see MODEL
FORMULATION section) to estimate the effective forward rate constant for reaction
between linker and PEG.
3.2.8 Residual Water Content after Drying
PEG900 was dried under 100 pm Hg at 90*C in a two-neck round bottom flask
where one neck was used to apply vacuum and the second neck was sealed with a rubber
septum. After designated periods of time, flasks were returned to atmospheric pressure
with ultra high purity nitrogen (Airgas, Salem, NH). Samples were withdrawn using a
syringe equipped with a long needle, transferred to a dried glass scintillation vial, and
dissolved in 100 p.L of anhydrous chloroform (Sigma-Aldrich, St. Louis, MO). Vials
were purged and sealed under ultra high purity nitrogen (Airgas, Salem, NH). Some
samples were withdrawn and exposed to ambient conditions in open vials for recorded
times before being sealed. Samples of the PEG prior to the drying were taken as a
control. The residual water content present in dried PEG was measured using a V30
Compact Volumetric Karl-Fischer titrator manufactured by Mettler Toledo (Columbus,
OH) following the protocol provided along with the equipment. In this method, trace
water reacts with a mixture of chemicals to produce iodine from iodide in a controlled
reaction. This reaction is monitored by potentiometric measurements and the water
content is calculated based on known electrochemical properties of iodine and iodide
[29].
3 This analysis assumes that VTHF and the total volume of the dissolved sample are equal. It also assumes
that the density of the reaction melt is constant throughout the period of sampling.
3.2.9 Molecular Weight Determination by Gel Permeation Chromatography (GPC)
To prepare the samples for GPC analysis, chromatography grade tetrahydrofuran
(THF, Sigma-Aldrich, St. Louis, MO) was added to the collected samples until fully
dissolved. Typically, one milliliter of THF was added to approximately 10-20 mg of
sample. The dissolved samples were then filtered with a 0.45 micron PTFE Acrodisc
syringe filter (Pall Corporation, Port Washington, NY) to remove the catalyst beads and
other particulates that may have been present. The filtered samples were then added to
sample vials and analyzed on a Breeze 2 HPLC system (Waters, Milford, MA) equipped
with an auto-sampler, UV/Vis detector (k = 250 nm), and refractive index detectors. The
column bank consisted of three Styragel@ high resolution GPC columns connected in
series (HR1, HR3, and HR4, Waters, Milford, MA). The mobile phase was THF and the
flow rate was 1 ml/min. The standard method involved a 60-min column preparation
stage to equilibrate the columns and purge the detectors, a 36-min run time for each
sample, and a 15-min elution to restore the columns to their resting state.
Chromatograms obtained from the GPC system were analyzed with the Breeze
software package (Waters, Milford, MA), which was used to calculate the product
number average (Mn) and weight average (Mw ) molecular weight based on a calibration
curve established using a kit of poly(methyl methacrylate) (PMMA) standards (Waters,
Milford, MA). The results of a study of the calculation of molecular weight from the raw
data measured by the detectors are presented in APPENDIX A. The definitions of Mn,
M, , and the polydispersity index (PDI) are presented in EQUATION 12:
-NNM- N 2 M 1 M
Mn = I x X M, = XwxMx = I X 2 PDI= _ W (7)
NX NXMX Mn
where Nx is the number of moles whose weight is Mx and wx is the weight fraction of
molecules who weight is Mx [11].
3.3 Homogeneous Model Formulation
Theoretical models were developed to determine under what conditions the
backbone polymer molecular weight could be increased. The models were also used to
quantify the extent to which molecular weight could be increased by improving the
reaction conditions. An ideal homogeneous reaction model was chosen as the base
system for the evaluation. In this ideal system, the reaction mixture is perfectly mixed
and the methanol concentration in solution is related to the vapor pressure in the vapor
space above the reaction mixture according to Raoult's law. Measured and/or estimated
rate and equilibrium constants were used with the model to predict the ideal molecular
weight progression for the system.
Considering the low backbone polymer molecular weight achieved previously, as
well as the prevalence of literature devoted to byproduct removal in condensation
polymerizations [11, 15, 16, 30], the potential contributions of excess methanol in the
reaction mixture to reduce molecular weight were of primary interest. This potential
mechanism was studied by varying the methanol concentration specified in the model.
Even though methanol partial pressure in the vapor space was kept very low
experimentally, elevated methanol concentrations can exist in the melt because of the
mass transfer limitations described qualitatively in FIGURE 3.5. This is important
because the liquid-phase methanol concentration is the key driving force of the reverse
reaction that inhibits the production of higher molecular weight polymer. The molecular
weight predictions at these elevated methanol concentrations will serve as a basis against
which experimental results will be assessed.
3.3.1 Overall Strategy for Homogeneous Model Simulations
The homogeneous model was used to simulated the theoretical backbone polymer
molecular weight as a function of time given a constant bulk methanol concentration, CM.
Multiple simulations were performed, each having a different specified value of Cm, and
the time-dependent molecular weight progressions were recorded and plotted for
inspection. Cm was varied over eight orders of magnitude to simulate the effect of
severely elevated (or depressed) methanol concentrations. These methanol concentrations
represented the deviations from ideality in a real, non-homogeneous mixture.
The same model was also used to simulate the equilibrium molecular weight as a
function of bulk methanol concentration. To generate these results, the model was solved
for a range of CM and the equilibrium molecular weight was recorded for each simulation.
The simulation time span was set high enough to ensure that the simulated reaction
system had reached equilibrium.
3.3.2 Kinetic Model Overview - System of Reactions
As described in the Introduction, the reaction of interest involves the
transesterification of polyethylene glycol (PEG) and dimethyl 5-hydroxyisophthalate
(linker) to form a chain-extended polyester and methanol byproduct. A second order
kinetic model was used to study this reaction; however, modifications to the classical
application of the second order model were required. Specifically, in the classical
example of A + B -> C, an individual reaction between A and B consumes the two
reactants. Conversely, for the polymerization reaction in question, reaction between
bifunctional monomers does not consume the reactants in the classical sense because the
second ester and hydroxyl present in the bifunctional linker and PEG remain and can
participate in further reaction. To account for the bifunctionality of the linker and PEG
monomers, the reaction model was formulated in terms of reactive endgroups and not in
terms of individual molecules [11].
In the primary chain-extension reaction (FIGURE 3.15a), a linker methyl ester
endgroup, A, reacts with a PEG hydroxyl endgroup, B, to form the chain extending ester
bond, L, and methanol, M. Two side-reactions were also included in the model
description to assess how residual water in the melt might affect molecular weight. In the
hydrolysis reaction (FIGURE 3.15b), a linker methyl ester, A, is hydrolyzed by a water
molecule, W, to form a carboxylic acid, C. This side reaction reduces the concentration
of methyl esters in solution, which, in turn, can affect the stoichiometric balance between
hydroxyl and methyl ester endgroups. Disruption of this balance, which is essential to
maximize extent of polymerization, may reduce the final molecular weight. In the
proposed model, the carboxylic acid hydrolysis product is allowed to react with PEG in a
chain extension reaction (FIGURE 15c) to produce a chain extending ester bond, L, and
methanol, M. Although the chain extension product, L, is represented in FIGURE 3.15 in
a molecule having only one repeat unit, any reaction between A and B or C and B will
lead to a chain extension and a corresponding increase in the average molecular weight of
the mixture. For all three reactions, the reverse reaction was also possible. For example,
methanol, M, could react with L to regenerate the linker methyl ester and PEG hydroxyl.
This reverse reaction would lead to a corresponding decrease in polymer molecular
weight.
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Figure 3.15. Model formulation: Polymerization reaction with side reactions represented by reactive
endgroups, which are labeled in the chemical structure representations of the proposed reactions.
The chemical kinetics and equilibria for these three reactions were modeled
assuming that all forward and reverse reactions were second order with respect the
reactive endgroups. The forward and reverse rate constants are k; for the
transesterification (FIGURE 3.15a), kih for the hydrolysis of the linker ester (3.15b), and
kic for the carboxylic acid-mediated polymer chain extension (3.15c), where the subscript
frefers to the forward reaction and r refers to the reverse reaction.
The system of equations for these reactions, again assuming second order
kinetics, is as follows:
dC
a.) A = -R-R
dt c
dCb.) B = -R-RHdt
dC
c.) L = R+Rcdt (8)dCd.) M = R+Rcdt
dC
e.) W =R H+Rdt H C
dCf.) c = RH-Rcdt
where,
a.) R=kCAC B kr CLCM
b.) RH CBW + C (9)
c.) RC =kCA C + LC W
For this model, kjJ are the effective homogeneous rate constants, which are
lumped representations of system-specific characteristics according to:
k = f enzAcatNcat (10)
Vmelt
where Kf is the intrinsic forward rate constant, aenz is the enzyme surface density, Acat is
the surface area per catalyst bead, Ncat is the number of catalyst beads present, and Vmelt
is the volume of the reaction melt.
The time-dependent initial conditions for A and B are known according to
experimental conditions and are CAO, CB', respectively. These two initial conditions are
equal because the linker and PEG are added stoichiometrically and both monomers are
bifunctional. The initial conditions for L and C, which are not present at the beginning of
the reaction, are all equal to zero.
The initial concentration for water requires additional discussion because the
modeled system is not a closed system, but an open, driven system due to the vacuum
pump. In the experimental system, the initial concentration of water is equal to the
residual water present in the system after drying and subsequent addition of solids. For
the proposed model, it was assumed that the residual water present after drying
represented the minimum amount of water that could be removed from the melt given the
temperature, pressure, and configuration of the experimental system. As a result, the
system was considered closed with respect to water. Karl Fischer titration measurements
were performed to determine the approximate order-of-magnitude of the residual water
present after drying. The initial water concentration was varied during the simulation
study in order to better understand the potential role of water on the polymerization.
While the other system components could be determined or estimated
experimentally, no inline measurement of liquid phase methanol or of the flux of
methanol from the reaction system was available due to instrumentation limitations.
Therefore, the only inline measurement available that related to methanol concentration
was the pressure measured in the vapor space above the melt, peP. The partial pressures
of all other components in the system, including water and linker (dimethyl 5-
hydroxyisophthalate) were assumed to be equal to zero. This assumption is safe for
linker, which exerts very little vapor pressure due to its high molecular weight (210 Da)
and will exert no vapor pressure once it becomes attached to PEG. The assumption is less
straightforward for water, although its pure component vapor pressure is more than four
times lower than that for methanol at 90 "C [31 ]fh. Therefore, the system pressure was
equal to the vapor-phase methanol pressure, pm. The bulk liquid phase methanol
concentration, Cm, was then calculated from the system vapor pressure according to a
vapor-liquid equilibrium relationship, such as Henry's Law:
PMp = KHCM (11)
where KH is the Henry's Law constant and PMexP and CMexP are the experimental partial
pressure and bulk concentration of methanol, respectively.
Because the measured pressure was constant throughout the reaction (after a brief
initial depressurization period of less than 5 min), the liquid phase, bulk methanol
concentration was assumed to be constant for all times in each particular simulation. This
assumption, which was applied even during the initial stages of the polymerization, led to
a physically unrealistic, non-zero value of CM' for the early times in the simulation. This
choice, which greatly facilitated program development, was not expected to have a
significant effect on the results due to the comparatively small concentrations of L and M
at the beginning of the reaction relative to those for A and B, even at the highest
simulated methanol concentrations (< 102 M versus IM, respectively).
3.3.3 From concentration to molecular weight
The system of differential equations and associated initial conditions was
implemented and solved in MATLAB using the ODE solving routine, 'ode 15s.' The
MATLAB code can be found in APPENDIX B. The differential and algebraic equation
solver yields the concentration of each species as a function of time. These concentrations
can be translated into molecular weight using the following definitions and
manipulations. First, let P,, the number average degree of polymerization be defined as
follows:
(t) total initial no. monomer units - N(t = 0) (12)
no. molecules remaining N(t)
where N(t = 0) is the initial number of monomer units present and N(t) is the total
number of molecules remaining at time, t. According to [11], the degree of
polymerization is related to the fractional conversion by the following:
1 +r (13)
(t) = 1 - 2ri(t)+ r
where i is the fractional conversion of either reactive endgroup (A or B) and r is the
stoichiometric ratio, which are defined as:
No - Ni(t)i(t)= IN t (14)
N?
N0
r= B (15)
where N is the number of reactive endgroups of species i present initially. By definition,
the stoichiometric ratio always contains the minority species in the numerator. When the
monomers are added stoichiometrically, as is the case for the polymerization in question,
r is equal to unity and EQUATION 14 reduces to:
- 1P1(t)= (16)
1- i (t)
While the subscripts A and B can be used interchangeably in EQUATIONS 13,
14, and 16 because any reaction of A must be accompanied by equal reaction of B, this is
not the case for a system in which side reactions can occur. In the proposed model,
conversion of linker methyl esters (A) does not necessarily indicate polymer chain
extension. On the other hand, all fractional conversion of PEG hydroxyls (B) leads to
polymer chain extension (FIGURE 3.15a and c). Therefore, for the proposed system of
reactions, the polymerization number could be calculated according to:
- 1P1(t)= (17)
l- t) B(t)
The output of the MATLAB program, the time-dependent concentrations of the
various components in the reaction system, can be converted to time-dependent fractional
conversions using the following relationship:
1it(t)=1 ) (18)
C?
where Ci(t) is the concentration of species i at a given time and Ci0 is the initial
concentration of species i. In order for this relationship to be valid, it must be assumed
that the volume of the reaction mixture is constant throughout the polymerization. This
assumption is likely valid because (1) the density of PEG is very weakly dependent on
molecular weight [32] and the relative mass of the condensation byproduct (methanol)
that may be removed during the course of the reaction is < 3% (assuming stoichiometric
reactants: 32/(210+900) = 0.03). The solution to the system of differential equations
(EQUATION 9), therefore, provides all of the information required to determine the
degree of polymerization as a function of time according to EQUATIONS 17 and 18.
The final step, then, is to convert degree of polymerization to either a number-
average or weight-average molecular weight. According to [11], the number-average
molecular weight, Mn, is related to the degree of polymerization by the relationship
1rvn = 2 Pn +Meg (19)2
where Mrepeat is the molecular weight of the polymer repeat unit and Meg is the molecular
weight of the monomer endgroups, which becomes negligible as Pn increases. For the
case of the polymerization of PEG900 and linker, a single polymer repeat unit is PEG900
connected to linker by an ester bond (FIGURE 3.16).
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Figure 3.16. The parts of the backbone polymer chemical structure that comprise a single repeat
unit.
The actual value of Mrepeat was calculated:
Mrepeat =:M PEG ± M ier - 2 Mmethanol = 900 +210 -2(32)= 1046 Da (20)
where the Mi are the molecular weight of PEG900, linker, and methanol, respectively.
The two equivalents of methanol are subtracted because one molecule of methanol is not
present in the repeat unit (outside the dotted line in FIGURE 3.16) while a second
molecule of methanol is the condensation byproduct. It follows that the endgroup
molecular weight Meg is 32 Da.
The weight average molecular weight can be calculated from the fractional
conversion of PEG using the following formula [11]:
Mw= rePea B. (21)
Combining EQUATIONS 17 and 21 yields a relationship between the weight-average
molecular weight and degree of polymerization:
- M
M = repeat (2 - 1). (22)
Therefore the number- and weight-average polymer molecular weight can be
modeled for the backbone polymerization MATLAB program using a differential
algebraic equation solver (see APPENDIX B for code) and the preceding definitions and
derivations.
3.3.4 Determination of Model Parameters
In order to solve this system of differential equations, a number of parameters are
necessary, including the six kinetic rate constants and initial concentrations of the
reactive species.
a.) Effective forward rate constant
The experimentally measured linker concentrations were used to estimate the
effective forward rate constant according to the experimental procedure described in the
Methods and the system of reactions presented in FIGURE 3.14. If samples are taken at
early times and CAB' << CA and CB', only the first forward elementary reaction will
occurs (all other reactions will be negligible). The polymerization can be modeled using
the same reactive endgroup strategy exploited during the formulation of the kinetic model
for the complete reaction system. The reaction between linker and mono-
methoxyPEG750 can be described by the second-order rate equation:
dCAkC
- ^ =kCA (23)
dt f B
where kf is the effective forward rate constant and CA and CB' are the volumetric
concentration of linker methyl esters and monomethoxy-PEG750 hydroxyls, respectively.
At t = 0, CA is equal to CA0. Because the monofunctional PEG was added in a 2:1 molar
ratio to the bifunctional linker molecule, CA and CB' are equal and EQUATION 23
becomes:
-dCA fA
A cA2 (24)
dt
The analytical solution to EQUATION 24 in linearized form is:
1 1
= kft + (25)
A WA
If the model assumptions are valid (i.e. CAB' CA, CB'), then a plot of the left-hand-side
of EQUATION 25 versus reaction time, t, should yield a straight line, the slope of which
is equal to the effective forward rate constant, kf. However, if the resulting plot is non-
linear, that would likely indicate that the other proposed elementary reactions were
contributing significantly to the time-dependent progression of the linker concentration,
CA. This empirically determined rate constant was assumed to apply for all steps in the
polymerization, an assumption which is commonly made for tractability [11, 30]. The
reverse rate constant was calculated according to the selected value for the equilibrium
constant, Keq, according to:
Keq = k (26)
k,
The exact equilibrium constant for the reaction was unknown and was therefore treated as
a variable during the execution of the simulations. Recall that the equilibrium constant for
transesterification reactions is typically 0.1-1 [11]. Finally, because no data were
available for the remaining two reactions (FIGURE 15b and c), the remaining forward
and reverse rate constants, for hydrolysis (H) and carboxylic acid-mediated chain-
extension (C), were also unknown and were assumed to be equivalent to kf as an
approximation.
b.) Initial Concentrations
The initial concentrations of the various reactive endgroups were determined
experimentally by measuring the volume of a stoichiometric mixture of 9 g of PEG900
and 2.1 g linker. The mixture volume was 10.0 mL. Because the number of moles of each
reactant was known (0.01 mol), the initial concentrations of the monomer species were
0.01 mol/10.0 mL, or IM. However, because there are two reactive endgroups for each
monomer, the initial concentrations of, CA0 and CB0 , were 2.0 M. Detailed results for the
model parameters that were determined experimentally are presented in the subsequent
results section.
3.4 Fickian Diffusion Model Formulation
The homogeneous kinetic model was used to determine the predicted molecular
weight for a variety of bulk methanol concentrations, not just for that which corresponded
to the experimentally measured vapor-phase pressure (according to EQUATION 11).
These Cm values, most of which were greater than that measured experimentally, were
intended to account for mass transfer limitations not addressed by the homogeneous
assumption. The results of the model at these various concentrations represent the
expected molecular weight that might be observed as a result of limitations in mass
transfer from the bulk to the catalytic surface. To supplement the kinetic model, a model
that incorporated Fickian diffusion across a stagnant film of thickness 6 was developed
and applied to several different situations. The goal of this model was to (1)
quantitatively predict the increase in the concentration of methanol participating in the
reverse reaction as a function of position relative to the bulk methanol concentration, and
(2) to use this information to estimate the effect on polymer molecular weight. The model
incorporates the physical properties of the system, including diffusivities, rate constants,
and length scales, for two different limiting cases: (1) a well-stirred solution with a
stagnant boundary layer around each individual bead, and (2) a completely stagnant
system in which the catalyst particles have settled to form a monolayer at the bottom of
the reaction vessel. A cartoon representation of the physical state in the flask reaction was
depicted earlier in FIGURE 3.4. The model framework for these two cases is shown
schematically in FIGURE 3.17. In order to describe the two cases by the same physical
model, curvature effects have been neglected for the boundary layer around the catalyst
bead. The height of the boundary layer, 6, is equal to (1) the radius of the catalyst bead
for the single-bead case (for the worst-case scenario for which the Sherwood number is
equal to 2) and (2) the height of the polymer melt for the stagnant case.
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Figure 3.17. Schematic representation of the Fickian mass transfer model proposed to describe mass
transfer limitations in the flask polymerization for the (A) single-bead and (B) stagnant cases. The
height of the boundary layer, 8, is equal to (1) the diameter of the catalyst bead for the single-bead
case and (2) the height of the polymer melt for the stagnant case.
In the proposed one-dimensional model the chain-extending chemical reaction
occurs at the catalyst surface at a position of y = 0. Potential reactions with water were
not included in this model formulation to simplify the analysis. The surface reaction is
governed by the effective forward and reverse rate constants, kf' and k,, where i can
represent either the single-bead or the stagnant case. The effective rate constants for the
two cases are related to the intrinsic rate constant by:
k fbead = KfGenz (27)
k stagnant - Kf(Yenz [fAcatNcat]
Aflask (28)
where Aflask is the surface area of the bottom of the flask and f is the efficiency of the
catalyst area, which is required because a portion of the settled beads cannot catalyze the
reaction. The remaining terms are defined as in EQUATION 10.
EQUATION 10 was rearranged to separate the known and unknown system
parameters:
K enz - kfVmet(29)KfO~e A cat N cat (9
The Fick's Law diffusion model was used to perform individual analyses of the
mass transfer limitation of the methanol byproduct, M, and the reactive endgroups, A and
B. After the initial stages of the polymerization, all of the reactive endgroups are present
as terminal groups on a polymer chain. Because of this, together with the 1:1
stoichiometry of the reaction, it was assumed that the mass transfer behaviors of A and B
were identical. Diffusion from the catalyst surface was assumed to be governed by Fick's
Law. In the single-bead case, diffusion occurs across a boundary layer into the
homogeneous liquid bulk, while in the stagnant case, diffusion occurs through a stagnant
region equal to the height of the entire liquid, which is bounded by the liquid-vapor
interface. Two assumptions were made: (1) the system was assumed to be at quasi-steady
state so that time derivate for Fick's Law is equal to zero. In order for this assumption to
be valid, the Fourier number (Fo), which relates the diffusive time scale to the
characteristic timescale of a system, must be O(1) or greater. (2) When modeling the
mass transfer of a particular species, the concentration of all other species were assumed
to be constant in space. For example, when modeling the methanol mass transfer
limitations, A, B, and L were all held constant with respect to space.
Based on these assumptions, the one-dimensional governing equation for
diffusion of methanol across the boundary layer (EQUATION 30A) and two associated
boundary conditions for the single-bead (EQUATION 30A-C) and stagnant cases
(EQUATION 30D-F) become:
a.) V2 CM = Id 2 y = 0 d.) VCM =d 2  = 0S2 dy dy dy2
b.) CM y 3 R = Cm(2R) e.) CM = CM(S) (30)
c.) -DM dCM kCAB kcLM(R) f.) -Dm dM kf1CACB kr'cLCM(0)dy y=R dy Y
The first boundary condition states that the concentration of methanol at the edge of the
boundary layer is known. For both cases, this methanol concentration is the bulk
concentration that was used as the input in the homogeneous reaction model. The second
boundary condition equates the rates of diffusion and reaction at the catalyst surface. The
superscript i indicates that different effective rate constants are required for both the
single-bead and stagnant cases. EQUATION 30 can be rewritten for other species, such
as the reactive endgroups, by selecting the corresponding reaction rate equation for the
right-hand-side of the second boundary condition.
The preceding model equations for methanol were non-dimensionalized according
to the following:
OM = " ;11 -- or 11 y (31)
CM () R 6
where the characteristic length was either the radius of the bead, R, or the melt height, 6,
and EQUATION 30 becomes:
1 d 2 dM = d20a.) ;T L d J= 0 d.) M
b.) M 1 e.) 0M  1 (32)
c.) M = Dabead - Dabead f.) dOM =Da - DalOM(0)
w e fM rMM(1) di
where,
Dabead _ kfbeadR CACB ; Da *ead =f beadR(CL)fM DM \ M(R)) DMKeq
D a f " k f f i C A B } D ar 
= k , ( C L ) ( 3 3 )
f,M DM (C Dm Ke
Daf,Ml and Dar,Ml are the respective forward and reverse Damkdhler numbers for the
methanol mass transfer model for the ith case.
Based on the previously described assumptions, as well as the assumption that CA
is equal to CB because of the stoichiometry of the reaction, a similar model was proposed
for the mass transfer of A, the methyl ester reactive endgroup:
=0dd6d2
a.) 1 d 2 dOA d.) A 0
9 d1 di) di 2
b.) OA n=2 1 e.) OA11 = 1 (34)
c.) dOA -Daead A (1) 2 - Da bead f)d - Da film ( 2 - Dafi
d q rM da 1 = fMOA(0) r,M
where the non-dimensionalized concentration and positions were defined as in
EQUATION 31 and,
Da bead =kf bead RCA(R) Da bead _ f bead R CLM
f,A DA rA DAKeq CA(R))
Dahn flm6CA (6) Dahn - kffihn6 LCM
f,A DA rA DAKeq CA(6)
A methanol mass transfer model was also proposed for the Protherm (FIGURE
3.18). In this model, the polymerization reaction is assumed to occur homogeneously
through the polymer thin-film in the Protherm. There is a no-flux boundary condition at
the wall.
L-V Interfacey=8 ------------------------------------- C()
Polymer Film A+ B - L + M
y=0 no flux C(O)
Figure 3.18. Schematic representation of the Fickian mass transfer model proposed to describe mass
transfer limitations in the Protherm. 8 is the thickness of the thin polymer film in which the reaction
occurs homogeneously.
For the Protherm mass transfer model, it was assumed that the time-dependent
term in the Fick's law mass balance was equal to zero. In order for this assumption to be
true, the characteristic relaxation time of the diffusion profile must be shorter than the
characteristic reaction time (i.e. how quickly the reaction affects a change in Cm).
Curvature effects were neglected allowing for the mass transfer model to be written in
rectangular rather than cylindrical coordinates (necessary for an analytical solution).
Under these assumptions, the mass balance becomes:
-DM CM 2 k T  ACB - kr CLCMdy
CM(6) (36)
dCM =
dy
Applying the same non-dimensionalization strategy as above, where concentration is
normalized by the C(6) and position is normalized by 6, yields:
d2 " = 
-DaPT + DaPT0
dr1
0(1) =1 (37)
dri
where,
k P~T62( ' DPT kPT 2 (8
I A B ; aT T2 (CL) (38
Da M CM(6) DMKeq
In this case for which reaction occurs homogeneously, the characteristic height is
squared in the two Damk6hler numbers and the effective forward rate constant for the
Protherm mass transfer model, kfI, is:
kfT -- (Yenz AcatNcat (39)
VmeltPT
where Vmelt,PT is the volume of the polymer melt in the Protherm.
Whenever possible, the model parameters were estimated experimentally. In lieu
of experimental values, empirical formulae were used to determine the necessary
parameters, such as the diffusion constant for methanol in PEG, Dm, which was
calculated using the Wilke-Chang correlation:
DM = 1.173x10-16 (gMBP)1/ 2  T0.6 (40)
pBPVM
where Dm is the diffusion coefficient of methanol in backbone polymer (BP) in units of
m2/s, T is the solvent association parameter (assumed to be equal to 1), MBP is the
molecular weight, T is temperature in Kelvin (363 K), paMP is the viscosity in Pa-s, and
VM is the molar volume of methanol in kg/m 3. The methanol partial molar volume was
estimated to be 0.72 g/mL according to a physical property table [33].
The diffusivity of A, DA, was assumed to be equal to the self-diffusivity of PEG
because the methyl ester groups become the terminal groups of the backbone polymer
early in the polymerization. The self-diffusivity and viscosity of PEG, both of which
were assumed to be representative of corresponding properties of the backbone polymer,
were estimated from the literature as a function of molecular weight and are presented in
the Results [31, 34].
3.5 Results
3.5.1 Conversion between Pm and CM
As previously discussed, the bulk methanol concentration was the primary
variable of interest during the simulations performed according to the proposed
theoretical models. Ideally, measurement of bulk methanol concentration during each
experimental polymerization would have been available in order to make direct
comparisons between experiment and theory. Due to limitations in instrumentation, bulk
methanol concentration measurement was not possible in our experimental system. The
only measurement available was the pressure in the vapor-phase headspace above the
reaction mixture. This experimental pressure data can be used to estimate the liquid-
phase methanol concentration by means of a relationship describing the vapor-liquid
equilibrium behavior of methanol solute and the bulk polymer solvent.
This vapor-liquid equilibrium approach has been used previously in mass transfer
modeling of byproduct removal-limited condensation polymerizations to convert from
vapor-phase pressure to bulk concentration [14-16, 35]. In the cited literature, well-
established empirical vapor-liquid equilibrium models were available for the simulated
systems, which included nylon-6,6 and poly(ethylene terephthalate). Unfortunately, for
our system of interest, methanol dissolved in either PEG or backbone polymer oligomers,
which are primarily comprised of PEG, no experimental information was available.
Consequently, the vapor-liquid behavior had to be approximated using simple models
informed by relevant solubility data from the literature.
For simplicity, it was assumed that methanol was the only species in the vapor
phase. As a result, the vapor pressures of all other system components, including water
and linker, were set equal to zero. This assumption is likely valid because the PEG is
dried before addition of linker and enzyme and the fact that the vapor pressure of
methanol is significantly greater than that for water at 90 *C (2000 vs. 500 mm Hg,
respectively). Given this assumption, P,, = p,' where Psys is the experimental pressure
measured in the system and pM is the partial pressure of methanol.
Two classical descriptions of vapor-liquid equilibria were considered: (1)
Raoult's Law and (2) Henry's Law. If the solute and solvent interact ideally, Raoult's
Law can be used to describe the vapor-liquid equilibrium behavior at all solute mole
fractions:
PM =MXM (43)
where, pM' is the pure component vapor pressure of methanol.
If the interactions are non-ideal, the solubility may vary as a function of the solute
mole fraction. For small solute mole fractions, the non-ideal solubility approaches
linearity and is typically described by Henry's Law:
PM =KHCM (44)
where KH is the Henry's Law constant. A qualitative representation of typical ideal and
non-ideal solubility behaviors is shown in FIGURE 3.19.
Lew~ slope = KHI
XM
Figure 3.19. Qualitative representation of the ideal and non-ideal solubility behaviors of methanol in
polyethylene glycol as a function of methanol mole fraction.
Depending on the nature of the interactions between solute and solvent, the
Henry's Law constant may deviate positively or negatively from the slope of the Raoult's
Law description of vapor-liquid equilibrium. The extent to which the two slopes differ
also depends on the solute-solvent interactions. If the solute and solvent molecule
interactions do not deviate from ideality by a significant amount, then the solubility
calculated according to Raoult's Law can be used as an approximation of the Henry's
Law constant. To estimate the extent of these deviations for our system of interest,
Hildebrand solubility and polymer-liquid interaction (Flory-Huggins x) parameter data
that was available for methanol, PEG, and methanol in PEG in the literature [36, 37] were
examined.
The Hildebrand solubility parameter for individual components in a mixture, 6,
can be used to predict the nature of the interactions between multiple components upon
mixture in solution. In particular, materials with similar Hildebrand solubility parameters
are likely to be miscible. The Hildebrand solubility parameters for several relevant
molecules are presented in TABLE 3.1. The values for methanol and polyethylene
glycols of various molecular weights are 29.7 and approximately 20 MPa1 /2 , respectively
[36]. From these data it was inferred that methanol and polyethylene glycol are
somewhat, but not completely, miscible with one another.
Table 3.1. Hildebrand solubility parameters, 8, for selected molecules, including an approximate
value for polyethylene glycol molecules of various molecular weights [361.
Molecule a
______________ [MPa]'2
PEG (various MW) 20 (approx.)
Methanol 29.7
Ethylene glycol 34.9
Water 48.0
The polymer-liquid interaction (Flory-Huggins X) parameter for methanol in PEG
was also used to determine the miscibility of the two compounds. In particular, X
parameters indicate the extent to which solute-polymer interactions deviate from ideality.
In an ideal solute-polymer mixture the X parameter is equal to zero, while a X parameter
less than 0.5 corresponds to complete miscibility of two compounds [38]. The X
parameter for methanol in poly(ethylene oxide) was measured between 90-110 *C and
determined to be 1.3 MPa 12 [37, 39] after extrapolation to the reference temperature of 25
"C. Because the corresponding X parameter was approximately 1 MPam2, this datum
provided further evidence that methanol and PEG are somewhat miscible and only
interact weakly with one another [38]. Previous studies have suggested that the electron
pairs of the PEG hydroxyl groups and the proton of the methanol hydroxyl form weak
hydrogen bonds [40, 41]. These weak bonds are responsible for the weakly interactive,
somewhat miscible solubility behavior implied by the solubility parameter data.
From the preceding analysis, it was inferred that the solubility of methanol in
PEG900 determined according to Raoult's Law would be a reasonable approximation of
the Henry's Law constant for the same mixture; i.e. the slopes represented schematically
in FIGURE 19 would not differ substantially. A relationship describing the Raoult's Law
solubility, KR, as a function of known system-specific parameters was derived using
EQUATION 43 and the following definition:
xM = CM - CM (44)
C Ctotal
where the denominator is the total molar density of the solution, Ctotai, which includes the
concentration of A, B, C, L, M, and W. A similar strategy has been used by others to
describe vapor-liquid equilibria in similar reaction systems [14, 16, 30].
Removal of methanol throughout the course of the polymerization can lead to a
nearly twofold decrease in Ctotai, assuming the volume of the polymer melt is constant.
The potential error introduced by the decrease in Ctotai was ignored because the accuracy
of the solubility estimate was not considered to be sufficiently high to warrant a
corresponding adjustment. Combining EQUATIONS 43 and 44 yields,
pM = pM M (45)PM mCtotai 45
Therefore, the Henry's Law constant for methanol in the reaction mixture, which was
approximated by the slope of the Raoult's Law solubility relationship, is described by:
K H R PM 46S~CKR tota
A physical property table [33] was used to determine that pM" at 90 *C was 2000 mmHg,
while Ctotai, which was assumed to be equal to Ctotai,initial, was 4.0 M. Therefore, KH was
equal to 500 mmHg/M.
As previously described, the bulk methanol concentration, Cm, was treated as a
variable during the kinetic and equilibrium modeling of the homogeneously catalyzed
polymerization. The methanol partial pressures that correspond to methanol
concentrations of interest are summarized in TABLE 3.2. The experimentally measured
headspace vapor pressure is also included. The pressure was maintained at 5x10-2 mmHg
throughout the course of all experimental polymerizations with the exception of initial
depressurization periods that lasted less than 5 min.
Table3. 2. Specific bulk methanol concentrations and their corresponding methanol partial pressures
used during the theoretical modeling. The experimentally measured headspace vapor pressure is
indicated by asterisks.
CM PM
(moYL) (mm Hg)
1x10-8 5x10O
1x10-a 5x10 4
1x10 4 ** 5x10 2
1x10 2  5
1 5x102
3.5.2 Forward Rate Constant Determination
A calibration curve for linker was constructed using the GPC (FIGURE 3.20).
Solutions with known concentrations of linker were dissolved in THF and their
chromatograms were recorded by GPC. The height of the GPC chromatogram peak (RI
response) was directly proportional to the linker concentration in the GPC sample vial.
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Figure 3,20. Calibration curve relating the height of the linker peak in the GPC chromatogram for
various concentrations of linker dissolved in known volumes of THF.
Samples were taken from the reaction between mono-methoxy PEG750 and linker
at various time points. The samples were weighed and the masses were adjusted to
account for the mass of the Novozym435 beads. Samples were dissolved in known
volumes of THF (typically 1 mL) and chromatograms were recorded on the GPC system.
The concentration of linker in each sample, CA, was calculated using the sample weight,
THF volume, and calibration curve presented in FIGURE 3.20 according to EQUATION
6.
The resulting concentration was assumed to be representative of the entire
reaction mixture. The inverse linker concentration was plotted against reaction time
(FIGURE 3.21) and the effective homogeneous forward rate constant, kf, was determined
by regression according to EQUATION 25
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Figure 3.21. Plot of the inverse of the experimentally determined linker concentration, CA, versus
reaction time for the reaction between mono-methoxyPEG750 and linker. The slope of the linear
regression is equal to the forward rate constant for the reaction.
The slope of the linear least-squares fit in FIGURE 3.21 was 9.0x10-3 ± Mmin-1
with a standard error of 0.4x10-3 M-'min-1, which is equal to the effective forward rate
constant for the model reaction. The resulting regression line did not significantly diverge
from the experimental data, implying that the initial rate of reaction was observed
through the final datum at t = 96 min.
The resulting effective forward rate constant, together with EQUATION 29, was
used to calculate the product Kfenz. The system-specific parameters for intact beads were
required for the calculation were determined according to the following. The surface area
of a catalyst bead was calculated assuming a bead diameter of 1 mm for an intact bead
(according to manufacturer specifications). A melt volume of 8.3 mL was measured
experimentally during the rate constant determination experiment. Finally, the number of
catalyst beads was determined as follows. One-hundred intact beads were counted and
weighed to determine the number density of the beads (beads/gram). This measurement
was repeated in triplicate. The measured number density (4300 beads/gram) was used to
determine the number of beads added during the rate constant determination experiment.
Together, these known values were used to calculate the product Of ice,, which was
subsequently used to calculate the effective forward rate constants for the single-bead and
stagnant cases according to EQUATIONS 27 and 28. For the latter, three system-specific
parameters were required: (1) Neat, which was determined from the number density, (2)
Aflk, which was calculated based on a measured flask diameter of 5 mm, and (3) f,
which was assumed to be 0.5.
This product, which was used to calculate the effective forward rate constant for
the other geometries studied throughout this work, was determined to be 1.1x10 10
m4/mol-s (in SI units).
3.5.3 Residual Water after Drying
Karl-Fischer titration experiments were performed to determine the residual water
remaining in the PEG900 after various periods of drying. The amount of water present
after various periods of drying of PEG900 is presented in TABLE 3. The water contents
for the PEG900 samples were not adjusted for the contribution due to water in the
chloroform since it was extremely low. These values were converted into concentrations
for use in the model as C,". The average value for the 1 and 2 hour drying times, 2.4x102
mol H20/mol PEG900, was converted into a molar volumetric concentration. The
resulting value, 1.5 mM, was used as C." in the subsequent simulations, as indicated.
Table 3.3. Water content measured by Karl-Fischer titration. The data are presented as moles of
water per moles of analyzed sample.
sample Drying Time Water Content
I_ _ (hr) (mol HgOfnol sample)
Anhydrous Chloroform NIA 3.3x10 4
None 2.2x100
PEG900 1 2.GxI 0-22 2.2x10-2
24 8.8x10-2
The dried PEG900 was also exposed to the atmospheric humidity in the
laboratory to determine the rate of water readsorption (FIGURE 3.22). This exposure
simulated the conditions in a typical reaction preparation during which the dried PEG is
exposed to the laboratory atmosphere while linker and enzyme are added.
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Figure 3.22. The water content measured by Karl-Fischer titration for PEG900 after 24 hr of drying
and subsequent exposure to atmospheric conditions. The rate of water adsorption was approximately
0.028 mol H20/hour.
The rate of water readsorption into the dried PEG900 was 0.028 mol H20/mol
PEG900 per hr. Normalizing this rate to the initial concentration of water in undried PEG
(2.2 mol H20/mol PEG) yields an initial readsorption rate of 1.3% of water removed per
hour. Because the maximum exposure time of PEG to atmospheric conditions was
approximately 30 min, with most exposures occurring for less than 10 min, the change in
the residual water present at the beginning of each polymerization due to water
readsorption was quite small.
3.5.4 Kinetic Modeling: Molecular Weight versus Time
The theoretical model proposed in the Model Formulation Section was
implemented and solved in MATLAB. The weight-average molecular weight, M., was
determined as a function of time (0-20,000 hr) at five different bulk methanol
concentrations from 10-8 to IM (FIGURE 3.23). The equilibrium constant, Keq, was set
equal to 1 for these simulations.
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Figure 3.23. Simulated M, as a function of time at various bulk concentrations of methanol. The
experimentally measured pressure in the reaction system was 5x10 2 mm Hg, which corresponds to a
methanol concentration of 104 M (dotted lines). The results of the entire simulation results are
plotted logarithmically (A) without (Co = 0) and (B) with (Co = 1.5 mM) water present; subsets at
short times are plotted linearly both without (C) and with (D) water present. Reaction times between
0 and 100 hr are similar to those the typically encountered experimentally.
The experimentally measured pressure achieved by the vacuum system with the
glass reaction vessels was 5x10-2 mm Hg, which corresponds to a bulk methanol
concentration of x10-4 M. The results at this concentration are represented by dotted
lines in FIGURE 3.23. In all simulations, the vapor-phase pressure was assumed to be
due entirely to methanol vapor. In simulations with water present, the initial water
concentration, Cw", was set at 1.5 mM, according to the results of the Karl-Fischer
titration measurements.
These results demonstrate the importance of decreasing methanol partial pressure
in order to substantially increase the weight-average molecular weight, particularly
considering the estimated equilibrium constant (Keq= 1) characteristic of similar
polyesterification reactions [11]. The simulated Mw increased as a function of time along
identical reaction trajectories for all values of Cm and departed from the shared trajectory
when the back-reaction (in which methanol reacts with esters within the backbone
polymer to reduce the chain length) became appreciable. At that point, the molecular
weight progression slowly leveled off until eventually reaching the equilibrium value in
all simulated cases except the lowest CM (10~8 M).
At CM = 1x10-4 M, which corresponds to a pM of 5x10-2 mm Hg according to the
Raoult's Law description of the vapor-liquid equilibrium, the weight-average molecular
weight increased linearly until the rate of reaction began to decrease at approximately
200 hr and ultimately reached an equilibrium value of 182 kDa after 1000 hr. At high
degrees of polymerization, the predicted value of Mw approached twice that of Mn, which
was expected according to EQUATIONS 19 and 22. Therefore, the equilibrium Mw can
be converted to Mn by dividing the simulation results by two. At all times, the exact
theoretical relationship between M,, and Mw applies.
The simulated reaction times required to substantially increase molecular weight
and ultimately reach equilibrium, especially at the lower partial pressures, were quite
long. The time required to reach 95% of the equilibrium M., teq, was calculated in the
model system both with and without residual water present (TABLE 3.4).
Table 3.4. Predicted time for the simulated M, to reach 95% of the equilibrium M, in the model
system both with and without residual water present.
CM t , 0 = 0 tq Co= 1.5 pM
(M) (hr) (hr)
10-8 7000 1050
10-0 950 720
10-4 105 95
10-2 27 23
100 3 3
The simulation was also performed with residual water present after drying, CW"=
1.5 mM. As was observed for the water-free case, the results of the simulations (FIGURE
3.23B and 3.23D) follow identical trajectories until finally leveling off to their
equilibrium values at long reaction times. The time to reach equilibrium (TABLE 3.4)
decreases with the inclusion of residual water in the model at all simulated methanol
partial pressures. Therefore, the presence of water not only reduces the final molecular
weight, but also decreases the total reaction time until equilibrium.
The presence of water had the greatest effect on molecular weight at the lowest
methanol partial pressures. At the higher partial pressures, the increasingly prevalent
back reaction overshadowed any effect that the simulated concentration of water may
have had on decreasing molecular weight. For the estimated experimental concentration
(1x104 M), the final weight-average molecular weight was 140 kDa with the residual
water and 147 kDa without, a reduction of about 5%. The time to -reach equilibrium was
95 hr with residual water present and 105 hr without the water. The differences were
much less pronounced at elevated levels of methanol.
The weight-average molecular weight was simulated as a function of time at the
estimated experimental CM at three different equilibrium constants to assess the
sensitivity of the results to the uncertainty in that particular variable. The molecular
weight progressions are identical for all three Keq until Mw begins to level off due to
increases in the reverse reaction. The equilibrium Mw was 48, 147, and 490 kDa for Keq
of 0.1, 1, and 10, respectively.
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Figure 3.24. Weight-average molecular weight, Mw, as a function of time at three different values of
the equilibrium constant, Kq. Simulations were performed at a bulk methanol concentration of 1x1o
4 M, which corresponds to the experimentally measured pressure of 5x10-2 mm Hg, with no water
present.
3.5.5 Equilibrium Modeling: Molecular Weight as a Function of PM
The equilibrium weight-average molecular weight was simulated as a function of
methanol partial pressure to supplement the results of the time-dependent kinetic model.
The equilibrium weight-average molecular weight was determined as a function of
methanol partial pressure, PM, at various Keq (0.1, 1, and 10), both with and without
residual water present after drying, C,"= 0 or 1.5 mM (FIGURE 3.25). The secondary x-
axis represents the methanol partial pressure, pM, that corresponds to each bulk methanol
concentration, CM, using the Raoult's Law vapor-liquid equilibrium description.
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Figure 3.25. Equilibrium weight-average molecular weight as a function of PM' at various Keq with
(solid lines) and without (dashed lines) the presence of residual water after drying. The experimental
pressure was measured as 5x10 2 mm Hg.
The equilibrium simulation results demonstrated the significance of both CM and
Keq on the equilibrium weight-average molecular weight. For the water-free case, the
equilibrium Mw increased logarithmically over the entire range of simulated methanol
concentrations. The simulation was sensitive to the selected Keq; increasing Keq by a
factor of 10 resulted in an increase in the theoretical equilibrium Mw by a factor of
approximately 3.2 for simulations without water present - the results were almost exactly
parallel when plotted logarithmically.
The effect of water was greatest at the lowest Cm and highest Keq. Interestingly, if
Cm is set equal to zero, the equilibrium Mw at the three simulated Keq converged to 692
kDa for 1.5 mM water. This suggested that a point could be reached experimentally
where methanol removal would provide little benefit due to the limit imposed by the
minimum in the residual water under the driest possible conditions. The resulting
disruption of the endgroup stoichiometry by the side-reaction, even in a small amount,
reduced the maximum achievable molecular weight.
The Karl-Fischer titration experiments demonstrated that exposed PEG readsorbs
water. To investigate the role of water in reducing equilibrium molecular weight,
additional values of Cw" (3, 7.5 and 15 mM) were examined over a range of Keq values,
0.1, 1, and 10 (FIGURE 3.26). As before, the secondary x-axis for pM was calculated
assuming Raoult's Law. In these simulations, increasing C,* had the greatest effect on
equilibrium Mw for Keq = 10 (FIGURE 3.26A) and little to no effect, except at very the
lowest simulated methanol partial pressures, for Keq= 0.1 (FIGURE 3.26C).
The increased Cw" had little effect on equilibrium Mw at high CM at all simulated
Keq. This implied that the presence of residual water at the simulated levels would have
no effect on equilibrium Mw until a CM of approximately 10 mM can be achieved. It was
evident from the presented results that maximal reduction in both CM and COw both
contributed to maximizing equilibrium molecular weight.
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Figure 3.26. Equilibrium M, as a function of Pm at various C," and three different K, values, (A) 10,(B) 1, and (C) 0.1. Dotted lines correspond to various C,* in units of mM, while solid lines correspond
to a water-free system. The secondary x-axis, pm, was calculated assuming Raoult's Law.
10 5
10 4
3.5.6 Methanol Mass Transfer Modeling: Analytical Solutions
A Fickian diffusion model was developed to determine the extent to which mass
transfer limitations could affect the results of the homogenous kinetic model. The quasi-
steady state, one-dimensional model was used to analyze the concentration of either
methanol or reactive endgroups as a function of the distance from the catalyst surface.
The model was solved for three cases: (1) a well-stirred bulk for which diffusion was
modeled in the boundary layer surrounding the catalyst bead, (2) a stagnant bulk where
catalyst beads have settled to the bottom of the flask, and (3) the thin film in the Protherm
in which the catalyst beads were homogeneously dispersed.
For the well-stirred bulk and the stagnant film cases, the polymerization reaction
is heterogeneous, and the solutions to the non-dimensionalized differential equation and
associated boundary conditions (EQUATION 32) for mass transfer of methanol in the
single-bead and stagnant cases are:
M(l) = [Da ed - Da *adoM(1) - + 1 (47A)
6.(n) = ' [Dan - Dn6(0)] (1 - 11) +alh 1aim (47B)
The effective forward rate constants for the single-bead and stagnant cases are described
by EQUATIONS 27 and 28, respectively. Solving EQUATIONS 47A and B for O(l)
and OM(O), respectively, yields:
2+Dabead
M( 2 + Da bead (48A)r,M
S1+Dan
M 1 Daim (48B)
r,M
Both EQUATIONS 48A and B provide the ratio of the methanol concentration at the
surface to that in the bulk. It represents the increase in the effective methanol
concentration at the catalyst surface due to mass transfer limitations.
For the Protherm case with homogeneous reaction, for which the effective
forward rate constant was defined in EQUATION 39, the solution is:
PTDaT cosh( Da DaP T
M Da J cosh (6 Dar) Da 49)
The solution to EQUATION 49 for OM(O) is:
Da -
T
Da DaP
O(O) = cosh(S Da)T Da (50)
An analytical solution was also determined for the mass transfer model for the
linker methyl ester reactive endgroup (EQUATION 34):
0A(r) = [Da *ad - Da AA (1)2]1 - J+ 1 (51)
OA (9) = Da" - Da (02A 2 -1) + 1 (52)
For r = 1 (single-bead) and r = 0 (stagnant), the term within the parentheses in
EQUATIONS 51 and 52 becomes (-1/2) and (-1), respectively. The (-2/3) factor was
approximated as (-1) and the quadratic equation was used to solve for OA(l) and OA(O).
1+ 1-4DaA + 4DaA DaA
OA (1) or OA(O) - DaA (53)
2Da f,
where i is 'bead' for OA(1) and 'film' for OA(O). The quadratic formula solution presented
in EQUATION 53 leads to two difficulties - multiple roots and a square root term. With
respect to the former, there is no way to a priori choose the correct root unless the
negative root provides a physically unrealistic, negative result. Similarly, because
imaginary solutions are unrealistic, as well, any results for which the determinant is
negative will be ignored.
3.5.7 Mass Transfer Modeling: Model Results
The solutions to the various mass transfer models were studied across a broad
range of molecular weights, up to 106 Da. The forward and reverse Damk6hler numbers
and the value of O1, the ratio of concentration of species i at the surface to either that in
the bulk or at the liquid-vapor interface, were calculated as a function of backbone
polymer molecular weight for each case. Some terms in these relationships varied with
molecular weight, while others were constant and specific to the geometry for the
respective case. The concentrations of the non-methanol species (A, B, and L) were
determined as a function of backbone polymer molecular weight according to
EQUATIONS 17, 18 and 19. For the methanol mass transfer modeling, these species
were assumed to be constant in space. For the endgroup modeling, the concentration of A
and B, as a function of molecular weight, was set as the bulk/liquid-vapor interface
concentration. The geometry-specific terms for each case are summarized in TABLE 3.5.
The bulk methanol concentration was set according to the experimentally measured
partial pressure assuming Raoult's law.
Table3. 5. Summary of estimates for various inputs into the Fickian methanol mass transfer model
for the stirred and stagnant cases. Parameters were tabulated using SI units for consistency.
Well-
.ed Stagnant PT UnitsStirred
6 or R 5.0x104 1x10.2  1X10-3  i
Nb.ad 3800 7600 beads
Aflask 2.6x10-3 M2
Aboad 3.1x10- 3.1xlO n2
f 0.5 dimensionless
VP- l.5x10-5 M3
K enz 1.x 10-10 Ime(mol-s)
CM( 6) 1 x0l7 (exp) mol/m
Keq 1 dimensionless
Finally, the diffusion coefficient of methanol in PEG was calculated using the
Wilke-Chang correlation (EQUATION 40) at 90*C. This calculation required the solvent
viscosity as a function of molecular weight, which was estimated according to the
literature [31] as follows. It is well-established [34] that the viscosity of low molecular
weight polymers is directly proportional to molecular weight. Once the molecular weight
is increased such that the polymers become entangled upon reaching the so-called critical
chain length, viscosity is approximately proportional to molecular weight raised to the 3.4
power. According to the tabulated data in the literature [31], which include entries for
PEG with M, of 500, 1000, 3350, and 8000 Da, the critical chain length for PEG is
between 3350 and 8000 Da. The PEG viscosity was modeled in three segments: (1) M" <
3350: a linear regression of the data for which viscosity a M, 1, (2) 3350 < Mn < 8000: a
straight line between the data points at either limit, and (3) Mn > 8000: an extrapolation
from the datum at.Mn = 8000 Da following the 3.4 power rule. The resulting PEG
viscosity as a function of molecular weight (FIGURE 3.27) was used to calculate the
methanol diffusivity (FIGURE 3.28).
A sample calculation of the forward and reverse Damk6hler numbers for the
single bead, methanol mass transfer case are presented in APPENDIX C. These
calculations are representative of those performed for the other species and other
geometric cases according to thee relevant equations detailed above (Equations 47-53).
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Figure 3.27. Viscosity of PEG presented as a function of weight-average molecular weight. The
viscosity was modeled according to literature data and polymer entanglement theory.
The self-diffusivity of PEG, which was assumed to be representative of the
diffusivity of the reactive endgroups, was modeled according to literature data [34].
According to the authors, the self-diffusivity of entangled polymers follows a minus-2
power law rule (D a M-2). The literature data were extrapolated according to this rule to
estimate the PEG self-diffusivity as a function of molecular weight (FIGURE 3.28).
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Figure 3.28. Diffusivity of methanol in PEG and the self-diffusivity of PEG presented as a function of
weight-average molecular weight. The diffusivities were modeled according to the Wilke-Chang
correlation, literature data, and appropriate power law rules for entangled polymers.
The geometric parameters in TABLE 3.5, the diffusivities in FIGURE 3.28, and
the corresponding equations from the Model Formulation section were used to calculate
the forward and reverse Damkdhler numbers for the methanol and reactive endgroup
mass transfer models (FIGURE 3.29). In all cases the Damk6hler number represents the
ratio of the rate of reaction to the rate of diffusion; for Damk6hler numbers much greater
than one, the rate of reaction is much greater than the rate of diffusion and the modeled
process is diffusion-limited. Conversely, when the Damk6hler number is much less than
one, diffusion occurs more rapidly than reaction and the process in question is reaction-
limited.
For the methanol models, Da was the highest for the stagnant film and the lowest
for the bead within the well-stirred bulk. This result was a direct consequence of
differences in the diffusion length and the effective forward rate constant for these two
cases. The results for DaiPT were at an intermediate level. The forward Damk6hler
numbers all followed the same trend, decreasing initially at lower molecular weights
before reaching a minimum at approximately 10 kDa. The initial decrease was due to a
decrease in the reaction rate associated with consumption of reactants, while the ensuing
increase was caused by the decreasing diffusivity of methanol, which decreased at a
faster rate than did the forward reaction rate. The minimum occurs soon after the critical
entanglement molecular weight (i.e. when viscosity shifts from the Mal rule to the M"3.4
rule).
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Figure 3.29. Forward and reverse Damkohler numbers for the methanol (A and B) and reactive
endgroup (C and D) mass transfer models estimated for the three different cases: a stagnant film, a
well-stirred bulk surround a catalyst bead, and the Protherm.
The reverse Damk6hler numbers were monotonically increasing across all of the
simulated molecular weights for all three cases. The magnitude of Dar is initially quite
small because there are minimal linker groups available to participate in the reverse
reaction. As before, the inflection point near 10 kDa coincides with the shift to an
entangled polymer model for the PEG viscosity. The reverse Damk6hler number
increases at a greater rate than the forward Damk6hler number because the reverse
reaction is relatively more significant than the forward at the increased molecular
weights. The fact that both the forward and reverse Damk6hler numbers are, with a few
exceptions, less than one, suggested that, although the predicted rate of diffusion may
have been slow due to the increased polymer viscosity, the rate of reaction was even
slower for the most part.
The ratio of the methanol concentration at the catalyst surface to that at the bulk
(bead) or liquid-vapor interface (film and PT) was calculated according to EQUATIONS
48A, 48B, and 50 (FIGURE 3.30A). For the film model, the methanol ratio begins at
approximately 2 at low molecular weights, reaches a local minimum at 10 kDa and a
local maximum of approximately 1.5 at 80 kDa before eventually decreasing below one.
The brief increase in the methanol ratio between 10 and 80 kDa suggested some, albeit
relatively small, accumulation of methanol at the catalyst surface because of mass
transfer limitations. A methanol ratio O(<1) is not physically realistic because it implies
that methanol is somehow being added to the system at the interface. In fact, the
methanol ratio for the film model is equal to one at a Mw of 147 kDa, which is exactly
equal to the equilibrium molecular weight predicted in the homogeneous modeling.
The methanol ratios for the bead and Protherm cases were approximately unity for
nearly all of the simulated molecular weights. This suggested that there would be no
methanol accumulation at the catalyst surface (bead) or reactor wall (PT) due to methanol
mass transfer limitations.
Because one of the goals of the mass transfer modeling was to determine whether
methanol accumulation occurred at the catalyst surface, it is instructive to determine
under which conditions significant methanol accumulation would occur by inspection of
the analytical solution. To increase the methanol ratio two conditions must be satisfied:
the forward Damk6hler number must be greater than (1) one and (2) the reverse
Damk6hler number. Because terms in the forward and reverse Damk6hler numbers are
both shared (Dm, effective kf) and interrelated (Ci), there are limited conditions for which
these requirements are satisfied. Specifically, the following ratio must be large:
CACB (54)
CLCM(R or 6)
Again, because the concentrations of A, B, and L are related to one another by
stoichiometry, this ratio can be large in only two situations: (1) early in the reaction when
CL is comparatively small or (2) when the bulk methanol concentration is further reduced.
The first case makes sense because there are few linkage groups available early in the
reaction to react with methanol in the reverse reaction. Overall, this analysis suggested
that methanol mass transfer limitations were not significant at the bulk methanol
concentration estimated for the experimental set-up.
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Figure 3.30. Ratios of concentration at the surface to that at the bulk or liquid-vapor interface for the
single-bead and stagnant cases, respectively. The concentration ratio, Oi, was determined for the (A)
methanol and (B) reactive endgroup models.
The forward and reverse Damk6hler numbers for the reactive endgroup mass
transfer model were also calculated (FIGURE 3.29C and D). Unlike the results for Daf,M,
the Daf,A were monotonically increasing. This was due to two factors: the reactive
endgroups (1) could only exist at the end of the same polymer chain and (2) were added
stoichiometrically. Therefore, the boundary condition at the catalyst surface contained a
squared variable term, which led to a different formula for the Damkihler numbers.
These factors also caused the Dai,A results to cover a much broader range of orders-of-
magnitude than were observed for Daf,M.
The endgroup concentration ratios were calculated according to EQUATION 53
(FIGURE 3.30B). The presented results omit any solutions for which the determinant in
the quadratic formula was negative, which was the case for the film model for molecular
weights between 30 and 100 kDa, as well as any negative values for the concentration
ratio, OA. Unfortunately, there was no way to distinguish between the positive and
negative roots that gave physically realizable results.
The concentration ratio at low molecular weight was less than 0(1), which means
that the surface concentration of the reactive endgroups was less than that at the interface.
This implied that limitations in the transfer of reactive endgroups to the catalyst may
inhibit the reaction rate at low molecular weights. At higher molecular weights, the ratio
increased to a value greater than 0(1) possibly suggesting regeneration of reactive
endgroups due to significant back reaction, which is an unlikely scenario in a real system.
3.5.8 Evaluating Polymer Molecular Weight by Gel Permeation Chromatography
Gel permeation chromatography (GPC), a type of size exclusion chromatography
(SEC) was used to evaluate the molecular weight of unknown polymer samples. GPC can
be used to make qualitative molecular weight comparisons between samples based on
their respective elution volumes. In SEC, higher molecular weight species elute at shorter
elution times than do lower molecular weight species because low molecular weight
polymers can enter the porous media thereby increasing their effective path length within
the column bank.
The GPC column bank was calibrated using a kit of narrow PMMA standards of
known molecular weights. Because retention time is related not only to polymer
molecular weight but to differences in hydrodynamic radius and non-specific interactions
with the packing media, as well, it was necessary to convert from PMMA molecular
weight to that of the backbone polymer. This conversion was performed using an
empirical relationship proposed by Mori [42, 43]:
(Mbackbone)i = s(PMlM)t (54)
where (M)i is the molecular weight of speciesj eluting at an elution volume, i, and s and t
are regressed empirical parameters. Application of this methodology to the GPC system
and PMMA standards is represented in FIGURE 3.31.
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Figure 3.31. Elution volumes for PMMA standards (9) were fit to a fifth order polynomial (solid
line). Elution volumes for known backbone polymer samples (m) and the and empirical relationship
of Mori [42, 43] were used to calibrate the GPC system for backbone polymer molecular weight.
The first step in the calibration was to determine the elution volumes for low
polydispersity PMMA standards of known molecular weights as represented by the
circles in FIGURE 3.31. A PMMA calibration curve was constructed by fitting the
individual PMMA data to a fifth-order polynomial (represented by the solid line).
The number of backbone polymer samples was limited because backbone
polymer standards could not be synthesized and were not commercially available4 .
Consequently, the elution volumes for PEG900 and short backbone polymer oligomers
were estimated from experimental data (FIGURE 3.32). The elution volume of PEG900
was determined for a sample containing only PEG900 dissolved in THF. A sample from
4 Monodisperse standards are usually synthesized by ionic or free-radical polymerization. Backbone
polymer can only be produced by condensation reaction. Moreover, although PEG standards were
available, their limited solubility in THF prohibited their use in the calibration.
an early time point in the polymerization (t = 30 min) is shown in FIGURE 3.32. The
three discernible peaks observed in the chromatogram were attributed to a mixture of
PEG900 and PEG900-linker (BA), BAB, and (BA)2B. The BAB and (BA)2B peaks likely
contain a mixture of BAB + BABA and (BA)2B + (BA)3, respectively. Unfortunately,
the column bank was unable to resolve higher molecular weight backbone polymer into
individual peaks. The solid squares in FIGURE 3.31 were determined according to the
elution volumes of the peaks and corresponding molecular weights in FIGURE 3.32.
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Figure 3.32. Chromatograms used to determine the elution volume for PEG900 and backbone
polymer oligomers of known molecular weights.
A least-squares regression was performed using the PMMA calibration and the
backbone polymer data according to the empirical relationship in EQUATON 54 (the
corresponding MATLAB code is included in APPENDIX B). The empirical parameters,
s and t, were determined to be 0.5 and 0.96, respectively. The dotted line in FIGURE 3.31
represents the backbone polymer calibration curve that results by transforming the
PMMA calibration according to the regressed parameters. The relationship of this dotted
line to the backbone polymer individual data points also represents the fit of the least-
squares regression used to determine s and t.
Samples were taken from the polymerization throughout the experimental study
of the backbone polymerization and analyzed by GPC. These measurements yielded a
chromatogram representing the molecular weight profile of the sample. Because it is not
possible to present and compare chromatograms for all time points in all of the completed
reactions, the information in a given chromatogram was reduced to representative values,
including Mn, M., and the polydispersity index, in order to compare results across a large
number of samples (see APPENDIX A for more information on these calculations). The
weight-averaged molecular weight, M., was chosen for the analysis because it best
represented the differences in the chromatograms observed throughout the study. Entire
chromatograms for specific samples will be presented and compared, as necessary.
3.5.9 Experimental Evaluation of Key Variables in Flasks
Backbone polymerizations were performed according to the procedure described
in Methods. All initial experiments were performed in glass flasks under a variety of
experimental conditions. Sixteen different reactions or sets of reactions were performed
during the polymerization studies. The conditions for these reactions were tabulated and
numbered for reference during the presentation of the results.
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Table 3.6. Summary of reaction conditions investigated during the polymerization studies. The
reactor, stirring, and presences of molecular sieves are listed for each reaction. The comment column
indicates other deviations from the standard reaction conditions, including those for reactions
investigating the effect of vapor-phase pressure, solvent weight percentage and the length of PEG
drying.
Reacton Reactor Srnng Sieves Comment
I Flask Magnebe No n=5
2 Flask Magnbc No P=360mmHg,n=2
3 Flask Mechanical No
4 Flask Mecharical No LML
5 Flask None No
6 Flask Mecharical No 25 vt% solvent
7 Flask Mecharcal No 50 Vt% solvent
8 Flask Mecharical Yes
9 Flask Mecharical Yes 10 min dpng
10 Rask Mecharical Yes No dring
11 Prooern 2000 rpm Yes
12 Proiherm 2000 rpm No
13 Proherm 2000 rpm No 25 vd% solinrt
14 Prolherm 2000 rpm Yes Doetle catdyst
15 Prolhemn 50 rpm Yes 1IrM
16 Prolherm 500 rpm Yes Repeat of 15
The effect of vapor-phase pressure above the reaction melt was assessed in flasks
with magnetic stirring of the reaction mixture (FIGURE 3.33). The vapor-phase pressure,
which was assumed to be directly related to methanol concentration in solution, was
varied using two different vacuum pumps. A diaphragm pump was used to maintain the
vapor-phase pressure above the reaction melt at 380 mm Hg. Under this condition, the
reaction was only modest with Mw = 3 kDa achieved after more than 50 hr. On the other
hand, a significant increase in Mw was observed when an oil-driven pump was used to
maintain a vapor-phase pressure of 0.05 mm Hg. The results for these high vacuum
polymerizations were quite variable, particularly at 48 hr; however, these results were
produced by a variety of experimentalists (including two 10.26 projects) over a range of
more than 3 years. Unfortunately, no further refinement in the polymerization behavior as
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a function of vapor-phase pressure was obtainable due to the inability to regulate the
system to intermediate pressure levels.
1 0 , , , , , , , , , , , ,
Vapor Pressure
(mm Hcg)
8 0 0.05 (n =5)
U 360 (n =2)
0
2
0 - - . ' . . ' . . .. . . .
0 10 20 30 40 50 60
Time (hr)
Figure 3.33. Backbone polymer M, versus time at two different vapor-phase pressures above the
reaction mixture. Flasks were magnetically stirred and total vapor pressure was controlled by an oil-
driven or diaphragm pump at low and high pressures, respectively. (Reactions 1 and 2)
The magnetic stirring bar stopped at reaction times corresponding to an
approximate M, of 4-5 kDa in the five reactions at 0.05 mm Hg presented in FIGURE
3.33. With the exception of one reaction in which Mw continued to increase to 11 kDa at
48 hr, the rate of Mw increase was drastically reduced once the stirring bar stopped. This
exception was the primary cause in the variability at 48 hr.
The effect of different methods of stirring the reaction mixture was investigated,
both at MIT and by our collaborators at UMass Lowell (FIGURE 3.34).
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Figure 3.34. Backbone polymer M, versus time under various stirring conditions. A stationary
magnetic stirring bar was placed in the reaction melt for the 'no stirring' case. Mechanical stirring
reactions were performed by different researchers at both MIT and UML. (Reactions 1, 3-5)
Two different stirring set-ups, magnetic and mechanical, were investigated at MIT
for polymerizations in flasks. The progression of the backbone polymer Mw in these two
different set-ups was nearly identical. Moreover, reactions in an identical mechanically
stirred flask set-up at UMass Lowell produced backbone polymer product very similar in
Mw (only final product was available for analysis - no intermediate time points were
sampled). The negligible differences between the two stirring methods was unexpected
because the mechanically driven blades were able to rotate for the duration of the
polymerization while the magnetic stirring bar typically stopped at a Mw of
approximately 4-5 kDa. The intact or crushed Novozym435 beads acted as tracers in the
mixture for visualizations of the mechanically stirred reactions. At early reaction times (t
< 12 hr), the reaction mixture was thrown up the sides of the flask with each rotation of
the mechanically driven blades. Under these conditions, mixing was achieved through the
combination of rotational and radial motion, the latter of which was caused by the
spreading and falling of the polymer melt along the flask wall. At longer reaction times (t
> 18 hr), the more viscous polymer melt accumulated in front of the blades to a height of
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approximately 2-3 cm. The rotating blades pushed the accumulated polymer in a circle.
The accumulated polymer did not appear to rotate or chum, remaining stationary relative
to the frame of reference of the rotating blade.
A blade 
melt
Figure 3.35. Schematic representation of the mechanically stirred polymerization in the flask. At
early times (A), the reaction is well-stirred, with the polymer melt spread repeatedly along the sides
of the flasks with each blade rotation. At late times (B), the polymer melt accumulates in front of the
blade and pushed around the flask with minimal mixing.
The reaction with no stirring used the magnetic set-up with a stationary stirring
bar. In this reaction, there was very little increase in Mw. In fact, even though a low
system pressure was maintained (0.05 mm Hg) for this experiment, the Mw for this
unstirred reaction was less than that for the stirred reaction at 360 mm Hg. This result
suggested that effective stirring was more important than methanol removal at the initial
stages in the reaction.
Polyethylene glycol-250 dimethyl ether, a non-reactive, negligible vapor pressure
solvent, was investigated to determine whether addition of a solvent could extend the
time that mechanical stirring could mix the polymer melt. The solvent was added at
varying weight percentages to reactions performed in the mechanical stirring set-up
(FIGURE 3.36).
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Figure 3.36. Backbone polymer M, versus time at various solvent weight percentages. PEG250
dimethyl ether was chosen as the solvent due to its non-reactivity and negligible vapor pressure.
(Reactions 1, 3, 4, 6, 7)
The M, for both polymerizations with solvent added (25 and 50 wt%) were lower
than that for the bulk polymerizations. Although the addition of solvent likely improved
the mixing conditions in the reaction, any related benefits were offset by the reductions in
reactive endgroup concentrations. These concentration considerations were one of the
key motivations behind performing polymerizations in bulk. The solvent addition also
has competing effects with respect to the methanol removal. While the solvent may
reduce diffusion limitations by decreasing the viscosity of the reaction mixture, it also
increases the methanol diffusion length due to the increased volume.
3.5.10 Polymerization with the Addition of 44 Molecular Sieves
Activated powdered 4A molecular sieves were added to the reaction mixture as a
potential scavenger of small polar molecules. Although sieves are traditionally used as a
drying agent, 4A sieves have the capacity, in theory, to trap both residual or reabsorbed
water and the methanol byproduct. The sieves were added at 10 wt% of the total mixture.
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Figure 3.37. Backbone polymer M, versus time in the presence of 4A molecular sieves compared to
reactions (A) with no sieves present and (B) under varying lengths of PEG drying. The typical drying
period was 2 hr. The data without sieves were reproduced from FIGURE 34.
The polymerization with molecular sieves added was compared to
polymerizations without sieves added (FIGURE 3.37A). Mechanical stirring was used for
the reaction with sieves. The results presented previously in FIGURE 3.34 were
reproduced for the reactions without sieves. Addition of molecular sieves led to a
significant increase in molecular weight compared to reactions without sieves added. The
increased molecular weight was observed at all times measured, which suggested that the
sieves increased both the initial rate of reaction as well as the maximum achievable
steady-state molecular weight. The molecular weight observed with the molecular sieves
added was the highest ever achieved for the backbone polymer. The molecular weight
also continued to increase even though poor mixing like that described in FIGURE 3.35
was observed after for time points greater than approximately 12 hr. Considering that
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they are designed to trap polar molecules smaller than 4A, it is possible that the sieves
were scavenging the methanol byproduct, essentially acting as small localized vacuums
within the melt.
Experiments were also performed with molecular sieves where the drying
conditions were varied (FIGURE 3.37B). In these experiments, the drying time was
either decreased to 10 min or completely omitted. The molecular weight still increased
substantially, reaching weight-average values of 10.5 kDa for both limited drying cases.
These molecular weights were also higher than that achieved in any previous experiments
without molecular sieves added, despite the fact that either no or minimal water was
removed from the hygroscopic PEG. The primary difference between the experiment
with complete drying (open squares) and those with incomplete drying (open circles and
triangles) was a slight delay in the molecular weight progression. Because the PEG was
not dry at the beginning of the reaction, the first part of the polymerization period may
have been devoted to PEG drying instead of chain extension. During this period, water
was likely removed both in the vapor headspace and by the molecular sieves.
During the course of the study, a number of polymerizations failed to achieve any
significant increase in molecular weight and were deemed failures, often for unknown
reasons. The cumulative failure rates for all reactions in both the flasks and Protherm,
either with or without molecular sieves present, were compiled (TABLE 3.7). A reaction
was designated as failed if the weight-average molecular weight was less than 4 kDa after
48 hours. Reactions without stirring or at high pressure were not included in this analysis.
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Table 3.7. Effect of 4A molecular sieves on the historical failure rate of backbone polymerization in
flasks and the Protherm.
Sieves? no. rxns Failure Rate
No 32 38%
Yes 12 0%
During the course of the study and particularly before the introduction of
molecular sieves, a significant number of reactions (38%) failed for unknown reasons.
However, not a single reaction out of the 12 in which molecular sieves were added failed.
This observation, together with the molecular weight increases achieved in the
polymerization (FIGURE 3.37), demonstrate the absolute necessity of adding molecular
sieves to improve the performance and reliability of the backbone polymerization.
3.5.11 Backbone Polymerization in the Protherm
The results of the polymerization study in the flask set-up were used to guide
experimental condition selection for reactions in the Protherm. The reaction conditions
investigated included the original reaction mixture ('no additives'), as well as reaction
with molecular sieves, 25 wt% PEG250 dimethyl ether solvent, or double catalyst loading
(FIGURE 3.38). The reaction times for the Protherm polymerizations were longer than
those for the flask reactions.
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Figure 3.38. Backbone polymer M, versus time in the Protherm under various experimental
conditions, including sieves, solvent, and double catalyst loading. The blade speed was 2000 rpm.
Samples were taken from the middle of the reaction zone. (Reactions 11-14)
In contrast to the flask polymerization study, a smaller total number of reactions
were performed because only a single reactor was available. The blade speed was set to
2000 rpm for all the polymerization data in FIGURE 3.38. This blade speed, which was
the maximum achievable by the Protherm drive motor, was chosen because it was
hypothesized that increasing the rotational speed would improve the mixing in the
system. Reaction in the Protherm produced significantly higher molecular weight product
in all cases compared to that observed in the flasks. Most importantly, the Mw for the 'no
additives' reaction at 196 hr represented the highest backbone polymer Mw ever achieved.
The Protherm produced higher Mw backbone polymer for the reaction with PEG250
dimethyl ether solvent (25% w/w), even though addition of the solvent significantly
reduced Mw in the flask set-up (FIGURE 3.36).
With the exception of the reaction with double catalyst (20 wt%), all Mw profiles
were concave upwards at early reaction times. This behavior is inconsistent with the
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concave downward reaction profile typically observed for condensation polymerizations,
The typical concave downward trend was restored by the addition of double catalyst,
which significantly increased the initial reaction rate. The Mw for the double catalyst
reaction converged with that for the other reaction conditions, which suggested that the
kinetic limitations may have been superseded by mass transfer limitations.
Based on the interesting concavity trends observed during the initial Protherm
reactions, a study was performed to better understand the fluid dynamics in the reactor,
specifically focusing on the characteristics of the thin film and fillet (TABLE 3.8). In
these studies, two different PEG molecules were used to simulate lower and higher
viscosities. The blade speeds were varied from 500 to 2000 rpm to simulate different
possible fluid mechanical regimes.
Table 3.8. Flow visualizations of the fillet and thin film in the Protherm for different PEG molecules
at three different blade speeds. Blade rotation is in the counter-clockwise direction.
PEG M, Speed
(Do) Opm) Observutions
1000 500 Observable fillet kom bottom to rihhL thinner st top. and not
4600
noticeable on left
Film thinner at top than at bottom, sirificant pooling.
1200 Fillet observed at lower rit with small fillet elsewhere,
Thin film i. still noticeably thinner on the top with some
pooling.
2000 Fills largest on right side and nearly disappears at the top
Thin filn appears to be approximately the same over stire
circunfernce.
500 Film appears competely uniform.
Fillet the same size at all circumferential positioru.
1200 Uniform thin film.
Fillet nearly uniform but signifcurtly smaller than seen St
500 rpm (about 1mm size).
2000 Uniform thin film.
Fillet is uniform and about the same size as at 1200 rpm.
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Significant differences in the extent of fillet development and fillet thickness were
observed during the Protherm fluid visualizations. At the lowest blade speeds and melt
viscosities, the fillet did not formed over the entire circumference of the reactor.
Consequently, the thin film was thinner at the top of the reactor and significant pooling
was observed at the bottom of the reactor. Under these conditions, the fluid viscosity and
blade speed were unable to overcome the force of gravity. For the low viscosity PEG at
the highest blade speed, 2000 rpm, which is close to the conditions in the reactor for the
polymerization results in FIGURE 3.38, the fillet exists throughout the circumference of
the reactor, albeit to a small extent at the top of the Protherm.
For the higher molecular weight PEG (Mn = 4600 Da), a uniform thin film and
complete fillet were observed over the entire reactor circumference at both 1200 and
2000 rpm. This result suggested that complete thin-film and fillet development likely
occurred between PEG molecular weights of 1000 and 4600 Da. The result for PEG
should be a reasonable proxy for the backbone polymer, which is composed primarily of
PEG900 monomer units.
During the Protherm reaction with molecular sieves added, samples were taken
from six locations throughout the reaction zone (FIGURE 3.39), including the front,
back, and four equidistant circumferential positions in the middle as detailed in the
Methods. There were no differences among circumferential samples taken at the middle
of the reaction zone. However, at the front and back of the reactor the backbone polymer
Mw did not increase beyond 5-6 kDa.
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Figure 3.39. Backbone polymer M, versus time at various positions within the Protherm reaction
zone. The reaction included 10 wt% molecular sieves. (Reaction 11)
The blades were set at 2000 rpm, the maximum attainable speed for the prototype
drive motor, in all of the Protherm results presented thus far. Two polymerizations, both
with 10 wt% molecular sieves, were performed at 500 rpm to assess Protherm
performance at a lower rotational speed. The Mw as a function of time for these
polymerizations are plotted along with the average Mw data for the 2000 rpm
polymerizations (FIGURE 3.40).
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Figure 3.40. Backbone polymer M, versus time for two different Protherm blade speeds. Two
polymerizations were performed at 500 rpm, both with 10 wt% molecular sieves. The data from
FIGURE 38 (Reactions 11-14) were averaged to produce the 2000 rpm curve for comparison.
In both of the experiments at the decreased blade speed of 500 rpm, the backbone
polymer M, was 17 and 19 kDa after only 48 hr. This M, was comparable in magnitude
to the highest previously attained Mw in approximately only one-fourth of the reaction
time. In both reactions, more than 75% of the mass of the initial reactants charged to the
reactor was observed to have been transferred from the walls to the blades, becoming
completely solidified on the unheated blade surfaces as a result. In both reactions, this
transfer occurred after the 48 hr time point and before the next sampling time. This
transfer of the melt out of the heated reaction zone and onto the blades likely prohibited
any further increases in Mw.
3.5.12 Comparison of Results in the Flask and the Protherm
Results for polymerizations in both the flasks and Protherm were selected for
comparison (FIGURE 41). Some reactions were omitted to avoid further complicating the
resulting plot.
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Figure 3.41. Comparison of backbone polymerizations performed in different experimental set-ups
and reaction conditions.
This direct comparison demonstrated that the combination of the Protherm thin-
film reactor at 500 rpm and the methanol and water scavenging capability of the
molecular sieves produced backbone polymer with the highest Mw. The Protherm
reactions at 2000 rpm proceeded more slowly than even the magnetically stirred flask
reactions without sieves added. However, all of the 2000 rpm Protherm reactions,
regardless of the addition of solvent, sieves, or double catalyst, ultimately reached or
were on a trajectory to reach Mw comparable to the Mw for the best recorded flask
reaction (magnetic stirring and molecular sieves, #8).
Three chromatograms were selected for closer analysis: (1) the flask reaction with
magnetic stirring at 48 hr (one of the five runs from which the average for reaction
condition 1 was determined), (2) the 144 hr time point from the 2000 rpm Protherm
reaction with sieves added (reaction condition 11), and (3) the 48 hr sample from the 500
rpm Protherm reaction with sieves added (reaction condition 15). The chromatograms
were processed to represent the absolute mass of species measured at the various
molecular weights by the procedure described in Appendix A, multiplying the relative
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mass by the total initial mass charged to the system in the form of PEG and linker (mass
losses due to methanol removal were ignored). This normalization technique accounted
for differences in the sample mass, allowing for direct comparison of the mass of
backbone polymer at each molecular weight.
- Magnetic - 48 hr (Rxn 1)
60 - PT 2000 + Sieves - 144hr (11)
- -PT 500 + Sieves - 48 hr (15)
E40
20 -
0 20 40 60 80 100
Molecular Weight (kDa)
Figure 3.42. Chromatograms for specific time points from select polymerizations. Data are presented
as the relative mass of backbone polymer at particular molecular weights
In addition to producing polymer with the highest M., the 500 rpm Protherm
reaction with sieves was the only chromatogram to produce any polymer species having
molecular weight greater than 40 kDa. Inspection of the shape of the chromatograms
provided additional insight. In particular, the sharp edge at 40 kDa for the 2000 rpm
Protherm reaction may have indicated that transesterification reactions were rearranging
any polymer chains greater than 40 kDa in length. This behavior is a characteristic trait in
condensation polymerizations as they approach or reach quasi-steady state [11]. There
was some moderate increase in molecular weight observed for this reaction beyond the
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144 hr time point (FIGURE 38, squares); however, the shape of the chromatogram was
unlikely to have been artifact. Moreover, transesterifications do not necessarily preclude
further increases in molecular weight - recall that the molecular weights are calculated as
averages of a distribution. Conversely, this phenomenon was not observed for the 500
rpm Protherm 48 hr time point. In this chromatogram, the diffuse right shoulder
suggested that the reaction had not yet reached quasi-steady state, providing further
evidence that the cessation of the molecular weight progression was caused by transfer of
the reaction mixture onto the unheated blades.
3.5.13 Comparison of Experimental Results and Model Predictions
Different models have been proposed and investigated to different extents. The
results of the homogeneous kinetic model were compared to experimental results for four
selected polymerizations (FIGURE 3.45). The experimental bulk methanol concentration
was estimated to be 1x10-4 M according to the Raoult's Law assumption. The model
predictions for this concentration (the steep solid line) were higher than the
experimentally measured weight-average molecular weights at all reaction times. The
experimental results were actually most comparable to the homogeneous model
predictions for a bulk methanol concentration of 1x10 2 M. This was particular true for
the 500 rpm Protherm reaction and mechanically stirred flask reactions, both with
molecular sieves added. The difference between the experimental results and the
predictions for the estimated experimental bulk methanol concentration (lx10-4 M)
suggested that the homogeneous kinetic model over-predicted the concentration of
methanol present in the reaction mixture by 2 orders-of magnitude or more. This
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discrepant prediction could be caused by insufficiencies in the homogeneous description
of the reaction mixture as well as uncertainties in the various model parameters.
30
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Figure 3.43. Comparison of various experimental polymerizations with kinetic modeling results. The
experimental bulk methanol concentration was 1x1O4 M.
Although Keq for similar reactions are typically 0(1) [11], the inability to
experimentally determine the Keq for the backbone polymerization created additional
parameter uncertainty. To address this uncertainty, the homogeneous model predictions at
equilibrium were also compared with selected experimental results (FIGURE 3.46). The
experimental data did not intersect the model predictions at any of the simulated Keq
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(between 0.1 and 10) in either a water-free or dried PEG system (Cw" = 0 and 1.5 mM,
respectively).
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Figure 3.44. Comparison of three experimental polymerizations with equilibrium modeling
predictions.
To try and identify the source(s) of the differences between the model predictions
and experimental results, two possible strategies could be invoked to explain the
aforementioned discrepancies: (1) decrease the equilibrium molecular weight predicted
by the model (i.e. shift the solid and/or dashed lines down) or (2) increase the methanol
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concentration corresponding to the experimental data (i.e. shift the open symbols to the
right).
The mass transfer modeling was completed, in part, to estimate the actual
concentration of methanol participating in the reverse polymerization reaction. The
proposed diffusion limitations would increase the concentration of methanol beyond that
designated in the bulk by the vapor-liquid equilibrium. Although the results of the mass
transfer modeling did predict some increase in methanol concentration due to these mass
transfer limitations (FIGURE 3.30), the predicted increase was uniformly less than a
factor of two. This predicted factor of two (or less) would not be sufficient to shift the
experimental data enough to align with the experimental results.
Inaccuracies in model parameters could also account for the observed differences.
In particular, if the initial water concentration in the system was much higher than that
measured by Karl-Fischer titration, then the resulting stoichiometric imbalance could
significantly reduce the predicted equilibrium molecular weight. Because there is no
experimental data for the equilibrium constant, it is also possible that the lowest
equilibrium constant simulated was not low enough. Both of these inaccuracies could
shift the model predictions downward and therefore closer to the experimental results.
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3.6 Discussion
Overall, the solubility data in the literature, in the form of Hildebrand solubility
and Flory-Huggins chi parameters, suggested that the Raoult's Law description was a
reasonable estimate of the vapor-liquid equilibrium behavior of methanol in PEG (or the
backbone polymer). Although some hydrogen bonding is clearly possible, particularly
between the free hydroxyl groups at the terminus of the PEG and the methanol in
solution, the other groups within the PEG, both the CH 2 and weak electron pairs of the
ether oxygen, would be minimally interactive with molecules the methanol.
Application of the Raoult's Law assumption also required that any effect of the
increase in moles in the polymer melt over the course of the reaction were essentially
ignored. That is, the Raoult's Law solubility was calculated at the very beginning of the
reaction and assumed to be equivalent to the Henry's Law constant, which is applied
independently of the number of moles in a particular solvent. If this assumption was
invalid, the estimated bulk methanol concentration could be considerably underpredicted.
However, Henry's Law should be the most appropriate description of the vapor-liquid
equilibrium in the system considering the high pure component vapor pressure of
methanol at 90 0C and the low level of vapor-phase pressure maintained in the reaction
system.
The importance of minimizing the bulk methanol concentration was emphasized
by the predictions for the homogeneous kinetic model. The model results also provided
an upper bound for the molecular weight that could be achieved under ideal experimental
conditions at the bulk methanol estimated according to the Raoult's Law solubility. This
upper bound of approximately 150 kDa was fifty times higher than any weight-average
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molecular weights achieved experimentally before initiation of the research described
herein.
The effect of residual water after drying was also investigated with the kinetic
homogeneous model. Using the amount of residual water measured by Karl-Fischer
titration experiments, as well as initial water concentrations up to 10 times higher,
molecular weight predictions were affected minimally at high Cm and moderately at low
CM. There is opportunity to adjust the system of reactions to include a stronger effect of
water on the stoichiometric ratio, r, and, therefore, a stronger influence in reducing the
predicted molecular weight. In the current model, the forward and reverse rate constants
for the hydrolysis reaction were set equal to those for the chain-extension reaction. One
could propose a system of reactions where the reverse rate constant for the hydrolysis
reaction was set equal to zero.
Interestingly, some researchers have observed deleterious effects on the catalytic
ability of immobilized lipases due to reduced water content in reaction mixtures [3].
These researchers proposed that some level of water was required to hydrate the enzyme
to promote binding and catalysis of the esterification reaction.
The model non-dimensionalization and resulting analytical solutions provided
insight into the mass transfer dynamics within the polymer melt in multiple geometries.
Damk~hler numbers, which relate the rate of reaction to the rate of diffusion, were the
result of the non-dimensionalization for all models studied. In addition to determining the
length of the mass transfer boundary layer, the system geometry was responsible for two
contributions to the model through (1) the calculation of the effective rate forward
constant according to the distribution and availability of enzyme sites in the polymer melt
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and (2) the coordinates applied when solving Fick's Law. For the single-bead model,
spherical coordinates led to a 2 instead of a 1 (for rectangular coordinates) as part of the
sum in both the numerator and denominator of the solution (see Equation 48A).
The analytical solution for the reactive endgroup species led to imaginary results
for some of the backbone polymer molecular weights evaluated. These imaginary results
(negative determinants) indicate a physically unrealizable state in the reaction mixture for
molecular weights between 20 and 90 kDa. This is due to a combination of two effects:
(1) the second order consumption of the reactive endgroups and (2) diffusion limitations
that reduce mass transport of the reactive endgroups to the catalyst surface. Although the
model continues to predict a reactive endgroup concentration ratio (OA) beyond 90 kDa,
this point cannot be reached in a real experimental system due to the imaginary solutions
beginning at approximately 20 kDa. The analytical solution for the reactive endgroups for
the well-stirred bead also required application of the quadratic equation; however, the
determinant for this case was never less than zero and, therefore, no imaginary solutions
were encountered. The determinant was only very narrowly positive and it is possible that
an imaginary solution was within the uncertainty of the model parameters.
The inability of the mass transfer modeling to account for the difference between
the homogeneous model predictions and the experimentally observed results was
surprising, particularly with respect to methanol mass transfer limitations, considering the
breadth of experience in both the literature and industry with byproduct removal-limited
polycondensation reactions. The primary difference between the system studied in this
work and those studied in the literature, most notably the polyamidation reaction for the
production of nylon 6,6, was the enzyme catalysis. It is well known that enzymatically
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catalyzed reactions oftentimes do not follow elementary kinetics such as the second order
kinetic rate equation assumed for the mass transfer analysis. Models, such as Michaelis-
Menten, have much more complicated dependences on the reactant concentration.
Although an analytical solution would likely not exist for the mass transfer cases studied,
a more complex rate equation may have yielded different results.
A second difference between the backbone polymerization system and nylon 6,6
was the relatively large size of the monomer units, particularly PEG900. The primary
effect of this difference is that backbone polymer viscosity increases much more
significantly with polymerization number than does that for nylon 6,6. This means that,
holding all else equal, for a given molecular weight and associated viscosity and diffusion
coefficient, the concentrations for the reactive endgroups will be lower for a polymer
having higher molecular weight monomer subunits. According to the analytical solutions
(Equations 48A and B), this could contribute to a corresponding decrease in the result for
OM(O), which suggests that some correction or adjustment to the model development may
be necessary to account for the large molecular weight of the PEG and linker monomers.
A wide range of variables were studied during the polymerization experiments.
Decreasing the vapor-phase pressure by nearly four orders-of-magnitude (from 360 to
0.05 mm Hg) only led to a modest, fivefold increase in polymer molecular weight. This
was in contrast to the homogeneous model, which would have predicted an
approximately two order-of-magnitude increase in molecular weight with such a drastic
change in vapor-phase pressure (and the corresponding decrease in bulk methanol
concentration). This first result was an early indication that significant non-idealities, in
particular, deviations from homogeneity, were present in the reaction system. The results
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for the stirring experiment (FIGURE 3.34) demonstrated that some fluid motion was
necessary to promote the reaction, which was likely related to the need for a multi-body
collision or sequence of collisions required to generate a chain extending ester bond. The
stirring would be necessary not only to homogenize the bulk but to increase the collision
frequency of reactants, as well.
The addition of molecular sieves was the key improvement to the experimental
conditions during the studies in flasks. The 4A molecular sieves were able to act as
scavengers for either water or methanol (or both). The addition of sieves improved the
absolute molecular weights achieved in the flasks and the reliability of the flask reactions.
In the experiments where either minimal or no PEG drying was performed, Mw greater
than those previously measured without sieves were still realized even though significant
water was present in the system upon initiation of the polymerization. The fact that the
molecular weight progressions were delayed in these incompletely dried experiments was
tangible evidence of water inhibiting the polymer chain extension most likely via its side
reaction with linker. The fact that the high molecular weight was still achieved suggested
that any hydrolysis reaction that had occurred was reversible to a certain extent.
The significant improvements in backbone polymer molecular weight achieved by
addition of sieves were surpassed by adapting the Protherm thin-film evaporator for use
as a batch thin-film reactor. With the exception of the reaction with double catalyst
loading, the initial reaction rate in the Protherm at 2000 rpm was slower than that
observed in the flasks. Flow visualizations were performed to try and develop an
explanation for this observed trend. For PEG1000 at 2000 rpm, a thin film was
completely developed, but fillet formation was incomplete. Conversely, a rapid increase
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in molecular weight was observed for the same reaction conditions with a blade speed of
500 rpm. Flow visualizations of PEG 1000 at 500 rpm showed significant pooling and
minimal fillet formation. It is unclear, a priori, whether the observed fluid dynamics were
causative or correlative.
Fluid dynamic modeling in the literature provides relevant information [17]. In his
work, Komori models the fluid dynamics in a falling thin-film evaporator. Although the
model results predict significant rotational fluid velocity within a fillet, very little mixing
is predicted either within the fillet or between the fillet and thin film. This would be even
more pronounced for fluids having viscosities greater than water. Because the reaction
mixture is more readily distributed into fillets and a thin film at the higher blade speed
and because minimal mixing occurs within fillets, limited mixing may cause the
decreased initial reaction rate at 2000 rpm. At 500 rpm, the centripetal forces are unable
to overcome gravity and the reaction mixture remains predominantly in a pool at the
bottom of the cylinder. In this situation, one could liken the mixing of the polymer melt
by the rotating Protherm blades to the motion in a conventional front-loading washing
machine. The minimal mixing predicted in the fillet does raise some concern for the later
stages of reaction, even for the 500 rpm case, where the fillets and thin films are well-
developed. However, given the correspondingly higher viscosities at the later stages in
the reaction5, it is unlikely that significant mixing, in either the laminar or turbulent
sense, could be achieved by any means, mechanical or otherwise.
For the 500 rpm Protherm reaction, further increases in molecular weight were
not realized because the polymer was transferred to the unheated blades from the reaction
5 Viscometry measurements were performed for three PEG MWs at various added solvent wt%, with and
without catalyst beads present. This study, which was performed by Nathalie Pinkerton as part of the
UROP program, is presented in detail in APPENDIX D.
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zone. This could be potentially avoided by heating the blades, which was not possible in
the prototype model used in these studies. It is possible that even higher Mw could be
achieved if such an improvement was implemented in the Protherm. Beyond the heated
blades, additional experiments at other blade speeds to determine a potential optimum are
recommended, as well. Further study of the polymerization in a scaled-up thin-film
reactor (larger bore cylinders are commonly manufactured by our industrial collaborator,
Artisan Industries) would also be interesting to investigate the scalability of the process.
The results from modeling and experiment were compared to assess the validity
of the various model assumptions and the accuracy of the model inputs. The methanol
mass transfer modeling, which only predicted a very minimal increase in the surface
methanol concentration due to mass transfer limitations, was unable to account for the
observed differences. The mass transfer modeling for the reactive endgroups did suggest
a possible explanation for the lower molecular weights achieved; however, the fact that
molecular weight increases were observed when molecular sieves were added strongly
suggested that the presence of either water or methanol played some role in inhibiting
molecular weight progression.
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3.7 Conclusion
The enzymatic polymerization of PEG and dimethyl 5-hydroxyisophthalate
(linker) to produce backbone polymer was investigated using both predictive modeling
and experiment. The production of high molecular weight backbone polymer was
desirable both as a reaction engineering problem as well as for the intended application
for the resulting backbone polymer. As described in Chapter 5, the production of high
weight polymer increased the design space over which the final synthetic product, the
targeted nanoparticle micelles, could be investigated.
Key experimental variables were tested, including vapor-phase pressure, stirring,
and PEG water content. Once suitable vacuum was applied, addition of molecular sieves,
which could participate by scavenging either residual water or methanol byproduct, was
the greatest factor in increasing Mw (12 kDa at 70 hr) in reactions performed in flasks.
The Protherm, which was modified to operate as a batch thin-film reactor, was employed
in order to improve methanol mass transfer and mixing within the polymer melt. Three
separate reactions in the Protherm produced the highest Mw backbone polymer
(approximately 20 kDa). A blade speed of 500 rpm with molecular sieves present was
able to achieve this Mw in 48 hr.
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Radioiodination Method Development for
Quantitative Analysis in vitro and in vivo
4.1 Introduction
In order to assess the performance of a nanoparticle delivery system in biological
applications, a label that is detectable under a wide range of conditions and
concentrations must be present within the molecule. Spectrophotometric measurements of
aromatic groups within a structure, such as tyrosine residues within a peptide, are a
straightforward example. In fact, one of the primary benefits of magnetic nanoparticles,
such as cross-linked iron oxide [1], or quantum dot based nanoparticles [2] is their
inherent measurability. However, for organic delivery system, such as polymeric
micelles, dendrimers, and liposomes, straightforward measurement techniques prove
insufficient as the introduction of cellular or even tissue components from biological
systems significantly increase the complexity of experimental conditions; consequently,
some exogenous label must be introduced to facilitate detection of the delivery system.
An ideal label will have the following properties: (1) high sensitivity to allow for
quantitative measurement across a broad concentration range, (2) negligible effect on
particle properties due to minimal interactivity and/or size, (3) straightforward chemical
reaction for simple introduction into the chemical structure, and (4) broad applicability in
a variety of analytical techniques.
Various fluorescent and radioactive labels have been developed that meet some,
but not all, of the above requirements. In particular, fluorescent dyes can be conjugated to
structures with well-established synthetic techniques. Unfortunately, commonly
employed dyes like those of the Cy or Alexa fluor@ families, though unquestionably
effective for a variety of microscopy studies [3], are large, hydrophobic structures. As a
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result, fluorescent dyes fail to meet the second criterion of minimal size and interactivity
with the particulate delivery vehicle. For the case of the polymeric micelles studied in our
research, the addition of highly hydrophobic moieties can disrupt the micellization
putting any subsequent analysis into question. A second major drawback of fluorescent
techniques is the short penetration depth of light within the body (typically < 50 mm),
which limits the use of fluorescent dyes in imaging of near-surface phenomena [4].
Radioactive isotopes are particularly attractive because they can be quantifiably
detected across a broad range of concentrations, are small, and broadly applicable. There
are some potential drawbacks, which include the occupational and waste disposal hazards
inherent to work with radioactivity, limited commercial availability and corresponding
high costs of certain isotopes, and comparatively difficult synthetic steps for conjugation.
Researchers, including those studying circulating delivery systems [5, 6], have
frequently used the P-emitting isotope tritium [3H]. Due to the weakness of the P decay,
sample activity is determined indirectly by measurement of ionizing radiation-induced
phosphorescence using a liquid scintillation cocktail. Accurate quantification requires
careful calibration as well as additional preparation steps to remove any photoactivity that
might obscure spectrophotometric measurements by the scintillation counter. The fact
that p emissions cannot penetrate the skin eliminates tritium as an option in live animal
imaging applications.
In response to the demands of the field, many researchers have conjugated high
energy-emitting isotopes, such as y and positron emitters, to their structures. Examples
used in the field include 64Cu [7], 67Ga [8], 99mTc [9], "'In [10], 125I [11], and 131I [12].
Radiolabels and relevant experimental procedures for use in nanoparticle research have
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been reviewed [13]. Due to their high penetration length and ease of detection via gamma
counting, these strong-emitting isotopes all satisfy the first criterion for an effective label
- straightforward quantification across a broad range of concentration - and, in terms of
research application, are excellent labels for in vitro and ex vivo biodistribution studies
[14]. Moreover, when compared to the large, hydrophobic structures of fluorescent dyes,
strong-emitting radioisotopes are small and should, in general, have minimal effect on
physical properties upon conjugation. This is also the case, but most likely less so, for
metallic isotopes, such as 64Cu, which are conjugated via small macrocyclic chelators like
DOTA.
In imaging, gamma emitting isotopes found early use in nuclear imaging
applications using planar gamma cameras. This technology has been surpassed by
subsequent nuclear imaging techniques, including single photon emission computed
tomography (SPECT) and positron emission tomography (PET), which provide increased
resolution and richer spatial information [4, 14].
There are many isotopes from which to choose to meet the four requirements for
an ideal label, and both the particular delivery system and intended application will
influence this choice. However, with respect to the fourth criterion, the various isotopes
of iodine provide many potential applications for an iodine-conjugated particle.
Specifically, 1241 is a positron emitter for use in PET [15], 123I and "'I can both be used in
SPECT [4], and 125, as previously described, can be used in research applications and
gamma imaging. Beyond the previously described imaging applications, an isotope of
iodine, 1311 has been used clinically for radioimmunotherapy of various cancers since
1943 [16].
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Although stability must be considered for all radiolabeled compounds and is of
particular concern for metal chelators such as those used for 64Cu [17], the relative
lability of the carbon-iodine bond, particularly when exposed to a class of enzymes in the
body known broadly as 'deiodinases,' must be considered when using radioiodine for in
vivo applications. Previous research suggests that deiodination occurs to a much greater
extent for iodine bound directly to proteins than for iodine bound to non-proteinaceous
compounds [18, 19]. Therefore, stability can be improved by incorporating non-protein
based carbon-iodine bonds into a delivery system.
There are a number of methods by which iodine is chemically conjugated to
organic molecules [20], including isotopic exchange, electrophilic substitution,
nucleophilic substitution, or replacement of an activated group, such as a trialkyl
stannane [21]. Electrophilic substitution of a hydrogen atom on an activated aromatic ring
is the most common method. This is accomplished by adding an oxidizing agent, such as
chloramine-T (FIGURE 4. lA) [20] to a solution of sodium iodide to generate oxidative
reactive iodine species. After addition of the material to be labeled, the reactive species
replaces a hydrogen atom in the position ortho (immediately adjacent) to an electron-
withdrawing group to produce the radiolabeled product (see structures in FIGURE 4.2,
[20]). The presence of this electron-withdrawing group at the ortho position creates a
partial positive charge that makes the carbon-hydrogen bond more susceptible to
oxidative substitution by the activated iodine species. Increasingly strong electron-
withdrawing neighbors impart greater reactivity. The electron-withdrawing group
typically does not affect carbon-hydrogen bonds at the meta or para positions, which are
further removed than ortho.
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Products, such as Pierce Chemical's Pierce lodination beads (formerly
IODObeads) and lodogen (FIGURE 4. 1B and 1C, respectively), have been developed to
reduce sample damage caused by excessively oxidative conditions as well as to facilitate
the separation of oxidizing material from the labeled sample [22]. Pierce lodination beads
are chloramine-T immobilized on a neutral bead, whereas Iodogen, which has very
minimal solubility in water, is used by coating glass reaction tubes with the chemical.
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Figure 4.1. Chemical structure representations of chloramine-T (A), Pierce iodination beads (B), and
the lodogen reagent (C).
The previously described techniques, though well-characterized and in common
use for decades, require the presence of an activated aromatic group, that is, an aromatic
substituted with some strongly electron-withdrawing group. lodination of proteins and
antibodies has been the most common application of the technique due to the phenol
group within tyrosine moieties (FIGURE 4.2C). In fact, Iodogen has been used to label
proteins in a microfluidic device [23].
However, activated aromatic groups are not nearly as common in the circulating
delivery field as in protein biology. The straightforward conjugation of radioiodine using
materials like Pierce Iodination Beads has inspired researchers to modify their chemical
structures to introduce tyrosine-like groups. In particular, tyramine [24] (FIGURE 4.2D),
tyrosinamide [25, 26], or other tyrosine-like groups [27] have been incorporated into
block copolymer structures in small quantities to allow for iodination. The Bolton and
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Hunter reagent (FIGURE 4.2E), which can be used to attach a tyrosine-like residue to
primary amines, has also been used to modify structures of a delivery system for easy
iodination [28].
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Figure 4.2. Chemical structures of various molecules designed for iodination by the reagents in
FIGURE 1, including (A) our alternating copolymer backbone polymer, (B) the backbone polymer
substituted with 100% hydrocarbon sidechains via an ester linkage (polymer 027), (C) tyrosine, (D)
tyramine, and (E) the Bolton and Hunter reagent. Asterisks indicate sites for iodination, which are at
the position ortho to aromatic electron-withdrawing groups.
Although these techniques are straightforward, the modifications introduce
additional synthetic steps and potentially obfuscate results by altering the system of
interest. Though instances of circulating delivery systems iodinated without modification
are few, two specific examples were identified: directly-labeled iron oxide magnetic
particles [12] and single-wall carbon nanotubes [29]. While these two examples are
interesting, they are separate from the polymeric micelle family of delivery systems. The
unique structure of our alternating copolymer [30-32] (FIGURE 4.2A), the
hydroxyisophthalate linker in particular, provides an intrinsic iodination target within the
structural design. Substituting the polymer backbone with hydrophobic groups to produce
an amphiphilic molecule transforms the aromatic hydroxyls into ethers or esters
(FIGURE 4.2B). The carbon hydrogen bonds in positions ortho to aromatic ethers and
esters, which are comparatively weaker electron-withdrawing groups, will likely have a
136
lower reactivity relative to that for aromatic hydroxyls. However, in contrast to proteins,
which may only have a few surface-exposed tyrosine residues available for labeling,
every repeat unit in our polymer contains two potential iodination sites.
Polymer 027 (FIGURE 4.2B), which is the backbone polymer fully substituted
with hydrocarbon sidechains via an ester linkage, was the primary polymer formulation
studied, (1) because it was synthesized in sufficient quantity to supply the breadth of the
desired studies; and, (2) like many of the polymers investigated in this work, polymer 027
contains a tyrosine-like group with an activated aromatic group that is sufficiently
chemically different from tyrosine such that successful labeling was not assured. In fact,
the ester sidechain linkage was the weakest electron-withdrawing group present in any of
the linkages studied (The electron-withdrawing capacity of the linkage groups studied
were: hydroxyl < ether < ester).
Though much research has carefully characterized iodination of small aromatic
compounds with a variety of techniques [33-35], we are aware of no investigation into
the direct iodination of macromolecules similar to our copolymer system. In this work,
we demonstrate successful attachment of radioiodine to our copolymer system by
adapting a standard method used to label tyrosine residues in proteins. This method was
adapted and directly applied to our novel alternating amphiphilic copolymer without any
additional modifications to the chemical structure of the target molecule because of the
tyrosine-like groups present within its repeating backbone structure. This adapted
procedure produced highly pure, stably radiolabeled polymer with high overall product
recovery. Radiolabeling yield was sufficient to supply radiolabeled product for use in a
variety of research applications, including quantitative cellular uptake and biodistribution
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studies using iodine-125, as well as positron emission tomographic imaging (PET) of
both mice and rats with iodine-124.
4.2 Materials and Methods
4.2.1 Materials
All polymers were synthesized by collaborators in the lab of Professor Arthur
Watterson at the University of Massachusetts at Lowell (UML) as described in Chapter 2.
Unless otherwise indicated, the backbone polymer starting material for all samples in this
study had a number average molecular weight (Mn) of 3 kDa with a polydispersity of
about 1.75 using measurement and data analysis techniques described in Section 3.2. The
molecular weight of the final polymer differed depending on the nature of the attached
sidechains. Aqueous solutions of known concentrations were created by weighing and
dissolving the solid polymer as received. The E13.4.3 targeting peptide was produced via
bacterial fermentation of Rosetta (DE3) cells (P/N 70954, Novagen, Madison, WI) in a
20 L bioreactor by Professor Carl Lawton at UML as previously described [36, 37]. All
other materials and reagents were obtained from commercial sources. Polyethylene
glycol (PEG-1000), dimethyl 5-hydroxyisophthalate, sodium metabisulfite (Na2 S205),
bovine serum albumin (BSA), tetrahydrofuran (THF) Trizma HCL, Trizma base, sodium
iodide, potassium iodide (KI), sodium azide, hydrochloric acid, and sodium hydroxide
were purchased from Sigma-Aldrich (St. Louis, MO). Phosphate buffered saline (PBS,
1 Ox) was purchased from VWR International (West Chester, PA) and diluted in
deionized water. Pierce Iodination Beads (formerly IODObeads) were purchased from
Thermo Fisher Scientific (Rockford, IL). Various Sephadex media, including G10, G15,
G25 ('Medium' particle size), and DEAE (diethylaminoethyl) Sephadex, were purchased
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from both Sigma-Aldrich and GE Healthcare (Piscataway, NJ). PD-10 desalting columns,
which are pre-packed with Sephadex G25, were purchased from GE Healthcare.
Disposaflex disposable columns were purchased from Kimble Chase (Vineland, NJ).
Finally, carrier-free sodium [1251]iodide (specific activity: 17 Ci (629 GBq)/mg,
radioactive concentration: 100 mCi/mL in 10-5 M NaOH, concentration: 5.88 pg/mL) was
purchased from PerkinElmer (Waltham, MA).
Preparation of Radioiodinated Product
A standard protocol was used for iodine attachment. Experimental conditions
were varied from this standard procedure depending on the requirements of the particular
experiment. For example, reaction time was varied to determine conditions for optimal
yield or concentrations were increased to provide sufficient material for certain assays.
All reaction conditions were as described in this standard protocol unless otherwise
specified.
4.2.2 Iodine Attachment
One iodination bead was washed with 1 mL of PBS, dried, and transferred to a 2-
mL conical-bottom microcentrifuge tube (Sarstedt, Newton, NC) before addition of 100
ptL Tris buffer. Sodium ['251]iodide solution (1 mCi total activity, 10 pL/mCi) was added
to the tube and allowed to activate for 5 min with occasional mixing by tapping the tube.
A 100-pL volume of sample solution (1 mg/mL) was added to the activated [125 1]iodide
and reaction was allowed to proceed for 5 min with occasional mixing. After reaction, the
product solution was removed from the iodination bead with a pipette. For procedures
labeling only protein (i.e. samples without polymer), the remaining bead was washed
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twice with 60 ptL of BSA chase solution (5 mg/mL BSA, 1 mM KI) to promote protein
desorption. For procedures with the polymer, BSA was deemed unnecessary due to the
low non-specific adsorption of the highly PEGylated polymer, and BSA chase solution
was replaced by an identical volume of PBS. Residual oxidizing species were inactivated
by addition of 60 [tL sodium metabisulfite solution (12 mg/mL in PBS). The bead and
inactivation washes were combined with the product solution.
4.2.3 Separation of Labeled Product and Free Iodine
Unreacted, free 1251 was separated from the labeled sample using Sephadex
separation media with either manually-packed Disposaflex columns (Kimble-Chase,
Vineland, NJ) or pre-packed PD-10 columns (with Sephadex G25, GE Healthcare,
Piscataway, NJ). The dimensions of the Disposaflex columns and PD-10 columns are
summarized in TABLE 4.1. For the manually-prepared columns, Sephadex media,
including G10, G15, G25, DEAE-Sephadex (diethyl aminoethyl), were swelled in PBS
(with 0.02% w/v sodium azide) for at least 1 day at room temperature.
All operations in both the Disposaflex and PD- 10 columns, including packing
(where relevant), equilibration, and separation, were performed by gravity flow.
Sufficient buffer was maintained in the reservoirs above each media at all times to ensure
that air did not contact the resin bed. The approximate flow rate was 0.4 mL/min for all
operations. Columns were packed by adding the Sephadex slurry to the Disposaflex
columns and allowing the resin to settle. PBS was added as necessary during the settling
period to maintain the flow rate and avoid airing out the resin. After the Disposaflex
column was filled with approximately 1 column volume (10 mL) of media, the Sephadex
was then washed and equilibrated by flowing approximately 3 column volumes (30 mL)
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of PBS through the settled resin bed. For purifications of labeled protein, 1-2 mL of BSA
chase solution was added in between the second and third column volumes of PBS in
order to reduce non-specific protein adsorption on the Sephadex. Columns were washed
with an additional 5 mL of PBS, again by gravity flow, and stored overnight at 4 "C.
On the day of the iodination, manually-packed columns were washed by flowing
1 additional column volume of PBS through the resin bed. The product solution (210
gL), which was combined with the bead and inactivation washes (180 gL) to yield a total
volume of 380 pL, was gently added directly to the top of the column by a P 1000 pipette
to avoid disturbing the resin. After the entirety of this solution entered the resin, PBS was
gently poured and replenished as necessary into the cone feeding the column inlet to
maintain flow and to avoid drying of the packed resin. At least 4-5 mL was maintained in
the reservoir at all times. A volume of PBS equal to that collected at the column outlet
was added over the course of the separation. The total amount varied depending on the
total elution time investigated for a particular experiment.
Fractions were collected in 2 mL microcentrifuge tubes, typically at 1-2 minute
intervals, and assayed for radioactivity using a QC2000 'table top' gamma counter
(Bioscan, Washington, DC). The total volume in each fraction was typically 150-300 tL.
The QC2000, which provided a crude measure of sample activity in less than 10 s, was
used to quickly screen the collected fractions in the iodination room to determine the
highest-activity fractions. The rapid screening of the fractions was necessary because of
the hazards associated with the labeling procedure, specifically, the volatility of free
radioiodine. The highest-activity fractions, which corresponded to labeled sample, were
pooled as the product (see FIGURE 3). For purifications of labeled proteins, 300 pL BSA
141
chase solution was added to the column immediately before and after the product solution
to minimize non-specific adsorption. As before, BSA chase solution was replaced with
PBS for polymer purifications due to the heavy PEGylation of the polymer. For
separation using the PD-10 columns, the manufacturer 'gravity protocol' was followed'.
The only significant difference between the Disposaflex and PD- 10 procedures was the
total volumes for each step, which depended on the relative column volumes (see TABLE
1).
4.2.4 Characterization of Labeled Materials - Analytical Tools
Activity Measurement
For activity measurements of the gamma-emitting isotope, iodine-125, the final
pooled product was measured on a Cobra II Auto Gamma counter (Perkin-
Elmer/Packard, Waltham, MA). Five microliter samples were added to
radioimmunoassay (RIA) tubes (VWR Scientific, Philadelphia, PA) tubes in triplicate
and counting was performed for 5 min such that at least 1000 total events were counted.
Total counts were often significantly (>100x) higher. The Cobra II, which was
significantly more accurate than the QC2000 gamma counter, was used for all activity
measurement unless otherwise specified.
Activity was also determined for polymer samples labeled with tritium, 3H, by
scintillation counting. Samples were combined with 3.5 mL of scintillation cocktail
(Ultima Gold XR), vortexed, and measured on a Beckman Coulter LS6500 Multipurpose
Scintillation Counter (Brea, CA). The measurement period was 5 min for each sample.
Refer to 52-1308-00 BB 'PD-10 Desalting Columns, GE Healthcare
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Mass Concentration Determination
Mass concentration of polymer samples was determined by absorbance
measurements on a Hitachi Model U-3010 UV/vis spectrophotometer at a wavelength of
250 nm. Calibration curves were constructed for backbone polymer and polymer 027
(FIGURE 4.2A and B) by determining the absorbance of solutions of known
concentrations of each polymer.
Mass concentration of free peptide was measured using the BCA (bicinchoninic
acid) Protein Assay (Thermo Fisher) using a SpectraMax M2 microplate reader
(Molecular Devices, Sunnydale, CA) according to the manufacturer protocol. The total
product activity and mass concentration were used to calculate the specific activity of
labeled polymer or labeled peptide samples.
Molecular Weight Measurement
Polymer molecular weight was measured using a Waters (Milford, MA) gel
permeation chromatography (GPC) system, equipped with both UV/vis and refractive
index detectors, with a bank of three Styragel@ high resolution columns (HR1, HR3,
HR4) and THF as the mobile phase. GPC methods were described in detail in the
Polymerization Chapter. For material generated for GPC measurement, stable sodium
iodide, Na I, was used as a substitute for radioiodine due to contamination and cost
considerations. For GPC analysis, samples, all of which were aqueous, were freeze-dried
because the mobile phase for the GPC system was THF. For the freeze drying procedure,
samples were frozen (-80 *C) and water was removed using a freeze dryer (VirTis,
Gardiner, NY) maintained at an absolute pressure of 10 pm Hg for at least 24 hr. The
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samples were then dissolved in THF and the amount of THF added was recorded in each
instance, varying from 1-5 mL.
Radio-High Performance Liquid Chromatography
Measurements were also performed using a radio-high performance liquid
chromatography (radio-HPLC) system (Agilent, Santa Clara, CA) equipped with a
UV/vis spectrophotometer and gamma detector. The column was a BioSep S2000 size
exclusion column having the following dimensions: 75x7.5 mm (L x D, Phenomenex,
Torrance, CA). The mobile phase was sodium chloride 0.9 wt % (w/v), 10 mM Tris
buffer and the flow rate was 1.0 mL/min. At this method flow rate, there was one minute
of elution time difference due to the length of tubing between the UV/vis and gamma
detectors.
Evaluation of the Standard Reaction Protocol
A number of variations on the standard protocol, in combination with various
analytical techniques, were used to evaluate the primary components of the standard
protocol - the reaction and the purification. These experiments were designed to
demonstrate that (1) radioiodine was covalently attached to the polymer and (2) that the
labeled polymer product was effectively separated from unreacted, free iodine. The
product was analyzed by a gamma counter, GPC, or radio-HPLC in different
combinations depending on the desired goal of each experiment.
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4.2.5 Confirmation of Covalent Attachment Using Sephadex
The components added to the standard reaction protocol were varied to determine
whether iodine was covalently attached to the target polymer molecule. The elution
profile of the product purification by G 15 Sephadex was the primary result used to
evaluate the different experimental conditions.
The first combination of components studied was (1) according to the complete
standard protocol: Iodination bead, iodine-125 and polymer 027 (FIGURE 4.2B). The
results for the Sephadex purification of the resulting reaction mixture were analyzed in
the context of an ideal size exclusion activity elution profile (FIGURE 4.3). In group
selection chromatography, a type of size exclusion chromatography, the media has a
relatively uniform pore size. Material with a hydrodynamic diameter larger than the
nominal pore size, such as our polymer molecules, travel in the voids between the resin
beads eluting at a volume approximately equal to the void volume, while material much
smaller than the exclusion limit, including unreacted iodide, completely enters the pores
eluting at a volume equal to the total column volume.
labeled
Activity isample lodide
Elution Volume
vold volume column volume
Figure 4.3. Schematic representation of an ideal size exclusion activity profile. The labeled sample,
which is excluded from the pores of the size exclusion media, elutes at approximately the void
volume.
The void volume and total column volume for both the Disposaflex and PD- 10
columns packed with Sephadex size exclusion media are presented in TABLE 1. The
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void volume was calculated assuming a void fraction in the packed bed of 0.30 according
to specifications for the Sephadex media provided by the manufacturer (GE). Per the
manufacturer recommendations for non-rigid gels, this void fraction was assumed for all
Sephadex media used in this study. The total column volume was calculated according to
the column dimensions. The Sephadex GXX resins are size exclusion media with
molecular size exclusion limits designated as 1000 Da for Sephadex G10, 1500 Da for
Sephadex G15, and so on. DEAE-Sephadex is an anion exchange media that can remove
anionic species, such as iodide, from a sample by electrostatic interactions.
Table 4.1. Void and total column volumes for the Disposaflex and PD-10 columns packed with
Sephadex size exclusion resins.
column Inner Diameter Length Void Volume Total Volume(cm) (cm) (mL) (mL)
Disposaflex 0.8 20 3.0 10.1
PD-10 1.45 5.0 2.5 8.3
If the elution profile for the reaction with all three components resembled the
ideal elution profile (FIGURE 4.3), it would indicate that the iodine was successfully
attached during the reaction. However, it is also possible that the elution peak observed at
the void volume would be due to either iodine associated with the polymer through non-
covalent interactions such as adsorption or encapsulation or to free, unbound iodine. To
address these possibilities, two additional combinations of components were studied: (2)
iodine-125 and polymer 027 and (3) iodine-125 only. If no activity was observed in the
void volume for the corresponding purifications, then that would indicate that a void
volume elution peak observed for the standard protocol mixture of components would be
due to covalently bound iodine-125.
146
4.2.6 Confirmation of Covalent Attachment Using Radio-High Performance Liquid
Chromatography (HPLC)
Radio-HPLC was used as a second method to confirm covalent attachment of
radioiodine to the polymer. All of these experiments were performed either by or under
the supervision of Dr. Mikhail Papisov, Professor of Radiology, at the Harvard Medical
School/Massachusetts General Hospital (HMS/MGH). The backbone polymer was
investigated in this study.
o 0
H3C0H
OH
Figure 3.4. Structure of the polymer investigated by radio-HPLC. Backbone polymer was labeled
and purified according to the standard protocol using iodine-124 and a PD-10 column.
The polymer was labeled and purified according to the standard protocol with the
two following exceptions: (1) iodine-124 was used instead of iodine-125 and (2)
purification was performed using a Phenomenex BioSep S-2000-equipped radio-HPLC
system instead of Sephadex G25 or PD-10 columns. Fractions were pooled according to
the results of the radio-HPLC, which simultaneously analyzed and purified the unpurified
reaction product. In total, samples at three stages in the procedure were analyzed by
radio-HPLC: (1) initial backbone polymer solution, (2) labeled, unpurified sample, and
(3) purified product.
4.2.7 Effect of the Iodination on Chemical Structure
Studies were performed to determine if the labeling procedure adversely affected
the chemical structure of the original polymer sample. Oxidative conditions are required
to generate the reactive iodine species necessary to iodinate the target. Ethers and esters,
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which are oxygen-containing functional groups present throughout the backbone polymer
(FIGURE 4.2A), are susceptible to oxidative breakdown under particularly harsh
conditions. Ethers and esters may also be present as linker groups between the backbone
polymer and attached sidechains as was the case for polymer 027 (FIGURE 4.2B). The
backbone polymer was chosen for this study to investigate the potential effect of
oxidative conditions on the polymer since any decrease in molecular weight, as
determined by GPC, would have to be due to degradation of the ether or ester bonds (or
both) within the polymer chain.
The standard protocol was performed, substituting 1251 with stable 127I to avoid
equipment contamination with radioactivity. It was assumed that there would be no
difference in the iodination behavior between the two isotopes. In order to obtain
sufficient signal for GPC measurement, the initial polymer concentration in the reaction
was increased to 10 mg/mL. The iodine concentration was increased proportionately to
58.8 ptg/mL. (Note: only one iodination bead was used because this condition was still
well within the oxidative capacity of a single bead [38]). Elution volumes from 0 to 8 mL
(i.e. the entire elution) were collected and freeze-dried before being dissolved in 5 mL
tetrahydrofuran (THF) for GPC analysis. The GPC chromatogram for the reaction
product was compared to those for raw polymer dissolved in THF.
An additional experiment was designed to measure backbone polymer
degradation at elevated oxidative conditions. To accomplish this, the concentration of
iodine was increased from 5.88 pg/mL to 5.88 mg/mL, while the standard initial polymer
concentration (1 mg/mL) was used. This significantly increased the number of oxidative
species in solution relative to the oxidative targets within the polymer. 1251 was
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substituted with 127 and the entire elution (0 to 8 mL) was collected, freeze-dried, and
dissolved in THF.
Evaluation of the Standard Protocol for Purification
4.2.8 GPC Analysis of Void Volume Fraction
The standard protocol for purification was followed (Disposaflex columns packed
with Sephadex media) to generate fractions of material. The fraction collected near the
void volume was analyzed by GPC to determine (1) if the polymer eluted near the void
volume and (2) if the entire range of polymer molecular weights was present in the
collected fraction surrounding the void volume. To accomplish this, 100 ptL of polymer
solution (1 mg/mL in PBS) was added to a Sephadex G15 column and a 2 mL fraction
corresponding to elution volumes between 2 and 4 mL was collected. This fraction was
selected based on the estimated void volume in the Disposaflex columns packed with
Sephadex - 3 mL. The collected fraction was freeze dried, resuspended in THF, and
analyzed by gel permeation chromatography.
4.2.9 Elution Profile of Free Iodine-125
Minimizing elution of free iodine during elution volumes over which labeled
polymer is typically collected (i.e. elution volumes near the void volume) is one of the
primary contributions to maximizing the purity of the radiolabeled polymer product.
Therefore, it is desirable to choose a purification media that significantly delays the
elution of free, unbound iodine. Elution profiles for five different purifications, Sephadex
G10, G15, and G25, DEAE Sephadex, and PD-10 columns, were recorded to evaluate the
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suitability of each purification media. With the exception of the PD- 10 columns, the
purifications were performed in Disposaflex columns.
In these experiments, the standard protocol for purification was followed;
however, the reaction mixture was replaced by the following mixture: 10 pL of stock
sodium [ 12I]iodide solution, 100 p.L Tris buffer, and 280 piL PBS. The volume of PBS
was in place of the 100 pL of polymer solution, 120 pL of PBS wash, and 60 pL of
sodium metabisulfite inactivation solution. Fractions were collected and analyzed using
the QC2000 gamma counter. As before, this less accurate gamma counter was used due
to safety considerations associated with handling of free radioiodine.
4.2.10 Elution Profile of Post-Reaction Mixtures Generated by the Standard Protocol
While it is important for a separation media to reduce the amount of residual free
12sI, it must do so without significantly affecting recovery of the labeled material. Three
purification techniques were selected based on the results from the experiments
measuring the elution profile of free iodine-125: G25 Sephadex, PD-10 columns, and
DEAE-Sephadex. These media were investigated further by measuring elution profiles
for unpurified post-reaction mixtures generated by the standard protocol. The results of
these measurements were compared with the elution profiles for free iodine- 125.
4.2.11 Fractional Recovery for the Purification Step with and without BSA
Bovine serum albumin (BSA) was often added to reduce non-specific adsorption
of the target molecule and the corresponding loss in product recovery. Although the non-
specific adsorption of PEGylated polymers is typically quite low, an experiment was
performed to determine whether BSA was required to maximize product recovery.
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To study fractional recovery, a 100-pL volume of polymer solution (1 mg/mL)
was added to Disposaflex columns packed with Sephadex G25. Two different
experimental conditions were examined: the standard protocol for column packing and
purification was followed either with or without BSA chase solution. For experiments
without BSA chase solution, equal volumes of PBS were used as a substitute. Elution
volumes between 0 and approximately 5 mL were collected in a single fraction. For the
experiments without BSA chase solution, concentrations were determined directly using
the spectrophotometer calibration curve. For experiments with BSA solution, eluate was
collected from a control column in which 100 gL of PBS was added as a blank in
between addition of BSA chase solution as described by the standard protocol. The eluate
absorbance measured for this blank column was used to adjust for absorbance due to
BSA according to:
Ap,cor =AP -ABSA (1)
where Ap,cor is the corrected absorbance, which is the absorbance due to the presence of
polymer, Ap is the absorbance measured experimentally for the columns with BSA added,
which is due to both polymer and BSA, and ABSA is the absorbance measured in the
control experiment, which is due to BSA only. This calculation relies on the assumption
that the absorbances measured in the polymer-BSA mixture are additive.
The fractional recovery of polymer across the column, R, was calculated by:
R = Cf Vf (2)Civi
where Ci and Cf are the initial and final polymer concentration, respectively, and Vi and
Vf are the load and collected fraction volume, respectively.
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The fractional recovery across the column was also measured radiometrically by
adding a solution of tritiated polymer at the top of the column. One milliliter fractions
were collected for elution volumes from 0 to 5 mL (the fraction size was decreased to
facilitate scintillation counting). In this radiometric experiment, the fractional recovery
across the column, R, was calculated by:
La.
R = j (3)
a
where aj is the activity of the jth fraction and ai is the total initial activity added to the
column (note: activity has units of cpm - counts per minute).
4.2.12 Labeling Yield
Reaction conditions, including reaction time and both polymer and radioiodine
concentrations, were varied to measure their effect on overall fractional labeling yield,
which is the fraction of the total initial 121 added, ai, that was covalently attached to the
final product. The fractional labeling yield, Y, was calculated by:
Y= af (4)
a.
where af is the final activity of the labeled and purified product.
4.2.13 Radiolabel Stability
The stability of the covalent bond between iodine and the polymer was
investigated using PD-10 columns. Labeled polymer samples were stored for different
lengths of time and added, in their entirety, to the top of PD- 10 columns. Elution
fractions were collected and assayed for radioactivity according to the standard protocol
for purification. The resulting elution profile was used to assess the stability of the iodine
label. If the only activity detected during the elution was within fractions near the column
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void volume, then all of the activity in the sample remained as iodine covalently bound to
(or otherwise associated with) the polymer sample. Conversely, any activity that eluted
near the total column volume would correspond to iodine that had become dissociated
from the polymer over the storage period.
4.3 Results
Evaluation of the Standard Reaction Protocol
4.3.1 Confirmation of Covalent Attachment Using Sephadex
The polymer designated 027 (FIGURE 4.5) was used in the initial covalent
attachment confirmation study. Sephadex G15 media was used for all experiments in this
study.
0 0
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Figure 4.5. Chemical structure of polymer 027, which studied during the attempt to demonstrate
covalent attachment of iodine.
The standard protocol was completed and the elution profile during the
purification step was recorded (FIGURE 4.6). The reaction mixture for the standard
protocol contains all of the standard components: the Iodination bead, 1251, and polymer
solution. The elution profile had a sharp, high-activity peak that occurred very shortly
after the void volume, which was 3.0 mL for the Disposaflex column. High-activity
elution immediately after the void volume is often accepted as sufficient proof of
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covalent iodine attachment for peptide labeling applications. The second peak in
(FIGURE 4.6) corresponds to the elution of free iodine that was not attached to the
polymer during the reaction step. This peak was measured at an elution volume close to
that of the total column volume (10 mL).
During a typical iodination, the elution profile is used to determine which
fractions to pool to produce the purified labeled product. For the iodination of polymer
027 (FIGURE 4.6), the three fractions that were chosen for pooling are indicated by
asterisks. Over the course of the iodinations performed for this work, the fractions pooled
were the 2-3 highest activity fractions that eluted near the void volume. The small
number of fractions is collected to minimize both dilution and contamination from
unbound iodine. In the rare cases where no peak was observed in this range, no iodination
product was retrieved and the procedure was repeated with fresh reagents.
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Figure 4.6. Elution profile for the labeling of polymer 027 according to the standard protocol. The
void and total column volumes for this experiment, 3 and 10 mL, respectively, are indicated.
Asterisks indicate fractions that were collected and pooled as the final labeled, purified product.
As described in the Methods, two more combinations of components were
investigated in addition to that for the standard protocol. These additional reaction
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mixtures were uncatalyzed, having no Iodination bead added, and consisted of 125I and
polymer 027, and 1251 only. The results for these reaction mixtures were compared to that
for the standard protocol on semi-logarithmic coordinates to help determine whether or
not the standard reaction protocol covalently attached radioiodine to our polymer.
(FIGURE 4.7).
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Figure 4.7. Elution profiles for the three different reaction mixtures studied: lodination bead + 1251+
polymer 027, 12s1 + polymer 027, and 125I only. The results for the former, which represent the
standard protocol, were reproduced from FIGURE 6. Asterisks indicate fractions that were collected
and pooled as the final labeled, purified product.
The elution profiles for the two uncatalyzed reaction mixtures had much lower
radioactivity concentrations than that for the standard protocol. In fact, at the elution
volumes for the fractions that were pooled as the labeled polymer product (2.5-3.5 mL),
the radioactivity concentration was 3-4 orders-of-magnitude higher for the standard
protocol than for either of the uncatalyzed reaction mixtures. The significant difference in
radioactivity concentration was a strong indication that the sharp, first high-activity
elution peak for the standard protocol reaction was due to the covalent attachment of
radioiodine to polymer 027 catalyzed by the lodination bead.
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The elution profiles for the uncatalyzed mixtures were quite similar over all
elution volumes studied. Therefore, the two uncatalyzed mixtures, both with and without
polymer 027 present, behaved similarly during purification, which implied that polymer
027 did not strongly adsorb or encapsulate 125. The elution profiles for the uncatalyzed
reaction mixtures plateaued soon after 3 mL. The activity in this initial plateau remained
at a constant and relatively low level until the majority of the activity eluted near the total
column volume. Recall that, for the uncatalyzed reaction mixtures, the activity was added
in the form of 125 and should have been able to fully enter the pores of the resin.
The semi-logarithmic plot of the results for the standard protocol revealed that the
radioactivity concentration did not return to the baseline after elution of the labeled
product as might have been anticipated for an ideal purification (FIGURE 3).
4.3.2 Confirmation of Covalent Attachment Using Radio-High Performance Liquid
Chromatography (HPLC)
Radio-HPLC was used as an additional tool to confirm the direct, covalent
attachment of radioiodine to our polymer. These experiments were generously completed
by Dr. Mikhail Papisov, Assistant Professor of Radiology at the Massachusetts General
Hospital. Due to machine time limitations, only a few measurements were possible.
Unfortunately, due to a hard drive failure of the computer devoted to the radio-
HPLC system, only scanned images of chromatogram printouts were available for data
presentation (FIGURE 4.8). According to the manufacturer, the void volume in the
Phenomenex BioSep S-2000 column was approximately 2.9 mL, which corresponds to a
void time of 2.9 min. It is important to note that this relatively short and narrow size
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exclusion column was primarily intended for preparative and not analytical applications,
which may limit the interpretability of smaller chromatographic details.
The UV chromatogram for the initial sample provided a basis for comparison for
the reaction and product samples. The backbone polymer eluted approximately thirty
seconds after the void time (or volume) was reached. The wavelets in the absorbance
profile were due to the effects of pressure fluctuations on the optical detection. Such
fluctuations are common for low flow rates such as that used in this method.
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Figure 4.8. Radioactivity and absorbance (abs) detector response as a function of elution time
measured by size-exclusion radio-HPLC with a 7.5x75 mm BioSep S-2000 column. (A) The initial
solution, before labeling, was measured. (B) The backbone polymer was labeled with 1241 and
analyzed. This radio-HPLC analysis was used to determine which fractions to collect and pool
(indicated by the dashed lines). (C) The final, purified product was analyzed.
The activity profile for the labeled, unpurified product (FIGURE 4.8B) had two
distinct peak. The first peak corresponded to labeled polymer while the second peak
corresponded to unreacted, free iodine-124. In the purified product (8C), the labeled
polymer peak persisted, while the free iodine peak was no longer present. As described in
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the methods, there was a one minute delay for the activity measurements relative to the
absorbance measurements due to the lines in between the detectors.
The absorbance profile for the labeled, unpurified product (8B) was similar in
shape to the chromatogram measured for the unlabeled starting material. There were,
however, two minor differences: (1) a slight shoulder on the leading edge of the
absorbance elution peak and (2) a small, amorphous peak at an elution time of
approximately 3 min. The should is most likely a peak abnormality related to the
relatively low separation efficiency of the preparative size exclusion column, while the
peak at 3 min may correspond to a small amount of impurities in the unpurified sample.
This peak was more prominent in the final, purified sample (8C), suggesting that it was
not an artifact of the original measurement. However, there was no radioactivity
associated with this early elution time peak, which was encouraging. Finally, the elution
peak at 1.5 min in the purified product was an artifact because it occurred before the void
volume had been reached.
The absorbance profile for the purified product was much broader than the other
two profiles recorded. This was most likely a result of the comparatively lower
concentration of the polymer sample analyzed by the radio-HPLC. This peak broadening
for low concentration samples is a commonly observed phenomenon in chromatography
caused by diffusion within the lines comprising the post-column hold-up volume. The
main peak absorbance and activity profiles for the labeled, purified product were similar
in shape. This result suggested that the breadth of polymer molecular weights in the
initial backbone polymer sample received radioiodine labels.
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4.3.3 Effect of Iodination on Chemical Structure
Studies were performed to confirm that the labeling procedure did not adversely
affect the chemical structure of the original polymer sample. The starting material for
these studies was cold iodine-127 (in place of iodine-125) and backbone polymer
dissolved in PBS. The molecular weight profile of the backbone polymer after
undergoing the iodination procedure was the primary result. Therefore, the backbone
polymer starting material was subjected to two different chromatography techniques: (1)
the aqueous Sephadex column during the standard protocol and (2) the organic GPC
system for molecular weight analysis.
In the first experiment, the initial polymer concentration in the reaction was
increased to 10 mg/mL and the iodine concentration was increased proportionately to
58.8 pg/mL in order to obtain sufficient signal for GPC measurement. The reaction
product was freeze-dried, resuspended in THF and the resulting GPC chromatogram for
the reaction product was compared to that for raw polymer dissolved in THF (FIGURE
4.9). The raw polymer sample used for comparison was dissolved directly in THF from
the solid form and was never dissolved in water or subjected to freeze-drying. Refer to
APPENDIX D for greater detail concerning the calculation of fractional recovery and the
manipulation of the chromatograms presented in this section.
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Figure 4.9. GPC chromatograms to determine the effect of the iodination on backbone polymer
molecular weight. Data for backbone polymer labeled with cold iodine-127 (10 mg/mL polymer, 58.8
pg/mL iodine) compared to raw backbone polymer. The x-axis for these elution profiles refers to
elution volume in the analytical GPC system (and not in Sephadex).
The chromatograms were qualitatively similar, which implied that the bulk
molecular weight distribution of the recovered backbone polymer was largely unaffected
by the standard protocol. There were, however, two noticeable differences in the shape of
the chromatograms. There was an elevated refractive index response at GPC elution
volumes greater than 23 mL for the iodination curve relative to the raw polymer curves.
This was most likely a consequence of the freeze-drying procedure (see FIGURE 4.10).
The major difference, however, was the slight shift of the peak to the right (i.e. lower
molecular weights) and the slightly extended shoulder beginning at a GPC elution
volume of 20 mL. The shift and shoulder were probably not caused by freeze drying and
therefore may be considered to have been caused by the conditions of the standard
protocol. The fractional recovery of the reaction product was estimated to be 0.88 (see
APPENDIX for calculation details and associated discussion). Recovery at this level was
deemed acceptable (see also Section 4.3.8: Fractional Recovery).
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The weight-average molecular weights for the chromatograms presented in
FIGURE 4.9 were calculated according to the empirical calibration described in detail
during the Polymerization Chapter. The Mw for the 'reaction' polymer and the raw
polymer were 5.1 and 5.3 kDa, respectively. Although differences were observed
between the chromatograms, the bulk molecular weight properties of the polymer were
minimally affected during the augmented reaction protocol in this experiment.
Experience with another sample, polymer 027, provided the basis for the
interpretation of the elevated response at elution volumes greater than 23 mL.
Specifically, beginning from the solid state, polymer 027 was dissolved in water,
subjected to the freeze-drying procedure, resuspended in THF and analyzed by GPC. The
resulting chromatogram was compared to that for polymer 027 dissolved directly into
THF (FIGURE 4.10).
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Figure 4.10. Comparison of two chromatograms for polymer 027. In one instance, the polymer was
dissolved in water, freeze-dried and resuspended in THF. In the other, the polymer was dissolved
directly in THF. The x-axis for these elution profiles refers to elution volume in the analytical GPC
system (and not in Sephadex).
An additional experiment was performed to measure backbone polymer
degradation at elevated oxidative conditions (FIGURE 4.11). This was accomplished by
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increasing the initial amount of iodine-127 added to the reaction by 1000-fold while
holding the concentration of backbone polymer constant at 1 mg/mL. As before, the raw
polymer sample used for comparison was dissolved directly in THF from the solid form
and was never dissolved in water or subjected to freeze-drying.
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Absorbance response was chosen for these low concentration samples because of
the comparatively lower sensitivity of the refractive index detector2. Comparing the
reaction and raw polymer chromatograms, the major peak for the reaction polymer was
shifted significantly to higher elution volumes. This increase in elution volume indicated
a reduction in molecular weight caused by polymer degradation by the oxidative reaction
conditions. As before, the presence of small peaks at GPC elution volumes greater than
25 mL may have been produced during freeze-drying. The estimated fractional recovery
in this experiment was 0.36, considerably lower than that for the previous experiment
(0.88). The low recovery was likely caused by the lower initial polymer mass and the
2 Note: Refractive index response was preferred because PEG has very minimal absorbance at 250 nm.
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disproportionate loss of material due to process recovery limitations or, more likely,
losses within the phosphate buffer salts that were insoluble in THF.
The weight-average molecular weight was also calculated according to the
calibration for these two chromatograms. The M, for the 'reaction' polymer and the raw
polymer were 3.2 and 5.3 kDa, respectively. Although the thousand-fold increase in
iodine affected the molecular weight profile of the recovered polymer, the significant
increase in reactive (oxidative) iodine species did not completely degrade the polymer.
4.3.4 Effect of the Iodination on Older Polymer Samples
While the backbone polymer used for the previously described experiments was
synthesized and used within less than 6 mo (all but one experiment was conducted within
2 mo of synthesis), the preceding experiments were also completed using a backbone
polymer sample that had been stored in the solid form under ambient conditions for more
than one year after its synthesis ('old polymer'). A portion of this stored sample was
dissolved in PBS and subjected to the augmented standard protocol (10 mg/mL polymer,
58.8 pg/mL Na 127I) and subsequently analyzed on the GPC system. Another portion of
the stored sample was also dissolved directly in THF and the resulting chromatogram was
measured as a basis for comparison (FIGURE 4.11).
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Figure 4.12. GPC chromatograms to determine the effect of iodination (augmented standard
protocol) on old polymer molecular weight. The old backbone polymer was stored at ambient
conditions for over one year. The x-axis for these elution profiles refers to elution volume in the GPC
system (and not in Sephadex).
No discernible response was measured in the GPC analysis of the 'old polymer'
that was subjected to the standard reaction protocol, freeze dried, and resuspended in
THF. This result was repeated (n > 5) to confirm that experimental errors did not
contribute to the observed phenomenon. The elevated chromatogram at GPC elution
volumes greater than 23-24 mL implied that some lower molecular weight material was
present in the sample. The iodination may have also produced material that was insoluble
in THF or fragmented such that its elution would be indistinguishable from that of very
low molecular weight contaminants, which include dissolved gases. These low molecular
weight contaminants create an extremely noisy response, at GPC elution volumes greater
than 30 mL that varies greatly between runs. For this reason, only elution volumes less
than 27 mL were included in this and other GPC chromatograms.
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Evaluation of the Standard Purification Protocol
4.3.5 GPC Analysis of Void Volume Fractions
The standard protocol for purification was followed with Sephadex G15 and
polymer 027 and fraction collected near the void volume was analyzed by GPC to
determine (1) if the polymer eluted near the void volume and (2) if the entire range of
polymer molecular weights was present in the collected fraction surrounding the void
volume. Therefore, for this experiment, the fraction collected from elution volumes
between 2 and 4 mL from the Sephadex G15 column was analyzed using the analytical
GPC system. The resulting elution profile (chromatogram) is the detector response as a
function of elution volume in the GPC system (FIGURE 4.13).
-2-4 mL Sephadex Fraction
4 ----- Raw Polymer 027
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Figure 4.13. GPC chromatograms to confirm that the polymer co-elutes with the high activity elution
peak. A fraction was collected from a Sephadex G15 column at elution volumes (EV) between 2-4
mL, freeze dried, and measured by GPC. The normalized absorbance (to adjust for differences in
GPC sample sizes) was plotted as a function of GPC elution volume.
The chromatograms for the Sephadex 2-4 mL elution volumes and for the raw,
unprocessed polymer 027 were compared. There was excellent agreement between the
two chromatograms across the entire range of GPC elution volumes. Small peaks were
observed at GPC elution volumes greater than 25 mL for the sample collected from the
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Sephadex column. These peaks, which were not present in the raw polymer sample that
was dissolved directly in THF, are indicative of small molecular weight species and were
likely generated during freeze drying. It is highly unlikely that these peaks were caused
by interactions with the inert Sephadex media.
4.3.6 Elution Profile of Free Iodine-] 25
Various Sephadex media were assessed for their ability to separate the labeled
polymer product from the free, unlabeled radioiodide present in the post-reaction
mixture. The relevant measurements, including the void and total column volumes, for
both Disposaflex and PD- 10 columns were summarized in TABLE 4.1.
The elution profiles for free iodide (1251) were measured for the following
Sephadex media: Sephadex G10, G15, and G25, DEAE Sephadex, and PD-10 columns
(pre-packed with Sephadex G25). The radioactivity concentration in each fraction was
plotted as a function of elution volume (FIGURE 14A). The cumulative fraction of the
initial activity added was also plotted for each elution volume according to the following:
k
Lai
.- j= 1
k,cum a. (4)
where fkcum is the cumulative fraction of the initial activity added in the kth fraction
collected and ai is the initial activity of 125I added. The plots also include dashed lines
indicating the void and total column volumes for the Sephadex-packed Disposaflex
columns, 3 and 10 mL, respectively (the void volume for the PD-10 column was 2.5 mL).
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Figure 4.14. Elution profiles for free 1251 (1 mCi in pL PBS). Data are presented (A) radioactivity
concentrations and (B) as the cumulative fraction of the initial activity added to each column. The
approximate void and total column volumes for the Sephadex packed in Disposaflex columns (all but
PD-10) are indicated by the dashed lines. The results for DEAE were not plotted in (B due to the
extremely low activity in the collected fractions.
Elution volumes near the void volume comprised the region of greatest interest
because they corresponded to fractions typically pooled as the labeled, purified polymer
product. Consequently, the elution volumes from 2-4 mL were chosen as the focus for
analysis of these results. The radioactivity concentration was the highest in the G10 and
G15 Sephadex-packed columns, both of which reached a plateau before 3 mL at a
radioactivity concentration of approximately 1xi06 cpm/mL. The two columns packed
with G25 Sephadex were the next highest in activity; however, the radioactivity
concentration measured in the 2-4 mL range was 2-4 orders-of-magnitude less than that
for the G10 and G15 resins. The increased activity at early elution volumes (2-5 mL) in
the G10 and G15 resin experiments would lead to an increased co-elution of free iodide
together with labeled product in an actual separation, which would lead to decreased
purity of the pooled fractions collected for these media. The radioactivity concentration
for the size exclusion resins sharply increased as the elution volume approached the total
column volume.
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The radioactivity concentration for DEAE-Sephadex was extremely low for the
elution volumes near the void volume. This nearly complete reduction in activity was
caused by the ionic interactions between the positively charged DEAE functional groups
and the negatively charged iodide ions. The gradual increase in activity as the elution
volume approached the total column volume corresponded to flowthrough of iodide ions
not trapped by the charged groups of the resin.
The elution profiles for free 125I in various resins were also analyzed
quantitatively by adding the activity collected during elution volumes from 2-4 mL
(TABLE 4.2). The 125I only results were presented along with that for the purification of
the reaction mixture (lodination bead, 1251, and polymer 027, FIGURE 4.6). The results
for the two sets of material added to the column were presented together to provide a
rough order-of-magnitude comparison. The free iodide collected between 2-4 mL during
the G10 and G15 purifications was between 2 and 3 orders-of-magnitude less than that
collected for the post-reaction mixture for the labeling of polymer 027. The difference
was even greater for the PD-10 and G25 purifications - 4 and 5 orders-of-magnitude,
respectively. Although the difference was greatest for the DEAE media, it may not be an
appropriate comparison since the polymer 027 reaction mixture was purified using a size
exclusion media and not an ion exchange media (see next section for further detail).
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Table 4.2. Comparison of activities collected between 2 and 4 mL elution volume from various
Sephadex purifications. The results for the 1251 only experiments were determined from FIGURE 14,
while those for the reaction mixture were calculated from FIGURE 6.
Activty in 2-4 mLMaterial Added to Column Resin cpm(epm)
Post-Reaction Mbre G1 7.1x10C(95l-027 and Unreacthd 1) 015 7.1x0
Gi0 9.0x10 5
016 1.6x106
'2I only G25 1.4x103
PD-10 (G25) i.3x104
DEAE 2.1x101
4.3.7 Elution Profile of Post-Reaction Mixtures Generated by the Standard Protocol
Three methods were chosen based on the results for the free iodine elution profile
experiments for further examination: G25 Sephadex, PD- 10 columns (pre-packed with
G25), and DEAE-Sephadex. These methods were investigated by measuring and
comparing the elution profiles for unpurified post-reaction mixtures, which contain both
labeled sample and unreacted 125, to those measured in the previous section for solutions
of free 1251 only (FIGURE 4.15). The chemical structures of the polymer starting material
used in the study are also included. Polymer with 100% of sidechains substituted with
PEG3400 (067) was used for both the Sephadex G25 and DEAE-Sephadex experiments,
while polymer substituted with 10% PEG3400 (068) was used for the PD-10 experiment.
The fractions that were pooled to form the labeled polymer product were labeled
by asterisks. These fractions can be compared to the radioactivity concentrations in the
free 125j only elution profiles to estimate the amount of activity in the pooled fractions
that was due to unbound radioiodine. Because the total amount of activity added to each
column, 1 mCi, existed in both the bound and unbound forms, this type of analysis
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provides an upper bound for the level of free iodine impurity. For the G25 Sephadex
purifications, the radioactivity concentration in the pooled fractions of the reaction
mixture was five orders-of-magnitude greater than that in the corresponding elution
volumes for the 125I only experiment. This implied that the pooled, labeled polymer
product was 99.999% pure. This same difference for the experiments using PD-10
columns (pre-packed with Sephadex 25) was only approximately three orders-of-
magnitude, which implied a product that was 99.9% pure.
For the DEAE-Sephadex column experiments, the difference in radioactivity
concentration between the reaction mixture and iodine-125 only elution profiles at
approximately 3 mL was the greatest observed - nearly six orders-of-magnitude.
However, as indicated by the lack of asterisks in FIGURE 4.15C, no fractions were
pooled due to the extremely low activity. The absolute magnitude of the activity for the
DEAE-Sephadex purification of the reaction mixture was 10-50x less than that for the
size exclusion purifications in FIGURE 4.15A and B. This was indicative of the polymer
having become bound to the functional groups of the DEAE-Sephadex. If fractions were
to have been pooled, the resulting labeled product would have represented an overall
radioactive yield of less than 1%.
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Figure 4.15. Elution profiles for (A) Sephadex G25, (B) PD-10 columns, and (C) DEAE-Sephadex for reaction mixtures and free 125 only. Data are
plotted semi-logarithmically as the radioactivity concentration as a function of elution volume. Polymer 067 was used in the G25 and DEAE-Sephadex
experiments, while polymer 068 was used for PD-10. Asterisks indicate fractions that were pooled as the labeled polymer product (no pool was created
for DEAE experiment due to low activity).
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4.3.8 Fractional Recovery for the Purification Step with and without BSA
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Figure 4.16. Structures of polymers investigated in percent recovery studies. Backbone polymer and
Polymer 027 were measured spectrophotometrically, while Polymer 071, which contained a tritium
label on substituted as approximately 2% of the side groups, was studied radiometrically.
The fractional recovery for the purification step was measured to determine
whether the BSA chase solution was necessary in order to apply the standard protocol to
our heavily PEGylated polymers. The fraction recovery was measured
spectrophotometrically for Sephadex G 15 and radiometrically for Sephadex G25
(TABLE 4.3) for three different polymers (FIGURE 4.16), both with and without BSA
chase solution added as described in the Methods.
Table 4.3. Summary of results for percent recovery by mass experiments. Backbone polymer and 027
were run on Sephadex G15 and measured by UV/vis, while 071 was run on Sephadex G25 and
measured by scintillation counting.
Polymer BSA R
Backbone Y 0.94
N 0.93
Y 0.93027
N 0.97
071 N 0.92
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Under all measured conditions, the fractional recovery by mass of polymer, R,
was greater than 90%. There was no difference in recovery between backbone polymer
and polymer 027, which could form micelles. In previous work in our group, the critical
micelle concentration (CMC) of polymer 027 was determined to be 0.07 mg/mL by
surface tension measurements [39]. There was also no difference between experiments
with and without the BSA chase solution added at the appropriate steps. Finally, the
fractional recoveries determined according to the spectrophotometer and scintillation
counting were similar.
4.3.9 Labeling Yield
The fractional labeling yield, as defined in EQUATION 4, was measured as a
function of various experimental conditions, including reaction time, radioiodine
concentration, and polymer concentration (TABLE 4.4). For these studies, polymer 027
was the starting material and Sephadex G 15 was used throughout.
Table 4.4. Fractional labeling yield as a function of (A) reaction time, (B) polymer concentration, and
(C) initial radioiodine activity. Experiments were performed using polymer 027. Data in italicized or
underlined typeface indicate independent replicates of the same respective experimental conditions.
Polymer Conc InIt ActMty Rxn Time Y
(mg/mL) (mCi) (min)
7.5 0.06
A 1 1 15 0.20
30 0.30
0.01 0.007
0.1 0.02
B 1 15 0.23
5 0.51
0.1 0.43
0.25 0.45
1 0.59
2 0.58
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The greatest measured fractional yield, nearly 0.6, was for 5 mg/mL polymer
labeled with either 1 or 2 mCi of initial radioiodine for 15 minutes. Variations in polymer
concentration and reaction time had the greatest effect on reaction yield, while initial
iodine activity, which is directly related to initial iodine concentration, had comparatively
little effect on reaction yield for the measured conditions.
The fraction of linkers having radioiodine labels was calculated for the highest
observed labeling yield, 0.59. Assuming a polymer with 5 repeat units and 1 mCi of
initial iodine activity, it was estimated that only 1 in approximately 10,000 linker
molecules have an iodine label. However, even at this low substitution, more than
sufficient activity was present in the labeled product to support copious uptake
measurements.
Kinetic modeling was performed to determine whether certain elementary
reactions were applicable to the iodination system given the measured experimental
yields. Theoretical yield relationships were derived for zeroth, first, and second order
elementary reactions. The reaction was modeled as A + B -> P, where A represented 1251
B represented reactive sites, and P represented a labeled site within the polymer. The
initial conditions were CA(O) = CAo and Cp(0) = 0. The model formulations for the three
different reaction orders studied were solved to determine the corresponding analytical
solution for theoretical yield, Y (FIGURE 4.17). The theoretical yield, Y, was determined
for various reaction orders in iodine by deriving Cp as a function of time and dividing by
CAo. The time-dependent concentration, CA(t), was derived where necessary.
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Order -C d Y
dt dt
Qth 0 kCB kCBtCA
1St kC.ACB. kCBCAe kCIot 1-e ekCBot
2nd kCA2CB, kCB kC +1 B 1- kC 1t + 1
Figure 4.17. Model formulation and results for theoretical yield derivations based on zeroth, first,
and second order elementary reactions proposed as potential representations of the iodination. In the
model, A, B, and P corresponded to iodide, reactive sites on the polymer, and labeled sites,
respectively. The initial conditions were CA() = CAO and C(O) = 0, while CB was assumed to be
constant and equal to CB0 throughout.
As depicted in FIGURE 4.2, there are two reactive sites in each repeat unit of the
backbone polymer at the position ortho to the aromatic hydroxyl. In all of the derivations
the concentration of reactive sites, CB, was assumed to be constant, CBo, because, with the
exception of the 0.01 mg/mL polymer reaction, the number of reactive sites exceeded the
total number of 121 molecules in solution by seven times or greater for the experimental
conditions studied. For example, assuming a backbone polymer molecular weight of 3
kDa, with 3 repeat units and 2 reaction sites per repeat unit, there would be 33 mmol of
reactive sites in 100 ptL of 1 mg/mL polymer solution. For comparison, there were 0.47
mmol of iodide molecules in 1 mCi of the radioiodine stock solution. Therefore, for 1
mCi iodine and 1 mg/mL polymer, there were 70 times more reactive sites than iodide
molecules in solution. This ratio can be calculated proportionately for any of the other
reaction conditions.
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For the model that was first order with respect to A, no dependence on initial
iodine concentration was predicted according to the derived result for the theoretical
yield. This was reminiscent to the experimental results, which showed initial iodine
concentration had a very weak influence on experimental yield. The theoretical yield for
the second order model with respect to A predicted that initial iodine and reactive site
concentration would have equal influence on the experimental yield. Such behavior was
not observed in the experimental results. Finally, the 0 th order model with respect to A
predicted a theoretical yield that decreased as the initial amount of iodide added was
increased. This also was not observed experimentally. The theoretical yield for the 0th
order model was also increased monotonically and linearly in time, which would
eventually lead to a physically unrealistic yield (Y > 1). This was a consequence of the
assumption that the concentration of B remained constant.
The experimental data were used to estimate a rate constant for the iodination
reaction based on the theoretical yield for the first order model in A, Y1 :
Y1 =1 - ekCBot (5)
EQUATION 5 was rearranged to:
I .. Y-- e-kCBot (6)
and, according to EQUATION 6, the experimental yield data were plotted semi-
logarithmically with CBot on the abscissa and (l-Y) on the logarithmic ordinate (FIGURE
4.18). The product CBOt must be used because experimental yields were measured for
different reaction times as well as different initial polymer concentrations. According to
EQUATION 6, the slope of the data set plotted accordingly is equal to the opposite of the
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effective forward rate constant for the iodination. The rate constant that resulted from the
least-squares regression was 4.6x10-3 mL/(mg-min) with an R-squared value of 0.93.
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Figure 4.18. Experimental yield data plotted according to the theoretical yield derived for the first
order model. The slope of the regression line for the semi-logarithmic plot is equal to the opposite of
the iodination rate constant.
4.3.10 Labeling Yieldfor Ornamented Polymers
The yields reported to this point were the maximum observed. Many alterations
were made to the basic structure of polymer 027 to include sidechains with targeting
moieties such as peptides or the small molecule folate attached to the backbone by means
of polyethylene glycol spacers of varying lengths. Based on the results of the labeling
yield study for polymer 027, labeling of ornamented polymer formulations for the uptake
and biodistribution studies described in Chapter 5 was performed using an initial polymer
concentration of 5 mg/mL. During these labeling procedures, yields were typically
observed between 0.05-0.50.
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4.3.11 Radiolabel Stability
The radiolabel stability was investigated by applying labeled polymer 027 that
was stored in PBS at 4"C for 6 mo to a PD- 10 column (FIGURE 4.19). Equal volume,
one milliliter fractions were collected and the activity in each fraction was normalized by
the total pre-column activity added to the PD- 10 column. In this experiment, any activity
measured near the total column volume would indicate that radioiodine had dissociated
from the polymer, most likely through cleavage of the carbon-iodine covalent bond. The
PD- 10 column, which was able to separate free, unbound iodine from labeled polymer in
previous experiments (FIGURE 4.15), was chosen for convenience.
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Figure 4.19. Elution profile of radiolabeled polymer 027 in PBS after storage for 6 months at 40C.
Data for each collected fraction are plotted as the fraction of the total activity initially added to the
PD-10 column. The void and total column volumes for the PD-10 column are indicated by the dashed
lines.
The majority of the activity eluted shortly after the elution volume reached the
void volume (2.5 mL for the PD-10 column). There was a small tail from approximately
4.5 to 6.5 mL of elution. No activity peak was observed at the total column volume (8.5
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mL for the PD-10). Together, these results demonstrated that iodine remained bound to
the polymer 027 for the duration of the 6 mo storage period.
4.3.12 Considerations for Radiolabeling High Molecular Weight Backbone
Backbone polymer starting material with a number-average molecular weight of 3
kDa and polydispersity of 1.75 was used throughout the preceding studies. Although the
basic chemical structure of the repeat unit does not vary as a function of molecular
weight, decreased polymer solubility at increased molecular weight is a commonly
observed phenomenon in polymer science (see also Polymerization Chapter).
Consequently, the analyses performed for the lower molecular weight polymer, including
those for labeling yield, stability, and purity would not necessarily be reproduced for
higher molecular weight backbone polymer.
Labeling of higher molecular weight polymer was studied during the
radioiodinations performed in support of the uptake and biodistribution studies described
in Chapter 5. For these studies, polymers were synthesized using low polydispersity, high
molecular weight backbone polymer (Mn = 12 kDa, PDI = 1.15) as the starting material
(FIGURE 4.20).
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Figure 4.20. General structure of polymers synthesized using high molecular weight backbone
polymer starting material (12 kDa, PDI = 1.15). Formulations varied X and R. Polymers without
E13.4.3 targeting peptide attached were also synthesized.
Polymers were labeled using the increased polymer concentration (5 mg/mL) and
purified using either Sephadex G25 or PD-10 columns. Although labeling was performed
identically to the successful iodinations completed for lower molecular weight polymer,
the purity of the radioiodinated purified high molecular weight polymers was uncertain
due to irregularities observed during in vivo measurements with the labeled high
molecular weight material. In particular, significantly higher levels of activity were
measured in the stomach during biodistribution studies with polymer synthesized from
high molecular weight backbone polymer relative to that for lower molecular weight
polymers. Increased activity in the stomach is a strong indicator of the presence free
iodine in vivo (See Targeted Delivery Chapter for greater detail).
Labeled polymer solutions were tested for purity using PD- 10 columns at
different lengths of storage time after the original labeling and purification procedure.
PD- 10 columns were used for this study due to the large number of columns required in a
short period of time. Activities of the collected elution fractions were measured and
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analyzed according to the same method used for polymer 027 stored for 6 mo and data
were plotted as the fraction of the total initial activity added to the PD- 10 column
(FIGURE 4.21).
Polymer substituted with 25% PEG3400-EI3.4.3 peptide and 75%
perfluorocarbon (PFC) sidechains (see FIGURE 4.20 for structure) was labeled and
purified and tested for purity 4 hr after the initial procedure (FIGURE 4.2 1a). The
secondary peak at an elution volume of 9.5 mL, which was approximately equal to the
total column volume, indicated the presence of free iodide in the labeled material. This
finding confirmed the suspicion raised during the biodistribution studies concerning the
purity of the labeled high molecular weight material.
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Figure 4.21. High molecular weight polymer substituted with 25% PEG3400-EI3.4.3 peptide and
75% PFC sidechains analyzed by a PD-10 column (A) 4hr, (B) 5 hr, and (C) 28 hr after initial
labeling and purification (t=0O). Asterisks indicate fractions that were pooled and either remeasured
(A, B) or used in biological studies (C). The void and total column volumes for are indicated by
dashed lines.
In addition to providing information about the purity, the PD- 10 column also
purified the sample. The high-activity fractions (indicated by asterisks) were collected
and analyzed using a fresh PD- 10 column one hour later, which was also 5 hr after
completion of the initial procedure (FIGURE 4.20B). For this measurement, the
secondary elution peak was significantly lower, but still present. The high-activity
fractions, again indicated by asterisks, were collected and analyzed using a fresh PD- 10
column 23 hr later, which was 28 hr after the initial procedure (FIGURE 4.20C). The
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resulting elution profile had no significant late elution volume peak, which indicated that
the sample added to the PD- 10 column was radiochemically pure. To confirm this, the
resulting sample was measured 3 days later and a similarly pure elution profile was
observed (data not shown).
4.4 Discussion
Evaluation of the Standard Reaction Protocol
4.4.1 Confirmation of Covalent Attachment Using Sephadex
Polymer 027 was labeled and purified according to the standard protocol. Two
distinct peaks were observed in the corresponding elution profile (FIGURE 6) near the
void and total column volumes. The sharp elution peak for the labeled polymer indicated
that the polymer was completely excluded from the pores of the resin. The peak
corresponding to the free, unbound iodine which are small enough to enter the entirety of
the porous resin, was comparatively diffuse. This is most likely due to dispersive effects
that are commonly observed for materials traveling through porous media.
Heterogeneities in the pore size could have also contributed to the observed diffuseness
of the free iodine peak.
When plotted semi-logarithmically (FIGURE 4.7), it was apparent that the
radioactivity did not return to the baseline after the primary elution peak of the labeled
polymer 027 product. This tailing of the elution peak can be attributed to mixing
occurring within the resin bed, which is usually a sign of loose packing. Loose packing
may be a consequence of the gravity flow method used to pack the Disposaflex columns.
Although it represents a deviation from the ideal profile presented qualitatively in
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FIGURE 4.3, the observed tailing was relatively small when compared to the height of
the elution peak.
For the uncatalyzed reaction mixtures in which no lodination bead was added, a
step change and subsequent plateau in radioactivity concentration was observed. This
behavior may indicate a small degree of channeling or bypassing of the Sephadex G15
resin bed. The small proportion of activity bypassing the media remained constant until
the major activity peak, which corresponded to free iodine, began eluting as the elution
volume approached the total column volume. The consequence of this channeling or
bypassing would be unbound iodine impurities in the pooled labeled polymer (indicated
by asterisks).
Even though some channeling and tailing was observed, the disposable Sephadex
G 15 column packed and operated solely by the force of gravity yielded purified product.
In fact, the observed 3-4 order-of-magnitude difference (FIGURE 4.7) was an initial
indication that the purified labeled polymer had a radiochemical purity of at least 99%, if
not higher. Subsequent experiments were performed to further improve the purification
step.
4.4.2 Confirmation of Covalent Attachment Using Radio-High Performance Liquid
Chromatography (HPLC)
The radio-HPLC experiments provided (FIGURE 4.8) additional evidence that
radioiodine was covalently attached to the polymer, as well as evidence that the
iodination reaction did not affect the bulk molecular weight characteristics of the polymer
starting material. The fact that the radioiodine was spread throughout all polymer chain
lengths in the starting mixture was important. This ensured that any activity measured for
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a given sample would have equal contributions from all molecules in a given polymer
sample. This result was achieved because the backbone was an alternating copolymer,
with linker groups and their potential iodination sites in every repeat unit.
4.4.3 Effect of Iodination on Chemical Structure
Analytical GPC measurements of the backbone polymer molecular weight were
performed to determine whether the iodination reaction had an effect on the chemical
structure of the polymer (FIGURE 4.9). Any change in the molecular weight profile,
whether gross or subtle, would be a direct result of the destruction of ester or ether bonds
within the backbone of the polymer. Both of these oxygen-containing functional groups
were considered the most likely targets of the oxidative conditions produced by the
Iodination bead.
The standard reaction protocol, for initial concentrations of iodine and polymer
elevated by a factor of ten, was shown to have a small, but measurable effect on the
molecular weight profile of the backbone polymer. The slight shift toward longer elution
volumes suggested a small decrease in the bulk molecular weight of the backbone
polymer likely due to the conditions in the reaction. However, the shift was
comparatively small and this fact, together with the sharp elution peak observed near the
total column volume activity (FIGURE 4.6), provided strong evidence that the iodination
reaction not only attached radioiodine to the polymer, but that it attached the radioiodine
to intact polymer chains.
Unfortunately, these measurements were complicated by the requirement to
freeze-dry the experimental samples for analysis in the organic mobile phase used in the
available GPC system. This complication was evident by comparing the chromatograms
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of freeze-dried polymer and raw polymer dissolved in THF (FIGURE 4.10). This
experiment demonstrated that one of the liquid manipulation steps required for sample
analysis produced the effect, albeit to a lesser extent, that was a potential outcome of the
experiment. The effect of freeze-drying on the molecular weight profile did appear to be
confined to the production of low molecular weight fragments at elution volumes greater
than 23 mL.
In a second experiment, the oxidative conditions during the reaction were
significantly elevated to determine whether conditions in the reaction could affect a
significant change in the backbone polymer molecular weight (FIGURE 4.11). A one-
thousand fold relative increase in oxidative species was achieved by increasing the
concentration of cold iodine added to the reaction mixture with the backbone polymer
and lodination bead. A significant shift in the molecular weight profile was observed,
which corresponded to a 60% reduction in weight-average molecular weight. This
reduction in molecular weight could have been caused by degradation of the polymer
backbone. However, it is also possible that the high concentration of iodine added to the
polymer backbone may have affected the polymer retention by the GPC columns by
changing the way in which the polymer interacted with the media.
4.4.4 Effect of the Jodination on Older Polymer Samples
Similar experiments were performed to assess the effect of the iodination on the
chemical structure of older polymer samples (FIGURE 4.12). The resulting GPC
measurements revealed complete degradation of the old backbone polymer upon
exposure to the standard protocol with a tenfold increase in both polymer and iodine
concentrations. These results suggested a potential mechanism for polymer breakdown. It
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is well established that PEG oxidation occurs in humidified environments [40]. It is likely
that the backbone polymer, which was stored for extended periods under ambient (i.e.
humid) conditions, contained partially oxidized PEG subunits prior to use in this
experiment (FIGURE 4.22). This partial oxidation could have made the backbone
polymer more susceptible to the strong oxidative conditions of the iodination. Because
the extent of this partial oxidation due to storage is related to the length, temperature, and
moisture content of the exposure, polymer stability during iodination can be improved by
storing polymer in a refrigerator and in the presence of a desiccant.
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Figure 4.22. Chemical structure representation of the proposed mechanism for the degradation of the
backbone polymer under oxidative conditions.
This proposed mechanism can be extended to the iodination reaction, wherein
oxidative conditions enhance the degradation process, either by increasing the rate of
peroxide formation or subsequent peroxide breakdown. Recall that each repeat unit in the
backbone polymer is composed of the isophthalate linker and PEG900, the latter of which
contains approximately 34 repeat units of ethylene oxide. The oxidative breakdown of
just one of these many ether groups within the backbone will fracture the polymer chain.
Evaluation of the Standard Purification Protocol
4.4.5 GPC Analysis of Void Volume Fractions
The complete molecular weight profile of polymer 027 was recovered within
elution volumes between 2-4 mL (FIGURE 4.13). This result implied that all lengths of
backbone polymer in the sample added to the top of the column were excluded from the
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pores of the Sephadex G15 media. The exclusion limit for this media was 1.5 kDa. As
was observed for previous samples, small molecular weight fractions in the recovered,
freeze-dried, and resuspended sample were likely generated during the freeze drying step.
This experiment demonstrated that the activity measured in the standard protocol
experiment (FIGURE 4.6) co-eluted with the breadth of the molecular weight profile
measured for polymer 027. This fact was an additional piece of evidence indicating the
successful attachment of radioiodine to the polymer.
4.4.6 Elution Profile of Free Iodine-125
The elution profile for free iodine-125 was measured in five different purification
experiments, which covered 4 different media and 2 different colunm configurations
(FIGURE 4.14). The results were used to evaluate the ability of each media to delay the
elution of free, unbound iodine, which directly contributes to the radiochemical purity of
the pooled labeled product. The significantly lower radioactivity concentration measured
in the range between 2-4 mL made the Sephadex G25 (PD-10 and Disposaflex) and
DEAE Sephadex columns most attractive for continued investigation. The promising
results for the Sephadex G25 media experiments are consistent with the widespread use
of PD- 10 columns for purification of radioiodinated proteins found throughout the
literature [1, 12, 13, 41, 42].
The sharp increase followed by a plateau in radioactivity concentration for the
G 10 and G 15 experiments are an indication of some channeling or bypassing of the resin
bed similar to that observed previously (FIGURE 4.7). The G1O and G15 exclusion
limits (1 and 1.5 kDa, respectively) were the lowest (i.e. smaller pore sizes) of the media
investigated. Although it does not seem likely that the lower exclusion limits themselves
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can explain the observed bypassing behavior. One potential explanation may be
incomplete swelling of the resin leading to small heterogeneities in the packed bed. While
bypassing was observed to varying extents for all four experiments involving size
exclusion media, the activity measured for the DEAE Sephadex was nearly at
background levels until at least 6 mL of elution volume. This observation suggested that
the charged groups of the DEAE media were able to compensate for any channeling or
bypassing fluid dynamics through strong ionic interactions.
4.4.7 Elution Profile of Post-Reaction Mixtures Generated by the Standard Protocol
While a successful purification must delay the elution of free, unbound iodine-
125, it must also allow for the recovery of the labeled product. The elution profiles for the
post-reaction mixtures provided the information necessary to address this second
requirement (FIGURE 4.15). For the G25 Sephadex, the five order-of-magnitude
difference between the post-reaction mixture and free iodine elution profiles over the
fractions pooled to yield the purified labeled sample (indicated by asterisks) were almost
exclusively representative of iodine associated with the polymer and not unreacted,
unpurified iodine. The PD-10, for which the labeled material was approximately three
orders of magnitude greater than the free 1251, also produced a product of >99.9% purity.
Depending on the sensitivity of the end-use technique to free iodine impurities, this level
of purity may be sufficient, which would make the PD- 10 columns an attractive option
because they arrive pre-packed with Sephadex G25 media.
Although DEAE-Sephadex yielded the labeled polymer with the greatest purity,
the column conditions led to significant product loss during purification. Specifically, the
buffer pH was not adjusted to (or beneath) the isoelectric point of the polymer. If the
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polymer were to have been charge neutral or positively charged, the DEAE-Sephadex
could have been operated in flow-through mode in which the labeled product would elute
while the free, negatively charge iodide would bind to the DEAE. Because the iodination
procedure is intended for a wide range of polymer formulations, one would likely have to
determine the isoelectric point of each polymer formulation, of which there are many,
and carefully control pH in order to maximize recovery of labeled material. There may
also be stability issues at lower pH due to potential acid hydrolysis reactions of esters
throughout the polymer.
Because the process was intended for use across a range of polymer formulations
and it would be time-consuming to determine the pKa and appropriate buffer
characteristics for each polymer formulation, it was determined that the Sephadex G25 in
Disposaflex should be used as the universal media for the purification step due to its
strong purity profile and general applicability. There may be opportunity to revisit the
DEAE Sephadex either for applications that demand higher purity or once a small
number of candidate polymer formulations are selected for intensive study.
4.4.8 Fractional Recovery
Although BSA is occasionally used in Sephadex purifications, particularly for
high-adsorbing proteins, it did not appear to have any effect for our polymer system
(TABLE 4.3). This result was not surprising due to the large amount of PEG in all of our
polymer formulations. Finally, since the labeled polymer product solutions were
frequently mixed with higher concentration, cold polymer solutions to produce the final
labeled polymer for use in uptake or biodistribution studies, fractional recoveries greater
than 0.90 were more than sufficient.
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4.4.9 Labeling Yield
The results for the labeling yield experiments demonstrated that the initial
polymer concentration added to the reaction mixture was the most significant factor in
increasing yield (TABLE 4.4). There are some practical limitations associated with
increasing the polymer concentration, including (1) limited solubility of heavily
PEGylated polymers, especially those having higher molecular weights, (2) limitations in
the availability of synthesized material, and (3) volume requirements in order to
adequately submerge the Iodination bead in solution. These three limitations set the
practical limit on initial polymer concentration at approximately 5-10 mg/mL.
The experimental labeling yield was also a function of total reaction time,
although the effect appeared to be more asymptotic than that for polymer concentration.
There were also practical limitations when considering an increase in reaction time,
particularly with respect to degradation of the polymer by the oxidative conditions in the
reaction. The longer reaction time increases the exposure of both the targeted sites on the
aromatic ring and the functional groups susceptible to oxidative degradation to oxidizing
species generated by the lodination bead. In order to determine the proper reaction time,
one would have to solve an optimization problem balancing yield and degradation
requirements.
The insensitivity of yield to initial iodine activity was the primary reason that the
particular kinetic model (first order in A, second order overall) was chosen as the
appropriate description of the process yield (FIGURE 4.17). The R-squared value
determined from the least-squared regression of the data, 0.93, indicated strong
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agreement between the data and the theoretical model (FIGURE 4.18), which was
particularly promising considering the relative simplicity of the model. Finally, the length
of the activation period (currently 5 min in the standard protocol) is an additional variable
that was not investigated.
4.4.10 Labeling Yieldfor Ornamented Polymers
The fractional labeling yield for ornamented polymers varied widely between
0.05-0.50. These were results compiled from production runs for a wide variety of
polymer formulations. The data were examined to try and determine trends in the yield
that corresponded to aspects of the chemical structure of the labeled polymers; other
contributing factors complicated the picture. The most common issue was partial
inactivation of the Iodination bead activity, which could only be determined after an
iodination was completed. In all cases, the yield was more than sufficient to supply a
breadth of in vitro update and in vivo biodistribution studies.
Although the optimum conditions may vary depending on the particular
formulation, determining individually optimized conditions was infeasible due to the
shear number of polymers investigated during the biological studies. A similar study
would be advised before initiating any large-scale animal studies with a small number of
lead candidate formulations.
4.4.11 Radiolabel Stability
The elution profile for polymer 027 stored for 6 mo at 4"C (FIGURE 4.19)
demonstrated that the label on the polymer was stable over the duration of the storage
period. Although one would probably not plan to store labeled material for extended time
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periods due to activity losses associated with radioactive decay, this result provided
information concerning the time-dependent reliability of the labeled polymer.
4.4.12 Considerations for Radiolabeling High Molecular Weight Backbone
The same radiolabel stability experimental procedure was performed on freshly
labeled, high-molecular weight, ornamented polymer (FIGURE 4.20) that was
synthesized for uptake and biodistribution studies. These measurements revealed that
free, unbound iodine impurities were present in the sample 4 hr after the original reaction
and purification. This could have been caused by experimental errors during purification
of the original labeled product. This seems unlikely because this free iodine peak at t=4hr
was observed for all of the polymer formulations in this high molecular weight series.
From this it must be inferred that the effect is phenomenological and not procedural. To
produce the effect, it is possible that some iodine had formed an association with the
polymer that was strong enough to endure the purification but not strong enough to
persist after 4 hr of storage.
The relatively higher molecular weight of the backbone polymer starting material
(12 kDa vs. 3 kDa) was the primary difference in this sample in comparison to polymer
027, which did not exhibit this behavior. Recall that solubility decreases as molecular
weight increases. Based on this, it was proposed that the strong association described in
the previous explanation was somehow mitigated by local insolubilities in the higher
molecular weight polymer.
For the second post-protocol purification (FIGURE 4.2 1B), the fact that the
secondary peak was not observed at the total column volume, but slightly earlier, may
suggest that the late elution volume activity was not caused by free iodine, but by
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broadening or tailing of the labeled polymer peak. This would certainly be the case if the
datum at elution volume of 6.5 mL was a low outlier that created a 'false positive' peak
due to the discrete nature of the collected fractions.
Although the mechanistic explanation for the observed phenomenon was
incomplete, the additional purifications of the high molecular weight polymer were
ultimately able to produce radiochemically pure polymer to supply in vitro and in vivo
studies. The additional purification steps reduced the overall process yield, the overall
fractional labeling yields for the various high molecular weight polymers were
approximately 0.05-0.10.
4.5 Conclusion
The preceding results represent the first demonstration that a nanoparticle-
forming polymer that can be directly labeled with radioiodine using a standard protein-
labeling technique without any additional chemical-alterations or intermediate reactions.
The process has been characterized using a variety of chromatographic techniques,
spectrophotometry, and radiometric measurements. These measurements have confirmed
covalent, stable attachment of iodine isotopes, including 1251 124 , and 127, to various
polymer formulation.
A variety of purification media were investigated to assess their ability to retard
the elution of free iodine while providing sufficient recovery of the labeled product for
use in subsequent biological studies. Both G25 Sephadex and PD-10 columns provided
excellent separation of labeled material from unreacted 125I. The fact that PD- 10 columns
require comparatively little preparation makes them attractive for future use, particularly
in non-research applications, such as in the clinic.
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Reaction yields above 90% have been reported for many proteins [14] and small
molecules [34] using various radioiodination methods. In this study, the tyrosine-like
groups within polymer 027 are esterified, and further optimization is likely possible.
Moreover, the specific activity of the labeled material, which is the key metric for
diagnostic. imaging applications such as PET or SPECT, can be increased as desired by
increasing the initial activity of radioiodine added. Although this is not the most cost-
effective method to achieve this aim, particularly considering the limited availability of
isotopes like 1241, the procedure as developed should provide radiochemical yields within
an acceptable range.
The free iodine impurities observed in labeled and purified samples synthesized
from high molecular weight backbone polymer was of concern. These results suggested
that some molecular weight-related phenomenon created a subset of polymer-iodine
associations that withstood the initial post-labeling purification only to dissociate less
than four hours after the initial procedure. The exact mechanism for this behavior is
unclear. Possibilities include high molecular weight-related adsorption of iodine by the
polymer or increasing bond lability due to local insolubilities of the higher molecular
weight polymer.
Overall, a broadly applicable process was developed to radiolabel a range of
polymer formulations for use in biological studies, including in vitro cellular uptake, in
vivo biodistribution, and live animal imaging by positron emission tomography (PET).
Further polymer-specific improvements or condition adjustments may be necessary
before cost-effectively translating the process to large-scale research or pre-clinical trials
to improve product yield and related cost-effectiveness.
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Physico-chemical and Biological Evaluation of E13.4.3-Conjugated Polymers
5.1 Introduction
A number of circulating delivery systems have been developed in response to the
need for efficient and selective drug transport to primary tumors and their metastases.
Circulating delivery systems fall into three categories - liposomes, polymeric micelles,
and dendrimers. These system are able to effectively circulate in the bloodstream by the
addition of poly(ethylene glycol) (PEG) either by adsorption or chemical attachment.
Addition of PEG to a delivery vehicle creates a dense 'conformational cloud' on the
exterior conferring a level of stealth to the particle [1]. It is proposed that both the
hydrophilic nature and the chain flexibility of PEG are necessary to avoid opsonization
by plasma proteins and subsequent macrophage attack [2]. Interestingly, the PEG often
serves a dual purpose in polymeric micelles, providing the hydrophilic 'head-group'
necessary for micellization.
Liposomes are composed of phospholipids that form closed bilayer structures
when in aqueous solution [3]. They are desirable as drug carriers due to their
biocompatibility since they are typically constructed either using biological materials like
phospholipids or made stealth via conjugation to PEG [4]. Moreover, liposomes can carry
both hydrophobic and hydrophilic materials and be varied in size and surface properties
by careful preparation. Liposomes are occasionally limited by issues of size; macrophage
recognition and subsequent clearance occurs for particles above ~200 nm. Conjugation to
PEG can slow macrophage detection, however this retarding effect decreases as liposome
size increases [5]. Other issues include low stability, non-sterility, and poor encapsulation
199
efficiency [6]. Most recently, liposomes have found application in delivery of
oligonucleotides for various therapeutic applications, including treatment of cancer [7].
Dendrimers are highly branched macromolecules synthesized by either divergent
or convergent methods [8] yielding particles with a high number of surface units per area
as well as an adaptable internal environment. An additional desirable property of
dendrimers is their monodispersity [9]. Although dendrimeric drug delivery systems have
achieved successes in in vitro studies [10], the synthesis is time-consuming, expensive,
and poorly scalable. In spite of these constraints, the group of James Baker has published
promising in vivo results using a PAMAM dendrimeric system targeted to the folic acid
receptor overexpressed in the KB human cancer cell line. In this work, the
chemotherapeutic methotrexate was delivered to mice bearing KB tumor xenografts. The
dendrimers were covalently attached to both FITC and tritium for post-experiment
histological assays. Their delivery system reduced methotrexate toxicity ten-fold and
nearly doubled survival time in the methotrexate-treated group in comparison to controls.
In their most recent work, the group of James Baker has begun using a new targeting
ligand for the KB cell line, riboflavin [11, 12]. It is unclear why they have moved away
from folic acid as a targeting ligand.
Additionally, current work in the Hammond lab in this department has focused on
linear dendritic block copolymer micelles as targeted delivery systems. In this system, the
linear block can be chosen to improve encapsulation, while the dendritic exterior
provides many surface groups for addition of targeting capability. In recently published
work and a current manuscript in preparation, dendritic block copolymers using folate as
a targeted ligand and paclitaxel as the therapeutic agent have shown a significant increase
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in efficacy relative to untargeted controls [13]. The synthesized particles were
approximately 80 nm in diameter.
In addition to the circulating systems described above, a number of novel contrast
agents have been developed, including superparamagnetic nanoparticles and quantum
dots. Cross-linked iron oxide (CLIO) particles, which are powerful MRI contrast agents,
are an example within the field of superparamagnetic nanoparticles for imaging [14]. The
group of Anna Moore has used CLIO particles coated with dextran and targeted them to
tumor cells demonstrating the utility of underglycosylated MUC 1 as a target. They have
also attached the fluorescent dye, Cy5.5, to CLIO particles to produce a multimodal
system with capability for both MR and near infrared fluorescence imaging [15, 16].
Although these CLIO particles are not best suited for carrying therapeutic agents to
tumors, a few methodologies converting iron oxide particles into simultaneous drug
delivery and imaging vehicles have been reported [14]. Quantum dots are fluorescent
nanocrystals that absorb a broad range of light while having a narrow and intense
emission spectra tunable by altering the crystal size [17].
5.1.1 Polymeric micelles
Polymeric micelles [18-21] are amphiphilic colloids that spontaneously form
aggregates composed of several amphiphilic molecules at concentrations and
temperatures conducive for doing so. The critical micelle concentration (CMC) is the
concentration above which micelle formation begins. Below the CMC, the amphiphilic
sub-units remain solubilized. The resulting particles are typically of the order 5-100 nm
in diameter and are usually spherical in morphology.
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Polymeric micelles are composed of two major components. The interior,
hydrophobic core is a hospitable environment for hydrophobic molecules, such as many
contrast and therapeutic agents. The solubilization properties of this internal environment
may be tailored to encapsulate these poorly soluble molecules. This encapsulation
shelters the molecule from biological degradation while protecting healthy cells from the
potentially cytotoxic agent. The second major component is the hydrophilic corona that
surrounds the hydrophobic core. As previously described, this corona is often PEG, a
molecule that gives a 'stealth' property to a circulating particle [19].
According to Torchilin, the ideal polymeric micelle system would have a diameter
between 5 and 100 nm, demonstrate stability both in vitro and in vivo (low CMC and
stability until reaching the desired destination), disintegrate into biocompatible materials
after delivery, and encapsulate the desired agent in sufficient quantities [18]. The upper
limit of the size recommendation is necessary in order to avoid clearance by the
macrophages of the reticuloendothelial system (RES). The lower limit ensures that the
delivery vehicle avoids rapid clearance by renal exclusion and that it takes advantage of
the enhanced permeability and retention (EPR) effect where passive targeting is possible
due to the 'leaky' vasculature often encountered in tumors [22-25]. It has been shown
that non-targeted particles greater than 5-10 nm preferentially accumulate in primary
tumors based on their size alone because of the EPR effect [23]. Acknowledging the
tremendous advantages in size, stability, biocompatibility, and adaptability attributed to
polymeric micelles, the next step is to then endeavor to construct delivery systems with
the most ideal biodistribution and pharmacokinetic characteristics. Significant thought
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has been devoted to the design of polymeric micelles since the seminal paper, including
significant contributions from Omid Farokhzad [26] and Torchilin himself [27].
There has been a great deal of activity in the field of polymeric micelle drug
delivery systems, particularly within the last 15-20 years. The following portrayal will
both highlight the achievement thus far and introduce the breadth of investigation in this
area of research.
The most extensive achievement in polymeric micelle delivery has been by the
group of Kataoka in Japan. Their work began with poly(ethylene glycol)-poly(aspartic
acid) block copolymers [PEG-PAsp] [28] and has since expanded to include other block
copolymers (including PEG-poly(D,L-lactide) [PEG-PLA]), as well as polyion complex
(PIC) micelles [20]. Most, if not all, of Kataoka's initial work does not include any
targeting, instead relying on passive uptake via the EPR effect. The original PEG-PAsp
system was chemically conjugated to the chemotherapeutic agent, doxorubicin, and this
system is currently in clinical trials in Japan [29].
Work using paclitaxel-loaded poly(DL-lactide-co-glycolide) [PLGA] block
copolymer nanoparticles targeted to the wheat germ agglutinin receptor have successfully
increased tumor doubling time from 11 days in control animals to greater than 25 days
for treated animals [30]. Poly(ethylene oxide)-block-poly(caprolactone) polymeric
micelles have been used as siRNA delivery vehicles to successfully increase cellular
susceptibility to the chemotherapeutic, doxorubicin [31]. Others have used polyester-
based polymeric micelles to achieve increased cell death by increasing the cellular
penetration of paclitaxel [32].
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Most recently, Farokhzad and Langer have developed PLGA-b-PEG block
copolymer nanoparticles encapsulating docetaxel [33] bioconjugated to an aptamer
targeted to the prostate-specific membrane antigen. Aptamers are oligonucleotides that
fold into conformations that bind to targets with high affinity and specificity [34]. In this
study, the treatment group receiving the targeted, drug-loaded nanoparticles had 100%
survival with 5/7 animals having complete tumor regression, whereas only 20% or less of
control group mice survived during the 109 day experiment.
A number of shell cross-linked polymer micelle systems (SCKs) have been
developed [35] in an attempt to improve micelle stability in the dilute conditions
encountered upon injection in vivo. These SCKs are typically block copolymer micelles
include polyion metal complex cores that may be chemically induced to form cross-links
[36]. Moreover, these SCK systems have been used to try to alter the delivery
pharmacokinetics. The group of Wooley has developed an extensive library of SCK
micelles that may be used for controlled release via thermolytic cleavage of the cross-
linking bonds [37-39]. Wooley and Wickline have collaborated to develop amphiphilic
fluoropolymer SCKs for fluorine magnetic resonance imaging applications.
5.1.2 Targeted Delivery with the Alternating Amphiphilic Copolymer System
The initial work developing the in vitro methodologies to test the alternating
amphiphilic copolymer system in targeted delivery applications was performed as part of
the thesis of Dr. Michelle Miller in the Colton lab [40]. The thesis also investigated two
different targeting pairs, both of which were discussed in the previous section: (1)
EPPT/underglycosylated MUC- 1, which was used in the work of Anna Moore, and (2)
folate/folate receptor (FR).
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Initial results with EPPT as targeting ligand showed an approximately two-fold
increase in selective uptake of EPPT-containing polymer over polymer without EPPT in a
receptor positive cell line. Focus shifted away from EPPT targeting ligand due to its
exceedingly high cost of production. Folate was chosen a model system for its cost,
affinity for its targeted receptor, and prevalence in the literature of the field. A library of
polymers containing folate was synthesized by collaborators at UMass Lowell. A wide
range of tests with these polymers were unable to show any increase in uptake due to the
presence of folic acid targeting ligand. From these experiments, it was concluded that the
measured uptake was due entirely to non-specific uptake. Dynamic light scattering
measurements were performed to investigate the lack of specific uptake. The
measurements revealed that the polymers, even those without hydrocarbon sidechains,
were forming large aggregates of at least 200 nm (previous DLS measurements showed
diameters -10 nm). This aggregate formation was attributed to self-association of folate
molecules, the consequence of which was a significant reduction in the exposed the
targeting ligand. For these reasons, folate was abandoned as a targeting ligand.
5.1.3 The E13.4.3 Peptide Targeting Ligand
After the disappointing results with folate as the targeting ligand, a new targeting
ligand option was determined through collaboration with Dr. Benjamin Hackel from the
laboratory of Professor K. Dane Wittrup in the Department of Chemical Engineering at
MIT. In his thesis [41], Dr. Hackel developed protein engineering techniques to produce
super-binding peptides for various targets. The tenth type III domain of the human
fibronectin protein, which is a small, stable, single-domain, cysteine-free protein, was
used as the scaffold for engineering.
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The E13.4.3 peptide was chosen from a library of super-binding peptide raised
against the epidermal growth factor receptor (EGFR). The E13.4.3 peptide was chosen
from the available options due to its extremely low dissociation constant, KD = 250 pM
[42, 43], and its comparatively low number of tyrosine moieties in the binding domain,
one.
5.2 Design of Targeted Polymers
In order to successfully design a polymer to maximize the uptake of targeted
polymers into target-bearing tumors in vivo, it is imperative to understand how varying
polymer components and resultant properties, including size, micellization, stability, and
targeting ligand density, affects performance in four biological areas: (1) receptor
binding, (2) access to the receptor, (3) time in circulation, and (4) the enhanced
permeability and retention (EPR) effect.
One might propose an experimental design investigating targeted delivery building
'from the bottom-up.' The in vivo behavior of free E13.4.3 peptide would be of primary
interest after which the behavior of the peptide attached to a single PEG-linker repeat unit
of the polymer would be studied. The next conceivable step in this bottom-up approach
would be to synthesize a polymer that can form micelles, that is, a polymer having more
than one repeat unit such that hydrophobic sidechains can be attached in addition to the
peptide.
As the number of repeat units increase, the design choices, which include the polymer
molecular weight, proportional substitution of the backbone with targeting and
hydrophobic groups, the nature of the hydrophobic groups themselves, and the length of
the spacer molecule connecting the peptide to the backbone, increase substantially and
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the bottom-up design approach becomes less useful. Therefore, a systematic, conceptual
evaluation of the various design parameters is needed in order to design a study that
effectively assesses the performance of the targeted polymers.
5.2.1 Targeting Density and Molecular Weight
The density of targeting peptides within the polymer is unquestionably a variable
of interest when designing a targeted delivery system. There are three interdependent
variables that must be considered: (1) the number of linkers per chain (or the backbone
polymer MW), (2) the number of peptides per chain, and (3) the percent of sidechains
substituted with peptides. The interrelatedness of these three variables is illustrated in
(FIGURE 5.1):
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Figure 5.1. Schematic diagram depicting the interrelatedness of the three key variables that
determine the targeting density: the number of linkers per chain, peptides per chain, and percent
substitution. The linkers (circles) can only be substituted with so many peptides (squares) before the
number of hydrophobic sidechains is reduced to the point where micelles can no longer form.
Holding the number of peptides per chain constant and increasing the linkers per
chain (MW) decreases the percent substitution. Micelle formation creates an additional
complicating factor because the number of peptides per micelle depends on the
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aggregation number. If the aggregation number did not change, then the conversion
would be straightforward. However, the micellization behavior could be a function of the
polymer MW or the percent substitution of peptides, or both.
Changing the percent substitution of peptides also affects the
hydrophobicity:hydrophilicity ratio of the polymer since greater percent peptide
substitution means fewer sidechains can be hydrophobic. This may also have an affect on
micellization behavior and therefore makes this ratio an additional potential variable
since there is the capability of adding PEG groups of various lengths as sidechains,
without targeting peptides. However, considering the already relatively low amount of
hydrophobicity in the amphiphilic polymers as they are currently designed (as seen
readily in the schematics above), one might instead consider varying the length of the
hydrocarbon (or perfluorocarbon) sidechains to increase the relative hydrophobicity of
the amphiphilic polymers.
There are many possible levels for the three dependent variables beyond what is
depicted in the preceding figure. TABLE 5.1 provides the various options in a useful
layout for experimental design. The highlighting and dotted lines on the table identify
potential series for investigation. An investigation focusing on the effect of the backbone
polymer MW would follow one (or more) of the vertical series. A study investigating the
effect of the number of peptides per chain would follow one (or more) of the horizontal
series. Finally, if the polymers within the selected horizontal and vertical series are
chosen properly, the data from these experiments can be used to evaluate the effect of the
third dependent variable, the percent of sidechains substituted as peptides.
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The circled values within the table represent a potential large study to
comprehensively investigate the affect of polymer MW, peptides per chain, and percent
substitution of peptide groups. In total, there are fourteen experimental levels circled.
There is also the option to synthesize identical polymers without the targeting peptide
attached as negative controls, which would immediately double the proposed polymer
library to twenty-eight. Considering the fact that study of other potential variables,
including sidechain identity and spacer length, are not included in reaching this value, it
is clear that, although experiments studying the performance of polymers compassing all
the circled levels would be ideal, significant reduction in scope is necessary. The other
variables will also be considered in detail before doing so.
5.2.2 Hydrophobic Sidechain Identity
There are also a number of options for the identity of the sidechains on the
remaining, unreacted linker hydroxyl groups. Hydrocarbon or perfluorocarbon chains can
be added to impart amphiphilicity and the ability to form micelles. The linker hydroxyls
can also remain unreacted (termed 'no sidechains'). Therefore, the identity of the
remaining sidechains determines the physico-chemical properties of the synthesized
polymer. Previous experiments by Jin Zhou Dawson revealed some trends. In particular,
perfluorocarbon particles had critical micelle concentrations (CMC) about one order-of-
magnitude lower than hydrocarbon particles. Additionally, particles with hydrocarbon
sidechains were slightly larger than those with perfluorocarbons.
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5.2.3 Spacer Length
The length of the PEG segment connecting the targeting peptide to the backbone
polymer is another variable for consideration. Geometric modeling completed by
Michelle Miller revealed the potential importance of spacer length, particularly for
targeted particles. To summarize, the amount of area sampled by a targeted delivery
system, for example one probing the cell surface for the targeted epitope, is directly
related to both the particle size and spacer length. Using geometric arguments, it can be
shown that for a given particle size, the number of targeting moieties available to
participate in targeting events increases drastically with spacer length until a threshold is
reached and strongly diminishing marginal returns persist.
5.2.4 Experimental Strategy
Before any of the previously described variables could be investigated, the first
step was to test the E13.4.3 peptide/EGFR targeting pair with our polymer system.
Therefore, initial experiments were designed to determine whether the presence of the
targeting ligand increased the uptake of our polymers in vitro relative to untargeted
controls. Having achieved this, the ligand density and hydrophobic sidechain identity
were selected as the variables of primary interest. PEG3400 was chosen as the spacer
length since it was deemed suitably long to avoid any spacer length-related limitations.
In order to vary the ligand density (number of peptides per chain) over a wide
range while still having sufficient linker hydroxyls available for substitution with
hydrophobic groups, the molecular weight of the backbone polymer had to be increased.
Using the backbone polymer produced in the Protherm (see Polymerization chapter), a
high throughput, preparative gel permeation chromatography fractionation process was
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developed to supply high molecular weight, low polydispersity backbone polymer for the
E13.4.3-conjugated polymer synthesis.
A library of E13.4.3 polymers, together with their untargeted control polymer
counterparts, was synthesized. These polymers were tested in a range of experiments,
including dynamic light scattering to determine particle size distributions, in vitro uptake,
and in vivo biodistribution and blood circulation studies.
5.3 Materials and Methods
5.3.1 Materials
All study polymers were synthesized as described in Chapter 2: Chemical
Synthesis of Alternating Amphiphilic Copolymers. With the exception of backbone
polymer synthesis, which was completed by the author, all chemical synthetic steps were
performed in the laboratory of our collaborator, Dr. Arthur Watterson at the University of
Massachusetts - Lowell. Unless otherwise noted, all polymers were weighed before
dissolution in phosphate buffered saline (PBS, Mediatech, Inc.) to create concentrated
stock solutions of 3-5 mg/mL. When the amount of polymer to be weighed was small,
particularly for quantities less than 20 mg, a vial was weighed and deionized water was
added. The polymer (typically about 10 mg) was dissolved into solution by pipetting up
and down and removed from the vial. Any remaining solution not removed from the vial
(typically a very small amount) was allowed to evaporate. The vial was weighed again
and the difference between the initial and final weights was equal to the amount of
polymer that had been dissolved in solution. Free peptide concentration was determined
using the bicinchoninic acid (BCA) assay (Pierce Chemical) as described by the
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manufacturer. Polymer radiolabeling was performed according to the protocol described
in the Radioiodination chapter.
5.3.2 Backbone Polymer Fractionation by Preparative Size Exclusion Chromatography
High molecular weight backbone polymer was produced and isolated from
reaction in the Protherm (500 rpm, molecular sieves) as described in the Polymerization
chapter. The deionized water used as the chromatography mobile phase was also filtered
using 0.2 pm IL polyester sulfone (PES) filter units (Coming, Lowell, MA). The filtered
water was degassed by applying vacuum while mixing and agitating with a magnetic
stirring bar.
Polymer fractionation was performed using an AKTA Explorer preparative liquid
chromatography system (GE Lifesciences, Piscataway, NJ) equipped with a high-prep
Superdex 75 26/60 size exclusion column (also GE). These GPC/size exclusion
experiments were performed on a different chromatography system with a different
column than the GPC system used to analyze the backbone polymer molecular weight.
The column and system pumps were much larger to increase throughput. This column is
an off-the-shelf product pre-packed with Superdex size exclusion media. The 26/60
designation refers to a column having a 26 mm diameter and 60 cm bed height. These
dimensions correspond to a total bed volume of 318.6 mL. The flow rate for all column
operations was 1 mL/min. The AKTA Explorer system was monitored with a UV/vis
detector (X = 250 nm) and equipped with an automated fraction collector. The Superdex
column was equilibrated with 3 column volumes (CV) of filtered, deionized water at the
beginning of each run.
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5.3.3 Evaluation of Preparative GPCfor Backbone Polymer Fractionation
The Hi-prep Superdex column was studied for its potential use in fractionating the
backbone polymer. The elution profile for backbone polymer was measured to evaluate
the performance of this system. Because the preparative size exclusion column was
packed with resin having variable pore sizes, polymer chains of different lengths would
have different path lengths through the column. The goal, therefore, was to determine to
what extent the Superdex column was able to spread the range of polymer molecular
weights across a breadth of elution volumes.
In this experiment, high molecular weight backbone polymer produced in the
Protherm (10 mg/mL in deionized water) was filtered using a 0.2 pm Acrodisc Supor*
syringe filter units (Pall Corporation, Port Washington, NY). A total of one milliliter of
this filtered sample was injected onto an equilibrated Superdex column via the injection
valve on the AKTA Explorer. Fractions of varying elution volumes were collected, freeze
dried, resuspended in tetrahydrofuran (THF), and analyzed using the Waters analytical
GPC system described in the Polymerization chapter. Therefore, the analytical GPC was
used to determine the molecular weight distribution of the fractions collected from the
preparative GPC.
5.3.4 Development of a High-Throughput Fractionation Process
The fractionation process should also be capable of processing a large quantity of
raw material into discrete fractions. To this end, the largest available column was
purchased to maximize capacity and the flow rate was set to the highest value possible
that also avoided the pressure limit for the column (1 mL/min). The remaining variables
available for increased throughput were the concentration and total volume of the load
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material and the scheduling of successive injections. The elution profile for the
preparative GPC measured according to the previous section, together with the AKTA
Unicorn method editor, was used to develop a method that minimized downtime between
success injections. Also, for these experiments, the high molecular weight backbone
polymer product was dissolved in deionized water at a concentration of 100 mg/mL and
filtered using 0.2 pm Acrodisc Supor* syringe filter units. The developed method was
used to perform a series of injections of high molecular weight Protherm-produced
backbone polymer (3 mL/injection, 100 mg/mL). As was the case for the flow rate, the
injection volume was set to the maximum possible without exceeding the pressure limit
for the column. Each subsequent elution was fractionated by the fraction collector.
5.3.5 Dynamic Light Scattering
The particle size distributions of the various polymers studied were measured by
dynamic light scattering (DLS). Stock polymer solutions were diluted to 0.5 mg/mL in
phosphate buffered saline and filtered with 0.2 im Acrodisc Supor* filters. The filtered
solution was immediately transferred to BRAND disposable UV cuvettes (BrandTech,
Essex, CT) and placed in a ZetaPALS (phase analysis light scattering) system
(Brookhaven, Holtsville, NY). Samples were interrogated for one minute with at least 10
replicates for each polymer. Measurements were repeated, as many as 30 total times, until
a steady response was achieved. Aside from the number and length of the measurement
periods, the ZetaPALS system required only two additional parameters. (1) The system
was instructed that the sample was aqueous, from which the appropriate fluid properties,
including viscosity and refractive index, were determined from a database within the
software. (2) The dust filter was turned off, which was possible because samples were
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filtered directly into a clean cuvette immediately before measurement. Measurements
performed with and without the dust filter showed no difference in particle size
distribution, which confirmed the cleanness of the samples.
The accuracy of the ZetaPALS equipment was confirmed using dextran standards
with known particle sizes of 20, 50, and 100 nm (Corpuscular, Cold Springs, NY).
5.3.6 Cell Culture, Lines and Media
All reagents were purchased from commercial sources. Dulbecco's minimum
essential media (DMEM), fetal bovine serum (FBS), penicillin-streptomycin solution
(pen-strep, 10,000 IU/mL), trypsin EDTA (1X, 0.25% trypsin/0.53 mM EDTA in HBSS),
phosphate buffered saline (PBS, IX), Hank's buffered salt solution (HBSS), and distilled
deionized sterile water were purchased from Mediatech, Inc (Manassas, VA). Eagle's
minimum essential media (EMEM) was purchased from American Type Culture
Collection (ATCC, Manassas, VA). Guava Viacount assay kit was purchased from Guava
Technologies/Millipore (Billerica, MA).
A43 1NS cells (epidermoid carcinoma, EGFR-positive) and MCF7 (breast
adenocarcinoma, EGFR-negative) cells were purchased from ATCC and cultured in
DMEM and EMEM, respectively. All cell growth media were supplemented with 10%
(v/v) FBS and 1% (v/v) pen-strep. Cells were grown at 37 "C in a humidified atmosphere
containing 5% CO2 .
5.3.7 Cellular Uptake Measurement with [I251]-polymer
This procedure was originally developed and described in the thesis of Michelle
Miller [40]. Cells were grown in their respective supplemented media, harvested with
trypsin EDTA (lX, 0.25% trypsin/0.53 mM EDTA in HBSS) one day prior to
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experimentation, and seeded in 96 well plates (1x10 6 cells/mL, 100 ptL/well). All passage
numbers were less than 20. Plating at this cell density resulted in wells that had just
reached confluency upon initiation of each cellular uptake experiment.
Cells were incubated with either polymer (0.5 mg/mL) or various concentrations
of free E13.4.3 peptide (5-500 nM) that had been labeled with radioiodine[12 51] at 37 0C in
a humidified atmosphere with 5% CO2. Samples were taken after different lengths of
incubation. The polymer or peptide was dissolved in the proper cell media for each
respective cell line as required. Experiments were performed in triplicate wells whenever
possible; however, material limitations for a small number of polymers required that only
duplicate wells were used in these rare cases.
At designated times, the solution was removed by pipette and cells were washed
three times with 100 gL PBS. Cells were harvested by adding 100 gL of trypsin EDTA
(1X, 0.25% trypsin/0.53 mM EDTA in HBSS) to each well. After incubation at 37 *C for
at least 15 min, the entire well volume was transferred to radioimmunoassay (RIA) tubes
(VWR Scientific, Philadelphia, PA) and assayed for radioactivity on a Cobra II Auto
Gamma counter (Perkin-Elmer/Packard, Waltham, MA). Samples were measured for 5
min each. The activity of each sample was measured in cpm and converted to mass using
the individual polymer specific activity.
Polymers or free E13.4.3 peptide were labeled according to the standard protocol
as described in the lodination chapter. In the iodinations performed to supply this study,
the initial concentration of the polymer was 5 mg/mL while that for free E13.4.3 peptide
was 1 mg/mL. Between one and two millicuries of activity were added at the beginning
of each labeling procedure. The remaining steps in the procedure were identical to those
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described for the standard protocol. The specific activity of each labeled material was
known (typically 0.1-1 mCi/mg).
Wells containing cells, but with no polymer added, were maintained to control for
cell growth during the course of the experiment. At the designated times, these wells
were also washed with PBS (3x), harvested with trypsin EDTA as above, and counted
using the Guava Viacount method. For experiments with 4 hr durations, the amount of
cell growth measured was very small, typically less than 2-3%. For the few experiments
with 24 hr durations, the longest time frame investigated in this study, the total cells
measured in the control wells increased by approximately 40%
The calculated polymer masses and cell count measurements were combined to
determine the mass of polymer per cell. The procedure was identical for the E13.4.3
peptide studies.
5.3.8 Cell Counting
Trypsinized cells were stained using Guava Viacount assay solution. Data were
acquired on a Guava Personal Cell Analysis (PCA) flow cytometer. Each sample was run
in triplicate and 1000 events were acquired using the Guava Viacount software. The
dilution factor and initial volumes of each sample were used to calculate the total number
of cells.
5.3.9 Biodistribution and Blood Circulation in a Mouse Model of Human Cancer
Female immunodeficient mice (nu/nu, <42 days) were purchased from Charles
River Laboratories (Wilmington, MA). Mice received subcutaneous injections of
A43 1NS tumor cells in their rear flank (1x10 6 cells/inj, 50 pL HBSS/injection). Once
tumors grew to approximately 0.5 cm in diameter (estimated by eye), typically after 10-
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14 days, mice were injected intravenously via the tail vein with 1251-labeled polymer (2
mg/mL, 100 pL PBS/injection, specific activity: 0.1-1 mCi/mg) and sacrificed at
designated time points. In addition to the excised tumor, the following organs were
harvested and weighed immediately after sacrifice: liver, spleen, kidneys, stomach, colon,
heart, lung, brain, and tail. Blood samples were taken from the thoracic cavity using a
graduated, heparinized capillary tube (VWR Scientific, Philadelphia, PA).
The harvested samples were assayed for radioactivity on the COBRA II Auto-
Gamma counter. Measurements of labeled polymer solutions of known concentration
were also performed to control for sample-to-sample variations in specific activity. Based
on these measurements, the percent injected dose in organ (%ID) and percent injected
dose per gram of tissue (%IDPG) were calculated as follows:
a
%ID = -(100%) (1)
tot
%IDPG= %ID (2)
m
where i is the mass of the organ or tissue, a is the activity measured in an organ and ao,* is
the corrected total injected activity, which can be expressed as:
*
atot =atot -a tail (3)
where atot is the total activity in the syringe and atail is the activity measured in the tail. By
subtracting the tail activity, the total initial injected activity in the circulation was
corrected for dose remaining in the tissue interstitia of the tail. Blood circulation data
were calculated only as %ID.
All animal experiments were performed in accordance with protocols approved by
the Committee on Animal Care in the Department of Comparative Medicine at the
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Massachusetts Institute of Technology. Additional animal studies were also performed in
collaboration with former Colton group member, Dr. Michelle Miller. The results of
these studies, which focused on other polymers and, in particular, other biomarker
targets, were presented in Dr. Miller's thesis [40].
5.3.10 Comparison of in vivo Results to Semi-Empirical Model Predictions
Due to the complexity of the biological system, it is difficult to predict the
behavior of a targeted circulating delivery agent a priori. To address this difficulty,
Schmidt and Wittrup have developed a tumor targeting compartmental model [44]. In the
model, which predicts the tumoral accumulation as a function of time post-injection in
mice, only two physical characteristics of the targeted agent are required: the
hydrodynamic radius and the binding affinity (KD). This model was used as one tool to
evaluate the in vivo biodistribution results for the alternating amphiphilic copolymer
micelles relative to those found in the literature or estimated by current theoretical
descriptions of tumor targeting.
The binding affinity contributes to the model by describing the active targeting
contribution to tumoral uptake. The hydrodynamic radius is used to calculate a variety of
mass transport parameters, including the permeability across the tumor capillary wall,
diffusivity within the tumor, available volume fraction within the tumor for mass
transport, and the plasma clearance rate [44]. Interestingly, while a small molecule may
benefit from increased rates of mass transfer into and within the tumor, it also suffers
from increased rate of clearance from the plasma by the renal system. Conversely, larger
molecules or particles will have an increased circulation half-life due to a lower clearance
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rate, but will also have a decreased rate of tumoral penetration because of their large
effective diameter.
In their work, Schmidt and Wittrup used structural and empirical models to
estimate the mass transfer parameters as a function of hydrodynamic radius. A two-pore
representation of the tumor interstitial space was used to estimate the interstitial
diffusivity, fluid volume fraction, and vascular permeability [45]. An empirical model
was used to estimate the renal and non-renal clearance rates of circulating particles. The
theoretical predictions according to the structural model were very comparable to
experimental data compiled from the literature for multiple classes of molecules and
particles (small peptides, PEG chains, and liposomes) covering a range of effective
molecular weights (1-80 nm). The plots presented in Figure 1 of the cited paper were
used to estimate the four mass transfer parameters for three different cases: (1) free
E13.4.3 peptide (MW = 12.5 kDa), and particles having hydrodynamic radii of (2) 5 nm
and (3) 10 nm (TABLE 5.1).
Table 5.1. Size-dependent mass transfer parameters estimated according to the structural and
empirical models of Schmidt and Wittrup. The pore diffusivity, Dpore, accessible void fraction, E,
capillary permeability, Pp.re, and plasma clearance rate constant, kiear, were estimated for three
cases: free E13.4.3 peptide and particles having hydrodynamic radii of 5 and 10 nm.
Case D PPM kw(cm2/s) (cm/s) (1/hr)
Free Peptide 7x10- 0.34 9.27x10-7  5.1
R = 5 nm 2.4x10- 0.23 3.74x10-7  0.20
R= 10nm 3x10-8  0.075 2.Ox1O- 0.05
In addition to the size-dependent mass transfer parameters, experiment-related
information is required to generate model predictions for direct comparison. These
experimental parameters include the dose in pg, the surface concentration of the targeted
antigen (EGFR in this case), the binding affinity of the circulating agent for the antigen,
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the cellular internalization half-time, and the radiolabel catabolism and efflux half-time
for 125I. These figures, which were determined either according to experimental
procedure or from cited literature, are summarized in TABLE 5.2.
Table 5.2. Size-independent parameters required by the tumor targeting compartmental model. The
binding affinity was varied to higher values of KD to account for potential steric effects or binding
site occupation by 1251.
Parameter Value or Range Source
Dose 200 pg Exp.
Antigen Conc. 2.5x10 6 receptors/cell [46]
Affinity 250 pM, 250 pM, 250 mM [41]
Cellular Internalization Half-Time 1 hr [41]
1251 Catabolism and Efflux Half-Time 2 hr [47]
The parameters summarized in TABLES 5.1 and 2 were used as inputs in the
tumor targeting compartment model. Schmidt and Wittrup have generously provided an
online applet for the calculation of the model prediction (http://tumormodel.org/). This
applet was used to generate model predictions for three different agent classes (free
peptide, 5 nm radius, and 10 nm radius) and three different binding affinities (250 pM,
250 pM, 250 mM). The three cases were studied to account for some of the possible
configurations present in our biodistribution studies, while the three binding affinities
were studied to account for potential disruptions in binding due to steric effects or
attachment of 125I to the tyrosine in the binding domain.
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5.4 Results
5.4.1 Polymer Naming Convention
A naming convention was developed to identify the polymers investigated in the
targeted delivery studies. In general, the chemical structure of the polymers studied
consisted of free hydroxyls on the backbone polymer linker group substituted with either
a hydrophilic or hydrophobic sidechain to varying levels (FIGURE 5.2). The hydrophilic
sidechain consisted of a hydrophilic spacer group (either PEG3400 or triethylene glycol,
TEG) and, for targeting polymers, an E13.4.3 at the chain terminus. The percentage of
linker hydroxyls substituted with hydrophilic groups was defined as X%. The balance of
the linker hydroxyls, (100-X)%, were substituted with either hydrocarbon or
perfluorocarbon hydrophobic sidechains (R).
E13.4.3 Peptide HC
PEG 3400 (or TEG) R= F FIF 2  F2  2o C C C1CF3 PFC0= F2  F2  F
0
O O
H3CO O H
on m p
O O x .(100-X)%
X -100 0
m+ p
R
Figure 5.1. General chemical structure of the polymers investigated in the targeted delivery studies.
The polymers were substituted X% with hydrophilic spacer groups (either PEG3400 or triethylene
glycol, TEG). The remaining substituted groups are hydrophobic sidechains, R, in the form of
hydrocarbons (HC) or perfluorocarbons (PFC).
The naming convention for E13.4.3-conjugated polymers follows the form: X+, R,
where X is the percent of sidechains substituted with hydrophilic spacer groups and R is
the identity of the hydrophobic groups attached to the remaining (100-X)% linker
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hydroxyls. The plus sign indicates that the polymer contains the E13.4.3 peptide. For
untargeted polymers, the plus sign is replaced with a minus sign ('-'). Finally, because all
but two of the polymers studied contained PEG3400 as the hydrophilic spacer group, the
identity of the spacer was not included in the polymer name. The two polymers with the
triethylene glycol spacer (TEG) will be indicated as such. Therefore, a polymer
designated X=10+, PFC would consist of 10% sidechains with E13.4.3-conjugated
PEG3400 spacers and 90% sidechains as perfluorocarbon chains.
5.4.2 In vitro Targeting with EI3.4.3-conjugated Polymers - Initial Study
As described in the Introduction to this chapter, the E13.4.3/EGFR targeting pair
was an attractive candidate for targeted delivery applications, particularly due to the very
high binding affinity (low KD) of the engineered targeting ligand. To evaluate whether
this targeting pair would be viable for use with our polymer system, a small set of four
polymers were synthesized and tested in in vitro uptake studies. If the targeted, E13.4.3-
containing polymers in this initial study showed increased, selective uptake relative to
untargeted controls, then significant further study with this targeting pair would be
justified.
Four polymers were synthesized with 10% of available sidechains substituted as
PEG3400 or TEG spacers, either with or without E13.4.3 peptide attached. The remaining
linker hydroxyls (90%) in all four polymers were substituted with hydrocarbon
sidechains, which imparted amphiphilicity to the molecules. The backbone polymer
starting material, which was produced before the molecular weight increases were
realized in the Protherm, was produced in a mechanically stirred flask with molecular
sieves present and had the following molecular weight characteristics: Mn = 5.2, Mw =
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7.2, PDI = 1.34. A summary of the polymers investigated in this initial study, including
the molecular weight attributes, peptides per polymer chain, and hydrodynamic diameters
as measured by dynamic light scattering, is presented in TABLE 3. Similar tables will be
presented for subsequent sets of polymers studied. The polymer chain number-average
molecular weights include the backbone, sidechains (PEG spacer and hydrophobic
groups) and peptide, if present.
Table 4.3. Four polymers investigated during the initial study of the E13.4.3/EGFR targeting pair
with our polymer system. The polymer chain number average molecular weight, M., was calculated
based on the components in the chemical structure. The number of peptides per chain was estimated
assuming approximately five repeat units per backbone polymer chain based on a backbone polymer
molecular weight of 5.2 kDa. The hydrodynamic diameter was determined by dynamic light
scattering (see FIGURE 3).
Hydrodynamic
Polymer Spacer Polymer Chain M. Peptides per Diamr(kDa) Chain Dim)(nm)
X=10+, HC 15.0 0.5 4.5
PEGS400
X=10-, HC 8.7 0 4.5
X=10+, HC 11.7 0.5 5.0
TEG
X=1%. HC 5.5 0 10.0
The particle size distribution for the X = 10+, HC polymer with PEG3400 spacer
at a concentration of 0.5 mg/mL in PBS was measured by dynamic light scattering (DLS)
is presented in both bar graph (FIGURE 2A) and linear (2B) representations. The linear
graph is a direct reproduction of the bar graph data in a different format, which allows for
direct comparison of more than one particle size distribution at once. The particle size
distributions for the polymers with PEG3400 (FIGURE 5.3A) and TEG (3B) spacers
were also measured by DLS.
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Figure 5.2. Particle size distribution of the X=10+, HC (PEG3400 spacer) polymer measured by
dynamic light scattering. Data are presented in the (A) bar graph and (B) linear representations.
The hydrodynamic diameters for the X=10, HC polymers with PEG3400 spacers,
both with and without E13.4.3 peptide attached, were approximately 4-5 nm. Although
there were approximately 0.5 E13.4.3 peptides (12.5 kDa/peptide) per chain for the
X= 10+, HC polymers, the ultimate particle size distribution was nearly identical to that
for the X=10-, HC polymer. Replacing the PEG3400 spacer with the shorter TEG spacer,
the hydrodynamic diameters were determined to be 8.5 and 10 nm for polymers with and
without E13.4.3 attached, respectively. The size distributions for all four polymers were
quite low in polydispersity.
226
12 0 . . . .... . . .-. . .
A PEG3400 Spacer TEG Spacer B
100 -X = 10+, HC -X = 10+, HC
-X=10-,HC -- X=10-,HC
I 80
E
60 -
~ 40
20
0 2 4 6 8 10 12 14 160 2 4 6 8 10 12 14 16
Hydrodynamic Diameter (nm) Hydrodynamic Diameter (nm)
Figure 5.3. Particle size distributions measured by DLS for the X=10, HC polymers with either (A)
PEG3400 or (B) triethylene glycol (TEG) hydrophilic spacers.
The four polymers were labeled with iodine-125 and purified according to the
procedure described in the Cellular Uptake Measurement with [I251]-polymer section of
the Methods. The uptake of these four labeled polymers was measured in the EGFR-
positive A43 INS human cancer cell line (FIGURE 5.5). The uptake was calculated as the
mass of polymer per cell. The mass of polymer was selected, as opposed to the number of
polymer chains, because the individual chains self-assembled into nanoparticles. The
uptake was normalized per cell to account for experiment-to-experiment and timpoint-to-
timepoint variations in the number of cells in each well.
For both sets of polymers, those with PEG3400 and TEG spacers, the uptake was
approximately 2-2.5x higher for polymers with E13.4.3 peptide attached than for those
without the targeting peptide present. The highest overall uptake measured was for the
X=10+, HC polymer with the long, PEG3400 spacer. In both cases, the greatest
selectivity, which was defined as the ratio of the uptake of the targeted polymers to that
for the untargeted equivalents, was observed at the four hour time point.
The hydrodynamic diameter for this polymer was approximately half that of
X=10+, HC polymer with the TEG spacer (FIGURE 5.3). The uptake of the untargeted
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polymers (FIGURE 5.5, open circles) was quite similar for both the PEG3400 and TEG
spacer polymers. This uptake corresponded to the non-specific uptake by the cells, likely
due to pinocytosis of the highly PEGylated polymers.
PEG3400 TEG
0 X=10+,HC 0 X=10+ HC
0 X=10-.HC 6 X=10-,HC
.i
0
1.-
CL.
0 1 2 3 4 5 0 1 2 3 4 5
Time (hr) Time (hr)
Figure 5.4. Uptake of 12s I-labeled polymer in the EGFR-positive human cancer cell line, A431NS.
Polymers contained 10% substitution as PEG3400 or TEG spacer, either with or without EI3.4.3
peptide attached. The remaining sidechains were hydrocarbons.
5.4.3 Evaluation of Preparative GPC for Backbone Polymer Fractionation
The selectivity observed in the initial studies with the EI3.4.3 peptide and our
polymer system demonstrated that further study of the EI3.4.3/EGFR targeting pair was
warranted. As described during the Introduction, there were a number of variables that
could be studied to improve the performance of the targeted polymer system, including
the number of peptides per chain (polyvalency) and the backbone polymer molecular
weight. To allow for full investigation of the former, the backbone polymer molecular
weight had to be increased to increase the number of linker hydroxyls that could be
substituted with targeting sidechains. Although the Protherm was able to substantially
increase the weight-average molecular weight of the backbone polymer, one consequence
of the increases realized for the condensation polymerization is increased polydispersity.
Polymer fractionation by preparative GPC was used to reduce the polydispersity of the
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backbone polymer in order to provide a clean, less polydisperse starting material for
subsequent synthetic steps during which targeting and hydrophobic sidechains would be
attached.
In order to determine whether the column was able to yield nearly monodisperse
fractions of backbone polymer from the high molecular weight, high polydispersity
Protherm product, one milliliter of raw backbone polymer (10 mg/mL) was injected and
the elution profile for the Superdex 75 preparative gel permeation chromatography
column was interpreted (FIGURE 5.6). Significant absorbance was measured over a 100
mL range in elution volume, even though the initial volume of the injected raw polymer
sample was relatively small. The preparative GPC Superdex 75 column appeared to have
effectively spread out the raw backbone polymer as desired.
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Figure 5.5. Preparative GPC chromatogram for a single injection of high molecular weight backbone
polymer (10 mg/mL, 1 mL/injection) produced in the Protherm. The elution volumes for the x-axis
are specific to the preparative and not the analytical GPC. Eight, 15 mL fractions were collected
between elution volumes of 95 and 110 mL for subsequent analysis by analytical GPC.
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Eight fifteen milliliter fractions were collected from the elution (indicated by
vertical dashed lines), freeze dried and analyzed by GPC to determine the molecular
weight characteristics of each collected fraction. These data would determine what
fractions the preparative GPC had created by spreading the backbone polymer across the
100 mL elution volume. The results of these measurements, along with that for the
unprocessed backbone polymer, are presented in TABLE 5.4.
Table 5.4. Summary of analytical GPC measurements, including M., M,, and PDI, for the eight
fractions collected from the preparative GPC (FIGURE 5). Results are compared to those for the
raw Protherm (PT) backbone polymer for comparison. The elution volumes listed under the
'Sample' heading are specific to the preparative GPC elution volumes.
Sample ( a (kw) PDl
_____________________ (k0a) (ka)
Raw PT Backbone Polymer 8.7 20.6 2.36
1 95-110 mL 14 17 1.15
2 110-125 12 14 1.17
3 125-140 9.0 10 1.16
4 140-155 6.6 7.2 1.11
5 155-170 4.5 5.3 1.15
6 170-185 3.3 3.7 1.13
7 185-200 2.3 2.6 1.14
8 200-215 1.7 1.9 1.12
The analytical GPC chromatograms were processed as described in APPENDIX
A: Molecular Calculation by Breeze Software and Chromatogram Manipulation, to
determine the relative number of polymer molecules at each respective molecular weight
(FIGURE 5.7). The chromatograms for the second, third, and fourth polymer fractions
(see TABLE 5.4) collected from the preparative GPC were compared to that for the raw
backbone polymer.
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Figure 5.6. Relative number of backbone polymer molecules at each molecular weight for the second,
third, and fourth fractions collected from the preparative GPC as analyzed by the analytical GPC.
The chromatogram for the raw backbone polymer produced in the Protherm is also included.
The number-average molecular weight of the 8 fractions collected from the
preparative GPC ranged from 1.7 to 14 kDa, while the polydispersity of each collected
fraction was less than 1.17. This result demonstrated that the preparative GPC was able to
create low polydispersity, comparatively high molecular weight fractions of backbone
polymer. This is particularly true in comparison to the backbone polymer starting
material used in the initial study of the E13.4.3 peptide/EGFR targeting pair, which was
produced by mechanical stirring in a flask with sieves added (but without fractionation)
and had a number-average molecular weight and polydispersity of 5.2 kDa and 1.34,
respectively.
The analytical GPC chromatograms in FIGURE 5.7, as well as the molecular
weight data in TABLE 5.4, revealed that the entire range of polymer molecular weights
present in the original raw backbone polymer sample was not recovered at the end of the
preparative GPC column. Specifically, no backbone polymer oligomers with molecular
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weights greater than 20-25 kDa were measured in the recovered fractions by analytical
GPC, while oligomers as large as 40-50 kDa were measured in the unprocessed, raw
backbone polymer produced in the Protherm.
Although each 15 mL fraction was low in polydispersity, the analytical GPC
chromatograms for consecutive fractions (FIGURE 5.7) overlap one another to a
significant extent. Because of dispersive effects commonly observed for processes in
porous media, such as gel permeation chromatography, there is an inherent distribution of
residence times even for a purely monodisperse starting material. This distribution was
the primary contribution to the overlap between fractions 2 and 3, fractions 3 and 4, and
so on. Variability in the porosity of the chromatography resin may also have contributed
to the overlapping chromatograms observed by analytical GPC.
5.4.4 Development of a High-Throughput Fractionation Process
The preceding experiments demonstrated that, although the entire initial
molecular weight range was not recovered, the preparative GPC was still able to create
low polydispersity, high molecular weight fractions from the raw backbone polymer
produced in the Protherm. In order to generate enough fractionated backbone polymer to
supply the synthesis of polymers for the targeted delivery studies, the throughput of the
fractionation process had to be increased significantly. The initial concentration of the
backbone polymer load solution was increased from 10 to 100 mg/mL, while the total
injection volume was increased from 1 to 3 mL.
Successive injections were scheduled every 300 mL of accumulated elution
volume. This injection schedule ensured that material from consecutive injections did not
overlap with one another in the column. This injection schedule also decreased the
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downtime between successive injections while still maintaining a safety factor to avoid
injection-to-injection overlap. Recall that the total column volume of the Superdex 75
preparative GPC column was 318 mL. The method that was developed and coded using
the GE Unicorn software is included in APPENDIX E. Fractions were collected at the
same post-injection preparative GPC elution volumes as those presented in TABLE 5.4,
while the elution profile for a typical production run is presented in FIGURE 5.8.
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Figure 5.7. Chromatogram for an eight injection preparative GPC run to process and fractionate
high molecular weight backbone polymer. Polymer was detected by an inline UV spectrophotometer
(k = 250 nm) and each elution was collected into eight 15 mL fractions for elution volumes between
95 and 215 mL post-injection.
The production run consisted of eight injections of the Protherm-produced
backbone polymer. Each elution peak was fractionated into eight 15 mL fractions for
elution volumes between 95 and 215 mL post each injection (dashed vertical lines not
shown). Each successive elution peak was nearly identical with the only notable
exception being the slight decrease in the peak maxima over the course of the eight
injections and elutions. This decrease was likely due to fouling of the column pores.
There was also an abrupt spike in the absorbance at the end of each elution peak. This
spike corresponded directly to each 3 mL injection and was related to the significant
233
increase in pressure associated with the injection of the highly concentrated, highly
viscous 100 mg/mL polymer solution.
The fractional recovery of backbone polymer was determined by weighing the
polymer in each collected fraction and assuming that the initial mass added was 300 mg
(3 mL of a 100 mg/mL solution). The calculated fractional recovery for each of the eight
injections varied between 0.60 and 0.65, with the lowest recoveries occurring for the later
injections. The pressure measured at the pump head in the AKTA Explorer system also
increased steadily throughout the series of eight injections and elutions. While the
pressure only increased from 0.20 to 0.25 MPa for the single injection and elution, a
pressure increase from 0.20 to 0.50 MPa over the duration of the eight injection
production run (FIGURE 5.8).
After each production run the column was cleaned with three column volumes of
a 0.5 M sodium hydroxide solution (0.5 mL/min) and re-equilibrated with three column
volumes of deionized water. After these two steps, the system pressure was restored to
the original baseline of 0.20 MPa.
5.4.5 Size Measurements of EI3.4.3-Conjugated Polymer Synthesizedfrom High
Molecular Weight Backbone Polymer
High molecular weight backbone polymer was fractionated by FPLC and the 110-
125 mL FPLC fraction (Mn = 12 kDa, PDI = 1.17, see TABLE 4) was used in the
synthesis of various polymer candidates. Physico-chemical and biological assays were
performed to evaluate their performance with different fractions of sidechain substitution,
X, and with different identities of the hydrophobic sidechain (HC, PFC, or no added
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sidechain). All polymers in the studies with the high molecular weight backbone polymer
had PEG3400 spacers. The molecular weight attributes, peptides per polymer chain, and
hydrodynamic diameters as measured by dynamic light scattering of two separately
synthesized polymer batches are summarized in TABLE 5.5.
Table 5.5. Summary of the (A) first and (B) second batch of polymers synthesized for the
investigation of the E13.4.3/EGFR targeting pair with high molecular weight backbone polymer. The
polymer chain M. was calculated based on the components in the chemical structure. The number of
peptides per chain was estimated assuming approximately ten repeat units per backbone polymer
chain based on a backbone polymer molecular weight of 12 kDa. The hydrodynamic diameter was
determined by dynamic light scattering (see FIGURES 8 and 9).
Polymer Polymer Chain M" Peptidee Per Chain Hydrodynamlo
(kDa) Diameter(s) (nm)
10+ PFC 30B 1 7.17
26+, PFC 542 2.6 10,1620
2&, PFC 22.9 0 10,21
A 10+, HC 29.7 1 8
26+, HC 62.A 2.6 17
2&o HC 21.1 0 1, 22 27
60+, HC 02.0 6 23, 43, 81
0+, NHS 91.5 5 30, 62 72, 7
26+, PFC 542 2.5 1, 22, 2
25., PFC 22. 0 14,1
50+, PFC 93.1 6 219
50- PFC 30B 0 2, 28, 36, 43
76+, PFC 132.1 7.6 10,19, 40,100
76-, PFC 38.3 0 17, 24, 29, 1
504, HC 92.0 5 11,24
Ma HC 29A 0 13,33
76+, HC 1315 7.6 Z 7, 17, 34, 44
76, HC 37A 13.16, 25, 39,62 73
The molecular weight of each polymer formulation by adding the molecular
weights of the individual components present in the polymer. Each backbone polymer
chain was 12 kDa. The PEG spacer was 3400 Da and the E13.4.3 peptide was 12.5 kDa.
Due to the comparatively large size of the E13.4.3 peptide (12.5 kDa) relative to the
molecular weight of the backbone polymer starting material (12 kDa), the number of
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peptides per chain most significantly affected the polymer chain molecular weight. The
polymer molecular weight varied from approximately 20-130 kDa for the 18 synthesized
polymers. Similarly substituted polymers either with or without the peptide attached
varied in molecular weight by factors ranging from approximately two to four.
The particle size distributions for both batches synthesized from the low
polydispersity, high molecular weight backbone polymer were measured by DLS
(FIGURES 5.9 and 10). For the first batch, the X=10+, HC polymer had a hydrodynamic
radius of 6 nm (FIGURE 9A). This result was quite similar to the size distribution
measured for the X=10+, HC polymer synthesized from the lower molecular weight
backbone (FIGURE 5.3). The size distribution for the X=10+, PFC polymer included two
peaks, at diameters of 7 and 17 nm (9B). The X=25 polymers (9C and D) had
hydrodynamic diameters between approximately 10 and 30 nm. The X=25+, HC
distribution was essentially monodisperse at 17 nm, while the X=25-, HC distribution
was broader and centered around 22 nm. The distributions for the X=25, PFC polymers
were quite similar both with and without the E13.4.3 peptide attached, with distinct peaks
at diameters of approximately 10 and 20 nm.
From this first batch, the two X=50 were the primary outliers, having three
distinct narrow particle size distributions that collectively ranged from 20 to 80 nm.
Interestingly, particles were observed for the X=50+, no hydrophobic sidechains (NHS)
polymer, even though there were no hydrophobic sidechains present on the 50%
remaining free hydroxyls within the backbone polymer (9F).
For the second batch of polymers synthesized from the low polydispersity, high
molecular weight backbone polymer, the hydrodynamic diameters for the X=25, PFC
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polymers were between 10 and 25 nm (FIGURE 10A). This result was quite similar to
the size distribution measured for the X=25, PFC polymers synthesized in the first batch
(FIGURE 9D). The X=50+, HC polymer had two distinct peaks in the size distribution at
diameters of 11 and 24 nm (1 OB). This result was different from the size distribution
observed for the X=50+, HC polymer synthesized in the first batch (9E), which was
broad and ranged from 20 to 60 nm.
Particles with hydrodynamic diameters of 2 nm were observed for a number of
the more highly PEGylated polymers synthesized in the second batch, including the
X=50, PFC and X=75, HC polymers. It is likely that the particles measured at this small
size correspond to individual polymer chains or associations of a small number of chains.
Overall, the particle size distributions with the lowest polydispersity were those
for the X=10 and the X=25 polymers. The diameters measured for these distributions
were generally observed over a narrower range than for the other measured polymers.
These polymers had a larger proportion of the sidechains devoted to hydrophobic
sidechains, either in the form of hydrocarbons or perfluorocarbons. Conversely, the
particle size distributions for the X=50 and X=75 polymers were generally more
polydisperse, with less well-defined sizes. The notable exception to this generalization
was the X=50, HC polymers from the second synthesis batch. Finally, the presence of the
E13.4.3 peptide targeting had varying effects on the ultimate particle size distribution.
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Figure 5.8. Particle size distributions of the first batch of polymers synthesized from high molecular weight backbone as measured by DLS. Solid lines
indicate polymers with E13.4.3 attached, while dotted lines indicate polymers without E13.4.3. Note: The scale of the X-axis for the X=50 (E and F)
polymers is twice that for the other data presented (A-D).
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Figure 5.9. Particle size distributions as measured by DLS for the second batch of polymers synthesized from high molecular weight backbone. Solid
lines indicate polymers with E13.4.3 attached, while dotted lines indicate polymers without E13.4.3. Note: The scale of the X-axis for the X=50 (D and E)
polymers is twice that for the other data presented (A-C).The X=75, HC polymers were not studied further due to labor limitations and their relative
similarity to the X=75, PFC polymers in composition.
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5.4.6 In vitro Uptake of Free EI3.4.3 Peptide
The E13.4.3 peptide was labeled with iodine-125 and the uptake of the labeled
free peptide was measured at three different initial concentrations, 5, 50, and 500 nM
(FIGURE 5.11). The uptake measurements were performed using the EGFR-positive cell
line, A43 INS.
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Figure 5.10. Uptake of free E13.4.3 peptide by EGFR-positive A431NS cells at three different initial
concentrations (in molar and mass units). The y-axes are scaled proportionately for the respective
initial peptide concentrations.
At the highest concentration measured, 500 nM, the free E13.4.3 peptide uptake
leveled off at 1 hr (or earlier), while the uptake still appeared to be increasing at 4 hr for
the 5 and 50 nM experiments. In addition, the amount of uptake was proportionately
lower at the increased concentrations. This observation was aided by the proportionate
scaling of the y-axes in FIGURE 5.11.
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5.4.7 In vitro Uptake of EI3.4.3-Conjugated Polymer Synthesized from High Molecular
Weight Backbone Polymer
The two batches of polymers synthesized from the low polydispersity, high
molecular weight backbone polymer (TABLE 5.5) were labeled with 125I and their uptake
was measured in EGFR-positive A43 INS cells at an initial polymer concentration of 0.5
mg/mL. Because the mass concentration was held constant for each polymer, the molar
concentration differed from sample to sample, primarily as a function of percent
PEG3400 substitution and presence of the peptide, according to the polymer chain
molecular weights in TABLE 5.5. The results for the first and second synthesized batch
are presented in FIGURES 5.12 AND 13, respectively. Due to material limitations, the
uptake of the second batch of polymers was only measured in duplicate wells.
The most relevant basis for presentation of the uptake results was not clear, a
priori, due to many complicating factors. Specifically, for polymers with and without the
peptide attached, such as the X=25+, PFC and X=25-, PFC pair, the molecular weight of
the individual polymer chains differs drastically depending on the presence of the
comparatively high molecular weight E13.4.3 peptide. This difference becomes more
pronounced as the targeting ligand substitution increases. Differences in the specific
activity of each polymer sample could also complicate analysis, particularly with respect
to the distribution of labels to tyrosine groups on the E13.4.3 peptide or the linker groups
within the polymer backbone.
For succinctness, the mass of polymer per cell was chosen as the method of
uptake data representation. Alternative strategies for representing the data were also
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explored, including the number of polymer chains per cell and the fraction of initial
activity per cell, and are presented in Appendix G.
For the first batch synthesized from high molecular weight backbone polymer, the
highest uptake observed was for the X-25+, PFC polymer (12A). The mass of polymer
per cell for this sample was two and four times higher than that its untargeted control
polymer, X=25-, PFC, at the 0.75 and 4 hr time points, respectively. This fourfold
increase in uptake relative to untargeted control was the greatest selectivity observed with
our polymer system thus far. (Recall that a twofold increase was observed for the X=10+,
HC polymer synthesized from the lower molecular weight backbone). Because the
particle size distributions for the two X=25, PFC polymers were nearly identical (9D), the
increase in uptake for the targeted polymer was attributable to the presence of the E13.4.3
peptide. Also, while the uptake for the X=25-, PFC polymer appeared to be leveling off,
that for the X=25+, PFC polymer had not leveled off by 4 hr, which suggested that
further selectivity was achievable at longer incubation times. Finally, the uptake of the
X=25+, PFC polymer was slightly higher than the uptake for the untargeted X=10-, PFC
polymer.
The next highest uptake was observed for the X=50+, HC and the X=50+, NHS
polymers (12B). For this batch, no control polymer counterparts without the E13.4.3
peptide attached were synthesized for these two targeted polymers. This made it difficult
to determine the selective uptake since there was no basis for comparison. If the uptake
for the X=25-, HC polymer is used as a basis for comparison, the selectivity for the
X=50+ polymers was a factor of approximately 4-6. The increased uptake of the X=50+
polymers occurred even though the particle sizes measured for these polymers were
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generally much greater than those measured for the other polymers synthesized in this
batch (9E and F).
The scale of the y-axis was decreased to facilitate further analysis of the results
(12C). For the X=25, HC polymers, the uptake of the targeted polymer was
approximately 50% higher at the 4 hr time point than that for the untargeted polymer.
Although this increase was modest, the trend was still in the direction indicating selective
uptake mitigated by the presence of the E13.4.3 peptide. Overall, the variability in the
data was significant, but not too large to obfuscate the data analysis. Using a two-tailed
Student t-test, the p-values for all of the previous comparisons were less than 0.05.
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Figure 5.11. Uptake in EGFR-positive A431NS cells for the first batch of polymers synthesized from high molecular weight backbone polymer. The
initial concentration was 0.5 mg/mL. Polymers were substituted with X% PEG3400 terminated either with or without E13.4.3 peptide. The balance of
the hydroxyl groups were substituted with perfluorocarbons, hydrocarbons, or no hydrophobic sidechains. The hydrocarbon sidechain data (B) were
reproduced with a smaller y-axis (C).
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Figure 5.12. Uptake in EGFR-positive A431NS cells for the second batch of polymers synthesized
from high molecular weight backbone polymer. The initial concentration was 0.5 mg/mL. Polymers
were substituted with X% PEG3400 terminated either with or without EI3.4.3 peptide. The balance
of the hydroxyl groups were substituted with perfluorocarbons or hydrocarbons. Note: The scale of
the y-axes for these plots is 30 % of those in FIGURE 11.
For the second batch of polymers synthesized from the high molecular weight
backbone polymer, the highest overall uptake was observed for the X=50+, HC polymer
(5.13B). The uptake for this polymer was approximately four times greater than that for
the untargeted control polymer, X=50-, HC. This batch included the second synthesis of
the X=25, PFC polymers. The results for the X=25, PFC polymers (12A) showed only a
25% increase in uptake due to the presence of the EI3.4.3 peptide, while a fourfold
increase was observed for the uptake measurements of the first synthesis of this pair.
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There was a significant difference in the absolute magnitude of the uptake results
between the two batches. The highest uptake observed in the second batch of polymers
(13B) was approximately 30% that observed for the first batch (12A). Aside from the
fact that the polymers were synthesized in separate batches, including different
productions of backbone polymer and E13.4.3 peptide, the uptake experiments were also
performed separately. This difference occurred despite the fact that the procedure was
carefully reproduced, including labeling and purification, plating density, and time
between plating and initiation of the experiment. Two different vials of A43 iNS that had
been frozen from the same initial expansion were used for each experiment, having
passage numbers of either 4 or 5.
There was, however, a difference in the total numbers of cells counted in the
control wells for the two uptake experiments. For the first batch, there were
approximately 1.5x1 05 cells in each well at the start of the experiment, while for the
second experiment, there were approximately 3.Ox 1 05 cells in each well. It is possible
that an error in cell counting or plating led to the increased cells for the second batch.
Increased uptake with the E13.4.3 peptide attached (selectivity) was observed for
all four pairs of polymers and was most pronounced at the longer, 4 hr time point. There
was also minimal variability in the data, although it should be noted that the second batch
polymers were only measured in duplicate.
5.4.8 Uptake Measurements in EGFR-positive and negative Cell Lines
Uptake was measured in the EGFR-negative MFC-7 human cancer line in
addition to the EGFR-positive A43 INS cells for the second synthesis batch. A difficulty
arose in trying to compare the results between the two cell lines. Although the identical
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number of cells was originally plated, the cell counts for the A43 1NS cell were four times
higher than those for MCF-7 at the 1 and 4 time points. (As described in the methods, the
uptake experiment was initiated on the day after cells were plated on 96 well plates. The
time between plating and initiation of the experiment was approximately 18 hr.)
Visualization of the two cell populations under the microscope confirmed that, although
wells in both cases were confluent, there were many more A43 1NS cells per well due to
their small size and extremely close packing.
To compare between the cell lines, the total mass of cell-associated polymer
measured in each well was normalized by the cross-sectional area of a well. This choice
was dependent on the anticipated basis for cellular internalization. Consider a limiting
case in which a hypothetical negative control cell line was so large, that only 10 cells fit
into a well at confluency. If the polymer uptake was mediated by the number of cells,
then it would be appropriate to normalize the data by the cell number. However, it
seemed likely that uptake would be mediated by some other mechanism, such as the total
cell surface area available, particularly for untargeted internalization into the EGFR-
negative cell line. For this reason, the uptake results in both the A43 INS and MCF-7 cell
lines were normalized by the area of a well in a 96-well plate (FIGURE 5.14). A plot of
the total cell-associated mass in each experiment would have been an equivalent
representation.
For these results, there were two variables studied, the presence of targeting
ligand on the polymer and the presence of the target on the cell surface. Each of these
variables had two levels, which led to four cases of interest. For three of the cases, the
untargeted polymer and EGFR-positive cell line and both of the EGFR-negative cell line
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cases, any cell-associated polymer measured should be due to non-specific uptake.
Ideally, the uptake results for these three cases should be identical. This non-specific
uptake can essentially be subtracted from the uptake observed for the targeted polymer
and EGFR-positive cell line to yield the uptake that occurred due to the presence of the
E13.4.3 peptide, the specific uptake.
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Figure 5.13. Uptake of batch 2 polymers in both EGFR-positive (A431NS, solid lines) and EGFR-
negative (MCF-7, dashed lines) human cancer cell lines. Polymers both with (closed symbols) and
without (open symbols) E13.4.3 peptide attached were measured. Data were normalized by the cross-
sectional area of a well in a 96-well plate. The, X=50, HC time points were purposefully offset to
clarify the error bars.
The greatest difference between selective and non-specific uptake was observed
for the X=50, HC polymers (14B). The uptake of the targeted polymer in the EGFR-
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positive cell line was 2-3 times greater than that for the other three cases that represent
non-specific uptake. The data for the three non-specific cases were essentially
indistinguishable from one another. Interestingly, there was no observed difference in
uptake for any of the four cases for the X=50, PFC polymer (14C). These two sets of
X=50 polymers differed only in the nature of the hydrophobic sidechain. There was also
minimal difference between the X=25+, PFC polymer and the three non-specific cases
(14A). The 4 hr time point for the X=25-, PFC polymer in the EGFR-positive case was
somewhat higher than the results for the EGFR-negative cell line. This may suggest that
the X=25+, PFC, EGFR-positive results were an outlier or that some other, unknown
effect contributed to the increased uptake.
There was also a significant difference in the uptake of the X=75+, PFC polymer
in the EGFR-positive cell line relative to the three non-specific cases at 4 hr (14D).
Overall, the results for the three non-specific uptake cases were not only similar to one
another within each set of polymers, but also across all four pairs of polymers studied in
two different human cancer cell lines.
5.4.9 Analysis of Uptake Normalized by Initial E13.4.3 Peptide Concentration
The preceding data analysis focused on normalization of the uptake data by either
the number of cells in or the surface area of an individual well. Because one of the
primary variables evaluated was the number of targeting peptides per polymer chain, the
initial E13.4.3 peptide concentration at the beginning of each experiment was also used to
normalize the uptake results. This normalization provided information about the targeting
efficiency of the E13.4.3-conjugated polymers, essentially the amount of material
entering the cells per peptide attached.
249
To normalize the data, the initial concentration of E13.4.3 peptide in solution was
determined for the two synthesis batches and free E13.4.3 peptide (FIGURES 5.11-13).
For each E13.4.3-conjugated polymer, the initial polymer concentration (0.5 mg/mL) was
multiplied by the weight fraction of E13.4.3 peptide in the particular polymer
formulation. For example, according to the number of peptides per chain, the molecular
weight of an individual chain and the molecular weight of the peptide (TABLE 5.5), the
weight fraction of peptide in the X=10+, HC polymer was 0.41 (12.5 kDa/30.8 kDa) and
the initial E13.4.3 peptide concentration was 0.2 mg/mL. The initial peptide concentration
for the free E13.4.3 peptide data was straightforward. The experimental results
normalized by initial peptide concentration are presented in FIGURE 5.15.
For the first batch of polymers, the greatest E13.4.3-normalized uptake was
observed for the X=25+, PFC polymer, while the second highest was for the X=10+, PFC
polymer. Although the absolute uptake was considerable for the two X=50+ polymers in
the first batch (12B), the efficiency of the uptake relative to the number of peptides in
solution initially was minimal when the E13.4.3-peptide normalization was applied. The
E13.4.3-normliazed uptake for the X=25+, PFC polymer was similar to that for the lowest
free peptide concentration. The initial peptide concentrations for the X=25+, PFC and 5
nM experiments differed by four orders-of-magnitude (0.26 and 6.25x10 5 mg/mL,
respectively). Although the free peptide uptake flattened out drastically with increased
concentration (FIGURE 5.11), conjugation of the peptide to our polymer allowed for
continued uptake beyond that predicted solely by the initial peptide concentration.
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Figure 5.14. Uptake of E13.4.3-conjugated polymer and free E13.4.3 peptide normalized by the initial
concentration of peptide in solution at t = 0. The asterisks indicate that the (A) batch 1 and (B)
peptide experiments were performed in the same 96-well plates. The scale of the y-axis for the batch
2 (C) results is one-fourth that of the others. The original uptake results used to calculate the values
in this figure were presented in FIGURES 5.11, 5.10, and 5.12, respectively.
The E13.4.3-normlized uptake for the second batch was significantly lower than
that for the first batch; this was due to the low absolute magnitude of the original uptake
results. For this batch, the E13.4.3-normalized uptake for the X=50+, HC polymer was
equal to or greater than that for the X=25+, PFC polymer. This was the opposite of the
trend observed in the first batch., which further emphasized the low uptake observed for
the X=25+, PFC polymer in the second batch. The normalized uptake was much greater
for the X=50+, HC polymer than the X=50+, PFC polymer because the weight fraction of
peptide in the two polymers were very similar.
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5.4.10 Biodistribution and Blood Circulation in a Mouse Model of Human Cancer
Candidates from both synthesis batches were investigated in in vivo
biodistribution and blood circulation studies. For the first synthesis batch, polymers were
selected according to which sample was synthesized in sufficient quantity to supply the
experiment. For the second synthesis batch, all polymers were available in sufficient
quantity. Together, this provided the opportunity to investigate a wide range of polymers
in in vivo biodistribution experiments to (1) evaluate their performance in targeting the
subcutaneous tumor and (2) to determine whether there was any correlation between in
vitro selectivity and increased tumoral accumulation in vivo. In order to screen a wide
range of polymers in in vivo studies, the time points studied and the number animals in
each experimental group had to be reduced. The total number of animals for
experimentation was somewhat restricted due to both labor and funding limitations.
Animals were sacrificed at specified times and organs were harvested, weighed, and
assayed for radioactivity to determine the accumulation.
The biodistribution for the first batch of polymers synthesized from the high
molecular weight backbone polymer was measured at 1 and 6 hr (FIGURE 5.16). The
uptake of the free E13.4.3 peptide was also measured at these two time points. The
highest tumoral accumulation was measured for the X=25+, PFC polymer at 1 hr, with a
%IDPG of nearly 3%. This result was higher than that for the X=25-, PFC polymer, with
a p value equal to 0.08. A p-value at this level, although not quite below 0.05, was
encouraging considering the limited number of test animals in the group. There was also
no difference in biodistribution between the two X=25, PFC polymers in all of the organs
harvested or in the blood. This fact, together with the similar particle size distributions of
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the two samples (9D), suggested that the increased accumulation in the tumor was due to
the conjugation of the EI3.4.3 peptide. Additionally, the tumoral %IDPG for the X=25+,
PFC polymer was 50% higher than that for the free E13.4.3 peptide, but the difference
was not statistically significant.
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Figure 5.15. Biodistribution and blood circulation results for batch 1 polymers and free E13.4.3
peptide (open bars). The number of animals, n, for each polymer at the 1 and 6 hr time points is
tabulated.
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Although there was significant in vitro uptake measured for the X=50+, NHS
polymer (12B) with hydrodynamic diameters recorded between 20 and 80 nm (9F), the
tumoral accumulation for this polymer was the lowest of all measured.
The highest overall %IDPGs were measured in the kidneys. Accumulation in the
kidney would typically be observed before excretion in the urine. For the X=50+, NHS
polymer, the low %IDPG in the kidney together with the low %ID in the blood indicate
that the majority of the injected dose had been excreted before the 1 hr time point. The
%ID for the X=50+, NHS was lower than that for the free peptide even though the
polymer contained approximately 5 E13.4.3 peptides attached to the high molecular
weight polymer backbone by PEG3400 spacers. It is also possible that the E13.4.3
peptides were associating with one another to lead to particle or aggregate formation and,
in doing so, became inaccessible to EGFR.
Overall, there was accumulation measured in the other clearance organs, the liver
and spleen, as well as some accumulation in the heart and, in particular, the lungs. It is
possible that bleeding in the thoracic cavity during organ harvest contributed to the
elevated activities measured in the lungs. Finally, there was no activity measured in the
brain for any of the samples, which indicated that the injected material was unable to
cross the blood-brain barrier. Based on this observation, the brain was not harvested in
subsequent biodistribution measurements.
For the second synthesis batch, the stomach was also collected because the
stomach as well as the thyroid, which was not recovered, can act as sinks for cleaved 1251
due to their iodide-specific ion channels [48]. For this second batch, the greatest tumoral
%IDPG measured was for the X=50+, HC polymer (17B). This polymer also had the
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greatest absolute uptake in vitro from this batch (13B). This %IDPG was over two times
greater than that for the untargeted X=50-, HC polymer. The p-value for these two sets of
data was 0.15.
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Figure 5.16. Biodistribution and blood circulation results for the second batch of polymers. All mice
were sacrificed 1 hr post-injection. Blood data are presented as %ID (right axis), while the remaining
data for the harvested organs are presented as %IDPG (left axis). There were three animals in each
experimental group.
There was also significant selective tumor accumulation observed for the X=25,
PFC polymer pair (17A). For this pair, the %IDPG for the targeted polymer was four
times that of its untargeted counterpart. The accumulation for the X=25+, PFC was also
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higher than that for X=25-, PFC in many of the organs harvested, most notably the
kidney and the stomach. Although the %IDPG values were significantly higher in these
organs, there was no statistical difference between the two X=25, PFC polymers for the
%ID in the blood (p = 0.64). The selective accumulation of the E13.4.3-conjugated
polymer relative to the untargeted control was observed despite the fact that minimal
selectivity was observed for this polymer in vitro (14A). The selective accumulation did,
however, reproduce the biodistribution results for this same polymer formulation when it
was synthesized in the first batch (16A). The %ID measured in the blood for the X=25,
PFC polymers was also comparable between the two batches.
Finally, no selective accumulation was observed in the tumor for the X=50, PFC
or X=75, PFC polymers.
5.4.11 Tumor Targeting Compartmental Model Predictions
The tumor targeting compartmental model of Schmidt and Wittrup was used to
simulate the tumoral accumulation of three different targeted delivery agents: (1) the free
E13.4.3 peptide (12.5 kDa) and particles with hydrodynamic diameters of (2) 10 nm and
(3) 20 nm. Larger particle sizes were not investigated because they would be out of range
for the developed model. Each particle size was also simulated at three different
dissociation constants: 250 pM, 250 RM, and 250 mM (FIGURE 5.18). The range of
dissociation constants was selected because, although the native E13.4.3 peptide had a KD
of 250 pM, steric effects or iodine-125 molecules in the binding site could reduce the
effective binding constant of either the free peptide or peptide-conjugated particles.
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Figure 5.17. Simulation results using the tumor targeting compartmental model for three particle
sizes (free 12.5 kDa E13.4.3 peptide, and 10 and 20 nm diameter particles) at three binding
dissociation constants (KD). The results are presented as theoretical %IDPG in the tumor as a
function of time. All y-axes are scaled identically with the exception of (K).
The general trend predicted by the model is an increase in accumulation in the
tumor followed by a gradual decrease. The most rapid increase in %IDPG was predicted
for the free peptide with a KD of 250 pM (18A). This peptide would bind strongly to the
receptors on the tumor while having comparatively minimal size-related mass transfer
limitations. For the particles with a 10 nm diameter, the greatest predicted accumulation
was actually for the particle having a KD of 250 mM (18G). Because the renal clearance
rate was identical for all of these equally sized particles, the decrease in predicted tumoral
%IDPG would be entirely due to label catabolism and efflux.
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The predicted %IDPG for the larger, 20 nm diameter particles increased more
gradually than the smaller, 10 nm particles. This relatively slower increase was
attributable to size-related limitations in the particle mass transfer. For the d = 20 nm, KD
= 250 mM simulation (18K), the predicted %IDPG increased monotonically over the
entire simulated timeframe. This result suggested that the particle circulated freely with
minimal renal clearance, but that it also bound and penetrated the tumor at a slow rate.
This slow tumor penetration would also lead to a low rate of label catabolism and influx.
It is also possible that the combination of these parameters led to a case that was outside
the intended range of the model.
The model predictions were also compared to the experimental results. For the
free E13.4.3 peptide, the %IDPG was approximately 2 and 0.75% at 1 and 6 hr,
respectively. These results compare favorably to the model predictions for the free
peptide with a KD of 250 pM, which were 2.4 and 0.6% for 1 and 6 hr, respectively. For
the particles, the model predicted much lower accumulation in the tumor at 1 hr, between
0.5 and 1% IDPG depending on the simulated particle size and dissociation constant.
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5.5 Discussion
5.5.1 In vitro Targeting with E13.4.3-conjugated Polymers - Initial Study
The E13.4.3 peptide was identified as a targeting ligand of interest due to its
extremely high affinity for its target (KD = 250 pM for EGFR), and its relatively
straightforward and economical recombinant production in bacteria. The particle sizes for
the four polymers synthesized for this initial study were consistent with polymers studied
previously in our lab by Dr. Jin Zhou Dawson [49].
Both targeted polymers, with either the PEG3400 or TEG spacer, demonstrated an
approximately twofold increase in selective uptake in vitro relative to untargeted controls
after 4 hr. This difference was statistically significant with a p-value < 0.01. Interestingly,
there was no selectivity at the 1 hr time point. This suggested that the binding and
internalization required more than one hour to yield selective uptake. The demonstrated
selectivity of the E13.4.3-conjugated polymers in vitro, together with the economic
advantages of E13.4.3 production, strongly indicated the potential of the E13.4.3-EGFR
targeting pair for further study.
5.5.2 Evaluation of Preparative GPCfor Backbone Polymer Fractionation
There was strong evidence in the literature [50-52], as well in previous work in
our group [40], that polyvalency - increasing the multiplicity of targeting ligands on a
particle or polymer chain - would be a key design variable for effective receptor
targeting. Low molecular weight backbone polymer provided little opportunity to
increase polyvalency due to the direct tradeoff between targeting and hydrophobic
sidechains; increasing targeting inhibits particle formation.
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Additionally, although the polymers synthesized from the lower molecular weight
backbone polymer formed particles with diameters of 5-10 nm, particles of this size did
not quite meet one of the key design constraints for circulating delivery vehicles.
Glomerular clearance in the kidney leads to nearly complete first-pass clearance of
particles with diameters less than 5 nm [2, 44, 53]. Blood circulation of particles with
diameters between 5-10 nm may also be affected by kidney filtration. Consequently, the
potential to form larger particles was a second benefit of increasing polymer molecular
weight.
The preparative GPC was used effectively to produce monodisperse fractions of
the backbone polymer with polydispersities between 1.12 and 1.17. These low PDIs were
particularly encouraging considering the polydispersity of the backbone polymer sample
loaded onto the preparative GPC column, 2.30. There is opportunity to create even more
monodisperse fractions by decreasing the volume of the collected fraction; however, this
leads to a tradeoff in the amount of mass in the particular fraction.
The highest molecular weight chains in the initial backbone polymer sample were
not collected in any of the fractions. It is possible that these high molecular weight chains
were not loaded onto the column in the first place, having been removed from the sample
during syringe filtration performed to remove any particulates that may clog the lines.
Removal during this initial filtration is possible considering the fact that high molecular
weight PEGs have limited solubility in water. These insoluble or, more likely, poorly
soluble high molecular weight backbone polymer chains could have been removed during
the filtration. Other possible points of loss include the preparative GPC process and the
freeze-drying of the recovered fractions. The increased system pressure during the course
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of single- or multiple-injection preparative GPC runs may have been a result of high
molecular weight chains exiting the solution and clogging the pores of the column;
however, the pressure increase in the system would have been much more substantial had
30% of the loaded mass become effectively stuck in the column. Finally, although some
polymer degradation was observed as a result of freeze drying, no degradation was
observed that could account for the large loss of the highest molecular weight material.
The overall goal of the preparative GPC experiments was to develop a tool to
isolate high molecular weight fractions from a raw, high molecular weight, polydisperse
backbone polymer starting material. This meant that some questions that arose during
these initial experiments were left unanswered. There is room for further improvement,
particularly with respect to the recovery of the highest molecular weight fractions. To this
end, different mobile phases for which the backbone polymer solubility is maximized
would need to be investigated. Fortunately, the Superdex 75 column has a broad range of
chemical compatibility.
Despite the unanswered questions, the developed high-through process was able
to supply the starting material for the synthesis of the targeted and control polymers used
in the biological studies.
5.5.3 In vitro Uptake of EI3.4.3-Conjugated Polymer Synthesized from High Molecular
Weight Backbone Polymer
Having identified the E13.4.3 and EGFR as a promising targeting pair, two
primary variables of interest were studied: (1) the targeting ligand density, which is
directly related to the percent of sidechains substituted with PEG3400 spacers, and (2) the
identity of the hydrophobic sidechain (hydrocarbon, perfluorocarbon, or no added
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sidechain). The polymer molecular weight was omitted as a variable to make the library
more tractable and to minimize the number of synthetic steps. Results were separated by
batch number to emphasize that each polymer was usually synthesized only once or, at
most, twice.
The fourfold increase for the X=25+, PFC polymer was the greatest increase in
selective uptake observed to this date with our polymer system. Unfortunately, it is
difficult to draw comparisons of this result to the literature. The in vitro data in the
literature typically relates to cell death caused by the delivery of a therapeutic agent or
the silencing of some gene by delivery of siRNA, for example. This makes direct
quantitative comparison tenuous. The fourfold difference in selectivity, however, is
within the range observed for other polymeric micelle [31, 54] and dendrimeric [11]
systems. It was also interesting that only minimal selective uptake was observed for the
X=25+, HC polymer, which was identical to the X=25+, PFC with the exception of the
hydrophobic sidechain. This result emphasized the importance of the sidechain identity as
a key variable, as well.
The uptake for the X=50+, HC and X=50+, no other SC also appeared to be
increased due to selectivity, but it was difficult to firmly conclude this because no
negative control polymers were synthesized for either of these two formulations. Because
of this, all polymers for the second batch were synthesized both with and without the
E13.4.3 peptide attached.
There was a significant difference in the absolute magnitudes of the polymer
masses per cell between the two sets of data. This discrepancy was partially attributed to
the total cell counts measured for the two uptake experiments, which differed by a factor
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of two. However, the cell count variations did not account for the entire difference. There
may have also been some unknown, systematic experimental error during the second
batch uptake experiment. As previously discussed, the ability to perform repetitions was
limited by both material limitations and the screening-oriented nature of the overall
experimental plan.
5.5.4 Uptake Measurements in EGFR-positive and negative Cell Lines
It was quite difficult to select an EGFR-negative cancer cell line to try and
measure passive, untargeted uptake. The MCF-7 cell line constitutively expresses EGFR
at a low level, especially relative to A43 INS cells (3x10 3 receptors per cell [46] versus
more than 2x10 6 [55]). The uptake data for A43 INS and MCF-7 cells were compared
after controlling for the significant difference in individual cell surface area. This
adjustment relies on the assumption that both passive and active (i.e. targeted) cellular
uptake were cell-surface area dependent processes. The results of this normalization by
the area of a single well (i.e. the cell surface area in a confluent well) validated the choice
to normalize by surface-area. The fact that the uptake per area for the untargeted polymer
in the EGFR-positive cell line was nearly identical to that for the polymers in the EGFR-
negative cell line confirmed that the MCF-7 cell line was a suitable choice as a receptor-
negative cell line.
Although significant emphasis has been focused on increasing selectivity by
increasing the uptake of the targeted polymers, selectivity can also be increased by
decreasing the non-specific uptake. The fact that the uptake for the three non-specific
cases is not only non-zero but the same order-of-magnitude as the specific uptake further
emphasized this point. Strategies to reduce non-specific uptake exist in the literature,
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most notably through the addition of negative charge to the particle surface. Such
modifications would require additional synthetic development, but may prove extremely
beneficial to increasing in vitro selectivity.
5.5.5 Analysis of Uptake Normalized by Initial E13.4.3 Peptide Concentration
The uptake data were also processed to determine targeting efficiency as a
function of peptide substitution. This analysis, which was independent of any size
measurements, was performed to determine a potentially optimal level of substitution that
maximizes targeting efficiency. In both batches, the X=25, PFC polymers exhibited
highly efficient targeting relative to the other studied polymers, while the X=50, HC
polymer was also highly efficient among the second batch polymers. Based on the results
of this analysis, additional peptide substitution levels should be investigated between
X=10 and X=50 to establish a greater continuum of substitutions.
5.5.6 Biodistribution and Blood Circulation in a Mouse Model of Human Cancer
Overall, the polymer accumulation in non-target organs, including the liver,
spleen, and kidney, was relatively low. Significant accumulation in these organs usually
indicates potential issues in toxicity studies. Comparing the %IDPG to comparable
delivery systems in the literature ([54, 56], among others), which report %IDPG for liver
and kidney greater than 10-20%, the general biodistribution profile for our system was
encouraging. There was very little measurable signal in the brain, which implied that the
polymers and free peptide were unable to cross the blood-brain barrier.
The greatest tumoral accumulation was observed for the X=25+, PFC polymer at
2.8% and the X=50+, HC polymer at 4.1%. This level of tumor accumulation compared
quite favorably with the literature, in which %IDPG in the tumor typically ranged
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between 1-4% [54, 56]. In their recent work, Poon and Hammond have successfully
achieved %IDPG of greater than 10% in the tumor using their dendritic block
copolymers. This result significantly outperforms other reports in the literature, including
those in this work.
At this absolute magnitude of accumulation (2.8%) and selectivity relative to the
untargeted control (twofold), the X=25+, PFC polymer labeled similarly with iodine-124,
a positron emitting isotope, would be able to be visualized by positron emission
tomography [57].
With respect to particle size and glomerular filtration, it is important to remember
that the polymeric micelles experience significant dilution both upon injection and as
particles are removed from the circulatory system. The rate of particle breakdown in the
bloodstream depends on the stability of the micelle and the local concentration of the
polymer. If rapid clearance was observed for a given polymer/particle, as was the case for
the X=50+, NHS polymer, this would be an indication that the particles were rapidly
dissociating in the bloodstream. There is also some evidence in the literature of PEG-
mediated specific accumulation in the kidney [58], which may account for the
substantially greater rate of clearance for the X=50+, NHS polymer relative to that for the
free E13.4.3 peptide. Overall, the increased circulation time, as evidenced by the
measured %ID values, suggests that the majority of the particles were stable in the
bloodstream at least to a certain extent.
For the second batch, biodistribution measurements were performed for four pairs
of targeted and untargeted polymer having different particle size distributions as well as
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various performances in vitro. The brain was not recovered during this study since there
was no evidence in earlier studies that the polymer crossed the blood-brain barrier.
The second biodistribution experiment was able to repeat the selective
accumulation of the X=25+, PFC polymer observed in the first study, with a %IDPG that
was four times higher than that for the untargeted control, X=25-, PFC. It was also
interesting that this selective accumulation was observed despite the fact that only
minimal selectivity was observed in vitro for the second synthesis of the X=25, PFC
polymer pair.
The elevated %IDPG values for the kidney and stomach were likely indicative of
deiodination, an oxidase-mediated process that occurs upon internalization into cells [44,
47, 48, 59]. While the kidney accumulation was a function of its normal blood filtration,
the stomach as well as the thyroid, which was not recovered, act as sinks for cleaved 125
due to their iodide-specific ion channels [48]. Because tumors do not actively accumulate
iodide, the measured tumoral activity was representative of radioiodine bound to either
polymer or peptide. The elevated %IDPG in the stomach and kidney, especially
compared to the untargeted control, may actually have been a 'symptom' of tumoral
accumulation because increased cellular internalization of the X=25+, PFC polymer
would lead to increased deiodination. (This label catabolism process was described while
presenting the tumor compartmental model of Schmidt and Wittrup.)
The targeted X=50, HC polymer achieved the highest tumoral accumulation
among the second batch with a %IDPG greater than 4. The experimental error was high
enough that there was relatively poor statistical significance between the targeted and
control polymers (p = 0.18). Selective accumulation of targeted polymer occurred even
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though the blood concentration of untargeted polymer was statistically higher (p<0.05, p
=0.0495) than the E13.4.3-conjugated polymer.
The lack of selectivity observed for the remaining polymers in the second batch
may be attributable to their inability to form well-behaved micelles. Their comparatively
broad and disjointed particle size distributions suggested that the highly substituted
polymers may have formed aggregates as opposed to micelles due to the high degree of
PEGylation. Past work has suggested the aggregation phenomenon for highly PEGylated
polymer is unstable and varies greatly with time [40].
It is also important to note that the experimental group sizes were small. Ideally,
group sizes would have been preferably 5 or more animals. Nonetheless, there was
moderate to high statistical significance observed for three different sets of polymers
studied: the X=25+, PFC polymer in both batches and the X=50+, HC polymer in the
second batch. Together, these were the first in vivo demonstrations of selectivity for our
polymers.
5.5.7 Comparison to Theoretical Model Predictions
The tumor targeting compartmental model of Schmidt and Wittrup [44], which
expanded upon the work of Thurber and Wittrup [60, 61], was solved for three different
particle sizes and three different binding affinities.
Since the in vivo studies were designed to screen for the most promising
formulation, the investigation of a multitude of time points was impractical; however the
model predictions suggest that time course data would be valuable in evaluating the in
vivo performance of a targeted polymer. For example, the time course data could be
compared to the nine plots generated by the tumor compartmental model to estimate the
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particle size and dissociation constant in vivo. Conclusions about the physical state of the
particle (i.e. micelle versus individual chain) should be apparent from these comparisons.
Schmidt and Wittrup also compared their model predictions to data from the
literature to assess the precision of their model. They found excellent agreement between
the model and experiment for small peptides and antibody fragments and less precision
for nanoparticles. Considering this, the differences between the model predictions and the
experimental results described herein were reasonable.
5.6 Conclusion
A novel construct combining the high affinity binder, E13.4.3, with amphiphilic
alternating copolymers was investigated. Backbone polymer produced by the Protherm
reactor was successfully fractionated into low polydispersity, high molecular weight
starting material for use in subsequent synthetic steps. These high molecular weight
fractions allowed for increased substitution of targeting sidechains while still allowing for
attachment of the hydrophobic sidechains required to impart amphiphilicity to the
molecule.
Initial studies demonstrated selective uptake of E13.4.3-conjugated polymers into
a target-bearing, EGFR-positive human cancer cell line relative to untargeted controls.
Polymers synthesized from the fractionated backbone polymer achieved the greatest
increase in selective uptake observed for this system (approximately 4-6X). Animal
studies were performed to assess the biodistribution, blood circulation, and tumoral
accumulation behavior of various polymer formulations. Selective tumor accretion was
observed for two different targeted polymers, X=25, PFC and X=50, HC, including for
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two separate syntheses of the former. A number of potential correlative relationships
were considered, including the effect of particle size on blood circulation and the ability
of in vitro experiments to predict selectivity in vivo.
The E13.4.3-polymers have proven a rich platform for study. Their demonstrated
ability to selectively accumulate in targeted tumors combined with their potential use in
diagnostic and/or therapeutic clinical applications makes them an attractive option for
intensified investigation.
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Appendix A: Molecular Weight Calculation by Analytical GPC Breeze Software
and Chromatogram Manipulation
The molecular weight was calculated using the Breeze software associated with
the Waters GPC system. The PMMA calibration data (molecular weights and associated
elution volumes) were entered into the software. To calculate the molecular weight for a
given a chromatogram, a baseline was drawn and the 'Quantitate' button was pressed in
the software to generate the number- and weight-average molecular weight,
polydispersity index, and a number of other parameters according to the PMMA
calibration.
In the screenshot (FIGURE A. 1) as well as all other analyzed chromatograms, the
baseline was drawn to include elution volumes between 15 and 27 mL. Any signal at
elution volumes greater than the total volume of the column banks, 27 mL, was excluded
from the analysis because any species eluting after this point, such as linker or water,
could not be resolved from one another since they can fully enter the pores within the
resin. The noisy signal at elution volumes greater than 29 mL is due to mobile phase
impurities and small amounts of air dissolved in the sample.
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The accuracy of the Breeze molecular weight calculation algorithm was analyzed
using a number of sample chromatograms. The chromatogram in FIGURE A.2, which
relates refractive index (RI) response at various elution volumes, was chosen as a
representative data set. As was the case in FIGURE A. 1, only elution volumes between
15 and 27 mL were included in the analysis
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Figure A.2. Raw data output from the Breeze software. The polydisperse polymer sample exiting the
column at various elution volumes is measured by a refractive index detector.
The instantaneous refractive index is recorded at equally spaced elution volume
increments of 0.0166 mL. The frequency at which the data are recorded makes it
appropriate to plot the chromatogram as a continuous line, as in FIGURE A.2. As
described in the Polymerization Results, a standard kit containing samples of nearly
monodisperse poly(methyl methacrylate) (PMMA) was used to calibrate the Styragel
HR1, 3, and 4 column bank. The empirical relationship of Mori was used to convert the
molecular weight according to PMMA into backbone polymer molecular weight. Using
the calibration and empirical relationship, the x-axis can be transformed from elution
volume to backbone polymer molecular weight (FIGURE A.3).
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Figure A.3. Raw data refractive index response as a function of backbone polymer molecular weight
on (A) rectangular and (B) semilogarithmic coordinates.
According to calculations performed within the Breeze software, this
chromatogram had a number average molecular weight, M, of approximately 5.5 kDa.
Upon inspection of the figure above, it may or may not be readily apparent whether or
not this calculation is correct because the y-axis is the RI response for the species having
various molecular weights and not the number of molecules at each molecular weight.
Manipulations were performed to convert the y axis from RI response to number in order
to better visualize the molecular weight distribution.
To convert RI response into number one must first understand the behavior of
refractive index. Like other light-based phenomena, for example absorbance, which is
governed by Beer's law, refractive index is proportional to the mass concentration of a
species in solution. Therefore, a polymer having n repeat units will affect the refractive
index of a solvent exactly the same way as n monomers in solution. Measurements of
various molecules at various concentrations using the Waters RI detector have confirmed
this (data not shown). The relationship between refractive index response, RI, and the
mass concentration, C, can be written as follows:
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RI= aC (1)
where a is a constant. The measurements shown in the preceding chromatograms are
instantaneous representations of the refractive index made at regular intervals. Since the
chamber through which the detector measures the RI never changes, the volume of eluent
measured for each reading is identical. This allows the refractive index for the ith
measurement, RI;, to be directly related to the mass of material, mi, associated with that
reading:
RlI - Il )Mi (2)
where Vceen is the volume of the cell in the RI detector. The mass present in the ith slice is
related to the molecular weight of the ith slice, M. Therefore, the following relationship
holds
N.
m = ' Mi (3)
NAv
where N is the number of molecules in the ith slice and NAv is Avogadro's number.
Combining EQUATIONS 2 and 3, yields an expression relating the number of molecules,
Ni, having molecular weight, Mi, to the refractive index response:
N VNAvRI (4)
pMi
Using EQUATION 4, the y-axis from the chromatograms above (FIGURE A.3) can be
converted from RI response to number by dividing by Mi. Since the pre-term is unknown,
it was not included in the conversion and the y-axis becomes the relative number of
molecules at a given molecular weight (FIGURE A.4). Knowledge of this pre-term is not
required because it will be canceled out in subsequent steps in the derivation.
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Figure A.4. Relative number of molecules at each backbone polymer MW for the sample
chromatogram.
The number-average molecular weight can be calculated directly from the
histogram in FIGURE 4 according to:
-- NiMi
- = (5)
" Nj
If it had been carried through, the unknown pre-factor in EQUATION 4 would cancel in
EQUATION 5 and, consequently, does not need to be determined for this analysis. The
number average molecular weight, M, calculated from FIGURE A.4 and EQUATION 5
is 5.5 kDa, which is identical to that determined by the Breeze software.
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Appendix B: MATLAB Code for Kinetic and Mass transfer Modeling
The following program was used to simulate the weight-average molecular weight
as a function of time for the homogeneous kinetic model. The program was also used to
simulate the equilibrium molecular weight by setting 'tf equal to 2x10 10.
function [tmat,Mn] = polymsimwaterPn testOct2OlO()
MA = 900;
MB = 210;
MM = 32;
M_0 = (MA +
M eg = MM;
% g/mol
MB - 2*MM)/2;
ti = 0; % hour
tf = 20000; % hour
tspan = [ti tf];
CAO = 2;
CBO = 2;
%mol/
CLO = 0;
CCO = 0;
% CWO = 1.5e-3;
CWO = 0;
r= 1;
from KF drying experiments
CO = [CAO CBO CLO CWO CCO];
kf = 9.0e-3*60;
Keq = 10;
kr = kf/Keq;
kfh =
krh =
kfc =
krc =
% L/mol-hr
all othe r ate constants equa .o k for starters
kf;
kf;
kf;
kf;
create a vector of methanol partial pressures and convert to
%. concenitrati.on
PM = logspace(-4, 2, 4); % mrIg
% = [50e-3,50e-3,50e-3,5e-3
v ave = 0.8; %Lmoli
PMO = 1900; % mmHg
for f=1llength(PM)
CM(f) = PM(f)/(v ave*PMO); %#o0k.<AGROW>
end
Clength = length(CM);
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tamt = 150;
tmat = zeros(tamt,Clength);
Mn = zeros(tamt,Clength);
for Ci=1:Clength
[t,C] = odel5s(@fun, tspan, CO, [],kf,kr,CM(Ci),kfh,krh,kfc,krc);
tlength(Ci) = length(t); %#ok<AGROW>
for count=1:tlength(Ci)
tmat(count,Ci) = t(count);
end
fA = 1 - C(:,1)/CAO;
fB = 1 - C(:,2)/CBO;
% fractional conversion of mor-nomer A
% calculate the degiree of polymerization based on hasic t herv
for time=1:tlength(Ci)
% call the function that caiculates Pn
Pn(time,Ci) = Pn calc(fA(time),fB(time),r);
% convert Pn to MW
Mn(time,Ci) = Pn(time,Ci)*M_0 + MIeg;
Mw(time,Ci) = M 0*(2*Pn(time,Ci)-1);
%#ok<AGROW>
%#ok<AGROW>
% Cl ean up plot by maki.g all indices that were left as zero equalt
the
% maximumn
for Cj = 1:Clength
tmax = tf;
Mnmax = max(Mn(:,Cj));
Mwmax = max(Mw(:,Cj));
for Tj = (tlength(Cj)+1):tamt
tmat(Tj,Cj) = tmax;
Mn(Tj,Cj) = Mnmax;
Mw(Tj,Cj) = Mwmax; %#ok<AGROW>
end
end
loglog(tmat(:,1),Mw(:,1),'r',tmat(:,2),Mw(:,2), 
'b',tmat(:,3),Mw(:,3),'g
tmat(:,4),Mw(:,4), ':m');
xlabel (' time (hr) ') ; ylabel ('Mw (Da) ')
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end
end
xlswrite('poly :tmat exp', tmat);
xlswrite('poly_Mmat exp', Mn);
xlswrite('poly_Mwmat._exp', Mw);
end
% System of differential equations describing the reaction kinetics
function dC = fun(t,C,kf,kr,CM,kfh,krh,kfc,krc) %#ok<INUSL>
R = kf*C(1)*C(2) - kr*C(3)*CM;
Rh = kfh*C(2)*C(4) - krh*C(5)*CM;
Rc = kfc*C(1)*C(5) - krc*C(3)*C(4);
dC = zeros(5,1);
dC(1) = -R - Rc;
dC(2) = -R - Rh;
dC(3) = R + Rc;
dC(4) = -Rh + Rc;
dC(5) = Rh - Rc;
end
% Thi Sfntion calcuila tes the dectree of pl. ymeri zation based on
equati.orIs derived
% in both Odian and Prof Hammvond' s Polymer Synthesis course
function Pn = Pn calc(fA,fB,r)
if r>=1
f = fA;
else
f = fB;
end
Pn = (1+r)/(1 - 2*f*r + r);
end
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The following program was used to estimate the forward and reverse Damk6hler
numbers as well as the ratio of the bulk methanol concentration to that at the catalyst
surface (0m). Similar programs were used to perform the calculations for the other
proposed geometries or reactive species, substituting the relevant lines of code with the
appropriate equations as specified in the main body of this text.
function Da f = Da calc bead()
KS = 1.05e-10; m4/mol-s
CM = le-11; % moIl/./m3
Keq = 1;
del-bead = lOe-4; % m
CAO = 2e-3; % l
r = 1;
CA = linspace(O,CAO,5000);
CB = CA;
for i = 1:length(CA)
CL(i) = CAO - CA(i); %#ok<AGROW>
fA(i) = 1 - CA(i)/CAO; %#ok<AGROVW>
fB(i) = 1 - CB(i)/CAO; %#ok<AGROW>
Pn(i) = Pn calc(fA(i),fB(i),r); %#ck<AGROW>
Mn(i) = Mn calc(Pn(i)) %#o-k<AGROW>
Mw(i) = Mw calc(Pn(i)); %#ok<AGROW>
muM(i) = visc calc(Mn(i)); %#ok<AGROW>
Dm(i) = Dm calc(Mn(i)) %# kAGROW>
end
for k = 1:length(CA)
Da_f(k) = (KS*delbead) * (CA(k) *CB (k) /CM) /Dm(k); %#okAGROW>
Dar(k) = (KS*delbead)*(CL(k))/(Dm(k)*Keq); %#ok<AGROW>
C_ratio(k) = (3 + Daf(k))/(3 + Dar(k)); %#ok<AGROW>
end
figure;
semilogy(Mn,Da f)
figure;
semilogy(Mn,Da r)
figure;
semilogy(Mn,C ratio)
xlswrite('Da calc_beadle-11', [Mn',Mw',Da f',Da r',C ratio']);
xlswrite('muM', [Mn',Mw',muM'])
xlswrite('C mat',[Mn',CA',CL']);
end
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% Diffusivity calculation fuction according to Wilke-Chani
function Dm Dmncalc(MW)
VA = 0.416; % /kgmol
Mb = MW; % kgkgml
phi = 1;
T = 363; % K
mu = visc calc(MW);
Dm = 1.173e-16*sqrt(phi*Mb)*T/(mu*(VA^0.6));
end
SViscositv calculation function
function mu = visccalc(MW)
ro = 1100; % kg/m3
if MW < 1000
v cSt = 0.0166*MW + 0.7149;
elseif MW < 3350
v cSt low = 0.0166*(1000) + 0.7149;
v cSt high = 58.81 + 3.980e-11*(3350)^3.4;
Mvec = [1000,3350];
viscvec = [v cSt low, v cSt high];
fit = polyfit(Mvec,viscvec,1);
v cSt = polyval(fit,MW);
else
v cSt = 58.81 + 3.980e-ll*MW^3.4;
end
v v cSt*le-6;
mu = v*ro;
end
function Pn = Pn calc(fA,fB,r)
if r>=l
f = fA;
else
f = fB;
end
Pn = (1+r)/(1 - 2*f*r + r);
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end
function Mn = Mn calc(Pn)
MA = 900; % g/mrrol..
MB = 210;
MM = 32;
M_0 = (MA + MB - 2*MM)/2;
M-eg = MM;
Mn = Pn*M_0 + Meg;
end
function Mw = Mw calc(Pn)
MA = 900; % g/rr
MB = 210;
MM = 32;
M_0 = (MA + MB - 2*MM)/2;
Mw = M 0*(2*Pn-1);
end
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Appendix C: Sample calculation of model parameters and model results
Calculation of the Intrinsic Rate Constant
The effective forward rate constant was estimated experimentally. Based on the
geometry of the system in which the forward rate constant was estimated, the effective
forward rate constant is related to the intrinsic forward rate constant according to
(reproduced from EQUATION 29):
_ kV
Kf Yenz - f melt
AcatNcat
The value for kf was determined from the forward rate constant determination
experiment, while the other parameters on the left hand side were known according to
system- and geometry-specific parameters. The enzyme surface concentration was
unknown. Fortunately, the product on the left hand side appeared as such in the effective
rate constant equations for the other situations considered: single bead, stagnant melt, and
Protherm (EQUATIONS 27, 28, and 39).
The terms on the right hand side used in the calculation are summarized below. SI
units were used throughout the calculations for consistency.
Term Value SI Units
k, 1.5x1C- m3/mol-s
Vmit 8.33x10-6  M3
Nbi.d 3.8x103  dimensionless
Awed 3.14x104 M2
These values were used to determine the product, Kfaenz, which was 1.05x10_' 0 m4/mol-s
according to EQUATION 29 (reproduced above).
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Calculation of the Damkdhler Numbers
The Damk6hler numbers were calculated over a range of polymer molecular
weights. These molecular weights were used to estimate polymer melt viscosity, which,
in turn, was used to estimate the diffusivities. A single polymer molecular weight, 10
kDa, was chosen to demonstrate the calculation of the forward and reverse Damk6hler
numbers for the case of a single bead. The relevant parameters for each geometric case
were summarized in TABLE 3.5. These values, together with the steps described above,
can be used to verify any of the calculations for the single bead, stagnant film, and
Protherm cases across the range of simulated weight-average molecular weights.
The methanol and PEG self-diffusivities in a polymer melt of 10 kDa are 2x10-1
and 4x1 0-14 m2/s, respectively. These values were determined according to the results
presented in FIGURE 3.28. The concentrations of the hydroxyl, linker ester, and ester
linkage groups also vary as a function of molecular weight. An increase in molecular
weight corresponds to a decrease in the concentration of the reactants A and B and a
corresponding equimolar increase for the concentration of L. (Note: the bulk methanol
concentration was assumed to be constant for all molecular weights.) The values for CA,
CB, and CL at a polymer weight-average molecular weight of 10 kDa were calculated
according to EQUATIONS 18 and 21 and summarized below:
Term Value SI Units
CA 1.98x 0-4
Ce 1.98x1 0-4 m3/mol
C1  1.80x10-3
The forward and reverse Damk6hler numbers for the single bead case were
presented in EQUATION 33:
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Dabead = fbead R _CACBfM DM Cm(R),k, eadRr CJ
Da ead -kf bead (CL
DMK eq
where,
k bead = faenz
The remaining terms required for the calculation were the bead radius, bulk
methanol concentration, and the equilibrium constant. According to the manufacturer, the
bead radius for the Novozym435 beads has a range of 1.55 to 5.0 mm. The bead radius
was assumed to be 5x10 4 m (5 mm) for the Damk6hler number calculations. The bulk
methanol concentration, 1x10~7 mol/m3 , was determined assuming a Raoult's Law
description of the vapor-liquid equilibrium. The equilibrium constant, Keq, was assumed
to be one.
The forward and reverse Damkbhler numbers for the single bead case were
calculated using the following combination of terms:
fM 2.0X10~" 1.00X10~7(1.0510- )(5010-4I) 1.3x0
Dar = ' (1.'xloo)(5.Ox (1.80x10-3 )= 4.73x10-6
r,M (2.Ox1O")(1)
These results can be compared to the corresponding points on the plots in
FIGURES 3.29 A and B.
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Appendix D: Viscosity Measurements of PEG and Catalyst
Note: This appendix was adapted from a report prepared by Nathalie Pinkerton (NP). All
experiments and data analysis were performed by NP during participation in the MIT
Undergraduate Research Opportunity Program (UROP) under the guidance of the author
and Clark K. Colton.
Overview
The viscosity of the polymer melt can significantly affect the backbone
polymerization. Specifically, the diffusivities of the species within the melt, including the
methanol byproduct and monomer or oligomer reactive endgroups, are inversely related
to polymer viscosity. Viscosity increases as the reaction proceeds and higher MW
backbone polymer is achieved. Viscosity can also be affected by the addition of solids
into the melt, such as the support upon which the catalyst is immobilized, or by addition
of solvent, such as the PEG250 dimethyl ether. As a result, a study was performed to
develop a quantitative understanding of the viscosity of the backbone polymer melt as a
function of MW, catalyst loading, and solvent wt% (w/w).
Materials and Methods
The effect of the aforementioned on viscosity was investigated by adding solvent
to samples of PEG4600, PEG8000 and PEG12000 with and without catalyst beads. These
relatively low polydispersity (PDI < 1.15) PEGs were assumed to be representative of
backbone polymer of comparable MWs. An AR-G2 plate-plate rheometer (TA
Instruments, New Castle, DE) was used to perform the viscometry measurements.
Measurements were performed at 90'C across a range of shear rates. Samples were dried
before viscosity measurement to remove water.
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Results
Addition of Solvent
Solvent was added to PEG12000 in wt% (w/w) between 5 and 25% without
catalyst beads present (FIGURE 1). Solvent addition significantly reduced the viscosity
across all measured shear rates. In particular, the average viscosity was reduced from
4.26 Pa-s to 1.33 Pa-s with the addition of 25 wt% PEG250 dimethyl ether. Interestingly,
the independence of viscosity with respect to shear rate implied that the polymer
exhibited Newtonian behavior over the range of shear rates investigated.
Viscosity vs. Shear Rate of PEG12000 and Wt%
Plasticizer
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Figure 1: PEG12000 viscosity measurements with different wt% of solvent added as measured across
a range of shear
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Addition of Catalyst Support
Polymer melts with catalyst beads (10 wt%, w/w) suspended were also measured
in order to assess the effect of such a solids addition. Solvent was also added at 5 and 25
wt% (w/w). The shear rate range was decreased for these measurements because of
technical issues - the catalyst bead polymer suspension was ejected from between the
plates at shear rates greater than 100 s-1. The gap size was increased from 1000gm to
2000gm to accommodate the beads.
The results for PEG4600, 8000 and 12,000 exhibited similar trends (FIGURES 2-
4). As anticipated, the presence of the catalyst support greatly increased the melt
viscosity, with a corresponding decrease in viscosity upon addition of solvent. In fact,
addition of solvent at 25 wt% (w/w) was able to restore the viscosity to a level below that
of the original, pure PEG sample. The addition of 5 wt% (w/w) solvent actually increased
the viscosity for both PEG4600 and 12,000. This result may have been an artifact of the
increase in the gap between the rheometer plates.
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Effects of Catalyst and Plasticizer on PEG4600 Viscosity
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Figure 2: Viscosity measurements of PEG4600 at various solvent wt%, both with and without the
catalyst beads added (10 wt%, w/w).
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Figure 3: Viscosity measurements of PEG8000 at various solvent wt%, both with and without the
catalyst beads added (10 wt%, w/w).
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Figure 4: Viscosity measurements of PEG12000 at various solvent wt%, both with and without the
catalyst beads added (10 wt%, w/w).
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Appendix E: Effect of lodination on Molecular Weight: Recovery Calculation and
Chromatogram Adjustments
In order to compare the chromatograms, the sample analyzed by the GPC system
had to be representative of that which was recovered at the end of the purification step.
However, in order to perform the GPC analysis, water had to be removed from the
sample before resuspension in the organic mobile phase solvent, THF. There were two
procedural difficulties that may have affected the quality of the sample during this
transition from water to THF. First, some polymer degradation had been observed due to
the freeze-drying process itself (FIGURE 4.10). Secondly, it was difficult to dissolve the
freeze dried product in THF due to the presence of crystallized salts from the phosphate
buffer solution. To maximize recovery, the vial containing the freeze dried product was
washed and resuspended in a known volume THF.
The overall recovery of polymer for the entire experiment, which included the
iodination with cold, 1271 freeze-drying, and resuspension in THF, was calculated
according to the peak area of the resulting GPC chromatogram. This calculation was
performed using a calibration curve constructed by analyzing samples of backbone
polymer dissolved in THF at a broad range of concentrations.
The calculation was performed according to the following steps: (1) the initial
mass of polymer at the beginning of the experiment was 1 mg (100 pL of 10 mg/mL
solution). This was the denominator for the fractional recovery calculation. (2) The
concentration of backbone polymer in the unknown sample was determined according to
the peak area calibration curve. (3) The total mass in the resuspended sample was
determined by multiplying the concentration by the total volume of THF used to wash
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and resuspend the freeze-dried sample. (4) The fractional recovery was determined by
dividing the final mass by the initial mass.
To construct the peak area calibration curve described above, chromatograms
were generated for a wide range of backbone polymer concentrations. The result with the
peak area most closely resembling each of the two cold iodination sample chromatograms
was selected from this library of chromatograms. Using this strategy, the library
chromatogram for the first cold iodination was that for backbone polymer dissolved in
THF at 0.25 mg/mL, while the concentration of the library sample for comparison to the
second cold iodination was 0.0625 mg/mL. Each pair of chromatograms, which included
that for each cold iodination sample and its corresponding library chromatogram for
comparison, were normalized by their total peak area. The resulting y-axis for the
normalized chromatograms was the normalized absorbance response.
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Appendix F: Unicorn Method Code for Polymer Fractionation
The following method was used to perform the polymer fractionation described in
Chapter 5. The code includes a loop command with the loop number set to 8.
Method: C:\UNICORN\Local\Fil\default\Method\Kevin Prep Run 5xw.mOl
Main method:
n (Main)
0.00 Base Volume 318.557 {ml}
(HiLoad 26/60 Superdex 75 prep grade)#Column
* 0.00 Block StartwithPumpWashPurifier
(Start with PumpWash_Purifier)
0.00 Base SameAsMain
0.00 PumpWashBasic On On
0.00 EndBlock
* 0.00 Block FlowRate
(Flow Rate)
0.00 Base SameAsMain
0.00 Flow (0.800)#FlowRate {ml/min}
0.00 End-block
* 0.00 Block ColumnPressureLimit
(ColumnPressureLimit)
0.00 Base SameAsMain
0.00 AlarmPressure Enabled (1.00)#ColumnPressureLimit {MPa} 0.02 {MPa}
0.00 EndBlock
n 0.00 Block StartInstructions
(StartInstructions)
0.00 Base SameAsMain
0.00 AveragingTimeUV (10.00)#AveragingTimeUV
0.00 End-block
a 0.00 Block EluentAInlet
(EluentAInlet)
0.00 Base SameAsMain
0.00 BufferValveAl Al1
0.00 End-block
a 0.00 Block EluentBInlet
(EluentBInlet)
0.00 Base SameAsMain
0.00 End-block
U 0.00 Block StartConcB
(StartConcB)
0.00 Base SameAsMain
0.00 Gradient (0)#StartConcB {%B} 0.00 {base}
0.00 End-block
n 0.00 Block ColumnValve
(Column Valve)
0.00 Base SameAsMain
0.00 ColumnPosition (Position7)#ColumnPosition
0.00 EndBlock
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* 0.00 Block ColumnEquilibration
(ColumnEquilibration)
0.00 Base SameAsMain
(325.00)#Equilibratewith EndBlock
* 0.00 Block AutoZeroUV
(AutoZeroUV)
0.00 Base SameAsMain
0.00 WatchOff UV
0.00 AutoZeroUV
0.00 End Block
0.00 Loop 8
* 0.00 Block Sample_Run
(Sample _Run)
0.00 Base SameAsMain
0.00 Gradient 100 {%B} 0.5 {base}
4.00 Gradient 0 {%B} 0.5 {base}
95.00
214.00
245.00 ColumnPosition Position 1 Bypas
245.10 ;
246.00 Flow 10 {ml/min}
286.00 Flow 0.800 {ml/min}
288.00 AlarmPressure Enabled 1.00 {M
288.40 ColumnPosition Position7
289.00 EndBlock
0.00 Loop_ End
a 0.00 Block IsocraticElution
(IsocraticElution)
0.00 Base SameAsMain
n 0.00 Block LengthofElution
(LengthofElution)
0.00 Base SameAsMain
(320.00)#Length-ofElution EndBlock
0.00 EndBlock
Pa} 0.02 {MPa}
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Appendix G: Additional Representations of the Cellular Uptake Results
The uptake results in FIGURE 5.11 were also calculated according to the number
of polymer chains per cell. To manipulate the data, the mass per cell results were divided
by the molecular weights presented in TABLE 5.5 and multiplied by Avogadro's number.
Hydrocarbon Sidechains Perfluorocarbon Sidechains
10
0-X 10+ HC -- X= 10+, PFC
-- X 25+. HC --X= 25+, PFC
--6-X 25.HC 
-X = 25-. PFC
. 8 -I-X=50+.HC
-O-X =50+. no other SC
4
0
0,
0 1 2 3 4 5 0 1 2 3 4 5
Time (hr) Time (hr)
Based on these manipulations, the greatest uptake observed was for the X=25+,
PFC polymer, which still exhibited selective uptake relative to its untargeted, X=25-,
PFC counterpart, albeit to a lesser extent than that observed for the polymer mass per cell
method of data presentation.
The uptake results for the second synthesis batch were also subjected to the same
manipulations to yield the number of polymer chains per cell.
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0ID -0-Y,25, PFC OH
--O- X "'1- F C --D X'5 HGC
2
0 0/
-*- ='50PFC 7 PF
=2
0-
Time (br) Thne (br)
For the second batch, no selectivity was observed based on the chains per cell
representation. In fact, the uptake for the untargeted polymers was higher than that for the
targeted polymers for three of the polymer pairs.
The data were also manipulated to determine the fraction of the initial activity
added to each well that was internalized or bound to the cell at given time point. These
results were also normalized by the number of cells in each well. The polymer mass and
bound radioactivity (as 12I) are related by:
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where a is the activity, Aspec is the specific activity of a radiolabeled polymer (units of
activity per mass), and m is the mass. The specific activity can be used to convert mass to
total activity. It can also be used to convert the initial mass added to the initial activity
added. When calculating the fraction of activity per cell at a given time point, the specific
activity of the polymer in question cancels. Therefore, the uptake results for the fraction
of initial activity per cell will be qualitatively identical to those for the polymer mass per
cell representation. This is a consequence of the choice to maintain the initial mass of
polymer in each experiment constant.
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Appendix H: Positron Emission Tomography (PET) of 12 4I-labeled polymers
A collaboration was established with Dr. Mikhail Papisov, Professor of
Radiology, Harvard-MGH. The polymer labeling and PET imaging weree graciously
completed by or under the supervision of Dr. Papisov. Image reconstructions and much
of the data interpretation described in this Appendix were also performed by Dr. Papisov.
The backbone polymer and polymer 027 (see FIGURE 4.2A and B) were labeled
with iodine- 124 according to the standard protocol and purified using the radio-HPLC
techniques described in Chapter 4. The labeled polymers were injected into non-tumor-
bearing rats as a proof-of-principle for the use of the amphiphilic alternating copolymers
as a diagnostic tool. The PET imaging of these polymers provided real-time, non-invasive
pharmacokinetic data. Images after 20 min for both the backbone polymer and polymer
027 were similar; the image for polymer 027 is presented below as a representative result.
Liver (median lobe)
Kidneys
Spleer, banmna-shaped
Addition from the
left lobe of the liver
Bladder (urine)
The greatest signal was observed in the bladder, which indicated that the majority
of the activity exiting the animal was due to excretion in the urine. This result was
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consistent with observations during the biodistribution experiments in which the greatest
activity within each experimental cage was measured in the urine accumulated by the
bedding. The other organs observed in the image, the liver, kidneys, and spleen, are all
heavily vascularized. The signal measured in these organs indicated that the labeled
polymer was present in the bloodstream at 20 min.
The best candidates from the uptake and biodistribution studies described in
Chapter 5 were also studied in the laboratory of Dr. Papisov. The goal of these
experiments was to replicate the selective uptake observed during the biodistribution
studies in a live animal. EGFR-positive tumors were grown subcutaneously on nu/lnu
mice, while three different polymer formulations were chosen for labeling with iodine-
124 and subsequent injection into the animals. The polymer formulations were: X=25+,
PFC, X=25-, PFC, and X=50+, HC.
The radio-HPLC result for the X=25-, PFC polymer is presented below.
Absorbance measurements for four different proteins and one small molecule were also
measured and plotted with the results for the X=25-, PFC polymer. The radio-HPLC
results, which include both the UV and gamma-detector response, are presented below.
701 1 S I I R I I
-- radioactivity
60 
-sample abs
50 standard abs50 'lndr Sample MWV (Ica)
40 thyroglobulin 670
0
30 g-globuln 158
0ovalbumin 44
10
a myoglobin 1
Vitamin B-12 13
0 200 400 600 300 1000 1200
Elutioni Time (s, radio-HPLC)
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The UV absorbance profile was broad, ranging from approximately 300 to 800
seconds in elution time. According to the protein and small molecule 'standards,' these
elution times corresponded to a breadth of molecular weights, from 670 kDa to 1.35 kDa.
This suggested that the X=25-, PFC polymers existed in both micelle and individual
polymer states under the analytical conditions. The radioactivity measurements
corresponded strongly with the absorbance measurements, which indicated that the
polymer was labeled uniformly throughout the polymer chains in the sample.
The radio-HPLC results for all three polymers after the labeling experiments are
presented below.
X =25+ PFC X= 25- PFC
-rad
0 200 400 600 800 1000 1200 0 200 400 60C
elution time (s) elution ti
X =50+) HC
40 -
30
-eUV
10
IMF
-10 
-
0 200 400 600 800 1000 1200
elution time (s)
800 1000 1200
me (s)
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The absorbance profiles for both of the E13.4.3-conjugated polymers were
drastically different from that for the X=25-, PFC polymer. In both of these profiles, there
was a small peak near approximately 300 s, which likely corresponded to a particle. The
remaining absorbance was recorded at much longer elution times (lower molecular
weights). This result could indicate the formation of smaller particles or associations of a
small number of chains with one another, such as dimers or trimers, during the analytical
testing procedure.
The activity profiles for both E13.4.3-conjugated polymers did not have a strong
correlation to the absorbance profiles. In fact, there was little activity signal at all in the
purified label polymer samples. The labeling yields for the E13.4.3-conjugated polymers
were extremely low (<1%). This result was unexpected because labeling yields of the
same polymers performed at MIT, albeit with iodine-125, were approximately 5-10%.
The result was also particularly interesting considering the fact that, although the
absorbance detector indicated the presence of significant material in the sample, material
which is known to have potentially iodination sites both within the linkers of the polymer
backbone and the tyrosines in the E13.4.3 peptide, minimal labeling was achieved. This
suggested that the iodination sites may had somehow become inaccessible to the
iodination procedure or that the iodination sites were inactivated.
The increased molecular weight of the polymer backbone (12 kDa) and the
associated decrease in solubility of the individual polymer chains was one proposed
explanation for the observed phenomenon. Additionally, due to significant restrictions in
the scheduling of PET machine time, the samples for all three polymers were refrigerated
for approximately 8 weeks. This refrigeration period occurred after the polymers were
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studied at MIT in uptake and biodistribution experiments. The stability of the polymers
and, in particular, the conjugation of the E13.4.3 peptide to the polymer backbone, was
unknown and not studied.
Unfortunately, due to the low labeling yield, no PET imaging was performed for
the E13.4.3-conjugated polymers because sufficient signal would not have been achieved.
Improvements in labeling yield are absolutely necessary for any viable PET studies due
to the high cost of iodine-124. It is recommended that future experiments minimize the
time polymers exist in solution before labeling and imaging and that additional labeling
yield and stability studies are performed on polymers synthesized from high molecular
weight, low polydispersity backbone polymer.
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